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Protein Dynamics and Entropy: Implications for Protein-Ligand Binding
Abstract
The nature of macromolecular interactions has been an area of deep interest for understanding many facets of
biology. While a great deal of insight has been gained from structural knowledge, the contribution of protein
dynamics to macromolecular interactions is not fully appreciated. This plays out from a thermodynamic
perspective as the conformational entropy. The role of conformational entropy in macromolecular interactions
has been difficult to address experimentally. Recently, an empirical calibration has been developed to quantify
the conformational entropy of proteins using solution NMR relaxation methods. This method has been
demonstrated in two distinct protein systems. The goal of this work is to expand this calibration to assess
whether conformational entropy can be effectively quantified from NMR-derived protein dynamics. First, we
demonstrate that NMR dynamics do not correlate well between the solid and solution states, suggesting that
the relationship between the conformational entropy of proteins is limited to solution state-derived NMR
dynamics. We hypothesize that this may be partially due to the role of hydration of the protein in its dynamics.
Next, we expand our empirical calibration to over 30 distinct protein systems and demonstrated that the
relationship between NMR dynamics and conformational entropy is both robust and general. Furthermore,
we demonstrate that conformational entropy plays a significant role in macromolecular interactions. Using our
empirical calibration, we then look to address if conformational entropy could be an important contribution
to drug design. The latter process is often a brute force approach, and subsequent optimization of initial drug
candidates is often a guess and check process. In silico drug design was thought to offer a more efficient and
rational approach, but often relies on static structures. This minimizes or completely neglects the role that
conformational entropy may play in binding. Here we experimentally determine the role of conformational
entropy in the drug target p38a MAPK in binding to two potent inhibitors. We demonstrate evidence that
conformational entropy may represent a tunable parameter in affinity optimization of lead compounds. This
has important implications for lead optimization and strongly suggests that the role of conformational entropy
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 The nature of macromolecular interactions has been an area of deep interest for 
understanding many facets of biology. While a great deal of insight has been gained from 
structural knowledge, the contribution of protein dynamics to macromolecular interactions is not 
fully appreciated. This plays out from a thermodynamic perspective as the conformational 
entropy. The role of conformational entropy in macromolecular interactions has been difficult to 
address experimentally. Recently, an empirical calibration has been developed to quantify the 
conformational entropy of proteins using solution NMR relaxation methods. This method has 
been demonstrated in two distinct protein systems. The goal of this work is to expand this 
calibration to assess whether conformational entropy can be effectively quantified from NMR-
derived protein dynamics. First, we demonstrate that NMR dynamics do not correlate well 
between the solid and solution states, suggesting that the relationship between the 
conformational entropy of proteins is limited to solution state-derived NMR dynamics. We 
hypothesize that this may be partially due to the role of hydration of the protein in its dynamics. 
Next, we expand our empirical calibration to over 30 distinct protein systems and demonstrate 
that the relationship between NMR dynamics and conformational entropy is both robust and 
general. Furthermore, we demonstrate that conformational entropy plays a significant role in 
macromolecular interactions. Using our empirical calibration, we then look to address if 
conformational entropy could be an important contribution to drug design. The latter process is 
often a brute force approach, and subsequent optimization of initial drug candidates is often a 
guess and check process. In silico drug design was thought to offer a more efficient and rational 
approach, but often relies on static structures. This minimizes or completely neglects the role that 
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conformational entropy may play in binding. Here we experimentally determine the role of 
conformational entropy in the drug target p38a MAPK in binding to two potent inhibitors. We 
demonstrate evidence that conformational entropy may represent a tunable parameter in affinity 
optimization of lead compounds. This has important implications for lead optimization and 
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CHAPTER 1: Introduction	  	  
Proteins and their interactions 
 Proteins power even the most basic functions of our cells. A seemingly simple polymer 
comprised of twenty amino acids has vast importance in the promotion of life. The prevalence of 
biophysical techniques such as X-ray crystallography and, more recently, protein NMR 
spectroscopy have allowed an unprecedented look into the intricacies of these molecules on an 
atomic level. This has revolutionized the field as we strive to deeply understand the world around 
us and, to a great extent, within us. Yet still we strive for a deeper understanding of these 
molecules known as proteins. Proteins demonstrate much of their functional prowess in the cell 
as part of a network where associations with other molecules (ions, small molecules, nucleic 
acids, and other proteins) power the cell through a multitude of functions. The models by which 
proteins interact with other molecules have evolved significantly, from the early ‘lock-and-key’ 
model to the ‘induced-fit’ and later the ‘conformational selection’ model [1-3]. While these models 
help us visualize the nature of protein-ligand interactions, the association of protein and their 
ligands is ultimately dictated by the Gibbs-Helmholtz equation: 
G H T SΔ = Δ − Δ  Equation 1-1 
This equation is fundamental to protein-ligand association. The free energy, ΔG, which dictates 
the affinity, is expressed in terms of the change in enthalpy (ΔH) and entropy (-TΔS) resulting 
from a binding event. The understanding of these relative contributions has been the subject of 
extensive study in the field of biology. Of these two thermodynamic quantities, far more is 
understood about the enthalpic contributions of binding, which has been greatly enhanced by 
three dimensional structures of proteins in complex with their ligands [4]. The components of the 
enthalpy include van der Waals interactions as well as hydrogen bonding and other electrostatic 
interactions [5]. The entropy has remained far more nebulous to understand in the context of 
biology, often because it is difficult to measure experimentally. Despite this, entropy plays a 
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fundamental role in the thermodynamics of the world around us and has recently been invoked to 
explain a new theory on the origin of life [6]. This highlights the fact that a detailed knowledge of 
entropy is essential for completing the thermodynamic understanding of macromolecular 
association. Calorimetric methods such as ITC are able to indirectly determine entropy [7], but 
cannot provide detailed information about its individual components. The major components of 
entropy in macromolecular interactions are outlined below: 
   solvent conf RTT S T S S S⎡ ⎤− Δ = − Δ +Δ +Δ⎣ ⎦        Equation 1-2 
In Equation 1-2, ΔSsolvent ,ΔSconf, and ΔSRT represent the solvent entropy, conformational entropy, 
and rotational-translation (RT) entropy, respectively. In the context of protein-ligand binding, 
solvent entropy in the form of the hydrophobic effect was historically thought to dwarf other 
contributions [8]. Changes in conformational and RT entropy were considered to be negligible. 
This view has evolved, as several theoretical and experimental measurements have argued that 
solvent entropy only represents part of the entropic equation and that contributions from 
conformational entropy and RT entropy cannot be simply ignored [9-14]. 
Of particular interest in this dissertation is the contribution of conformational entropy to protein-
ligand association. This quantity has hitherto resisted experimental measurement. The 
conformational entropy of proteins is intrinsically linked to their dynamics. NMR relaxation 
techniques can provide site-specific dynamic information and is uniquely positioned to probe this 
thermodynamic quantity. 
Solution NMR relaxation as a tool to study protein dynamics 
 It is well known that proteins, as polymers in solution, are not static. In fact, they are quite 
dynamic on a multitude of timescales [15]. The dynamic timescales at which NMR provides 
dynamic information are vast, ranging from picoseconds to hours or even days. (Figure 1-1). This 
allows for the collection of detailed dynamic information that has been invaluable for 




Here we are interested in motions occurring on the ps-ns timescale, which can be probed by 
solution NMR spin relaxation techniques. The relaxation of nuclear spins inherently contains 
information about the dynamics of both the overall protein molecule and the individual bond 
vectors within the protein. Spin relaxation occurs through a variety of mechanisms depending on 
the nucleus being probed. The primary relaxation mechanisms considered here are dipole-dipole 
interactions, chemical shift anisotropy, and (in the case of 2H nuclei) quadrupolar relaxation.  The 
measured relaxation rates have well defined dependencies on the underlying spectral density 
function, J , which corresponds to the probability of motions occurring at a given Larmor 
frequency, ω. Appendix A outlines the spectral density equations for the relaxation mechanisms 
outlined in this dissertation. It was shown over three decades ago by Lipari and Szabo [21] that 
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In Equation 1-3, τm refers to the overall rotational correlation time of the molecule, O2 is the 
squared generalized order parameter (described below), and τe refers to the rate of motion 
described by the order parameter. The Lipari-Szabo order parameter, O2, represents the degree 
of flexibility of a given bond vector in the context of the molecular frame.  O2 can range in value 
from 0, indicating completely isotropic disorder with respect to the molecular frame, to 1, 
indicating no internal motion of the bond vector. Of particular interest here is the squared 
generalized order parameter O2, as it represents the degree of motion of an individual bond 
vector in the context of the molecular frame. More formally, the order parameter is the 
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secondorder Legendre polynomial of cosine θ, where θ is the tip angle. A more intuitive way of 
considering the order parameter is that it is the limiting value of the autocorrelation function of a 
given bond vector's position at infinite time  
(Figure 1-2). The area under the curve (τe) 
represents the timescale of fluctuations of the bond 
vector. By measuring multiple nuclear spin 
relaxation rates at different magnetic fields (ω) and 
fitting Equation 1-3, one is able to obtain 
information about the overall motions of the protein 
(τm) as well as information about the overall 
motions of the molecules (τe, O2). We now 
consider how solution NMR relaxation studies of 
proteins can be used to characterize these 
motions. 
Backbone and methyl side chain order parameters 
 Experimentally, the order parameters of the backbone and methyl side chains are 
probed. Recently, methods have been 
developed to measure the order parameters of 
aromatic side chains [22], though these will not 
be discussed here. The order parameters of the 
amide backbone are obtained from the 15N T1 
and T2 rates as well as the H-N steady-state 
NOE. It is well established that the motions of 
the protein backbone are highly restricted by 
any sort of secondary structural element. 
Typically the only dynamic regions of the 
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backbone are in the termini of the protein and in unstructured regions such as loops (Figure 1-3). 
While some insight can be obtained through changes in backbone dynamics, recent simulations 
have suggested the changes in backbone order parameter (O2NH) upon ligand binding are often 
very small and contribute little to the change in entropy, which is of interest here [23].  
Motions of the methyl side chains are typically obtained through either 2H or 13C relaxation 
techniques. The relaxation of amides relies on a relatively simple AX spin system (where A=15N 
and X=1HN). Methyl groups, however, are natively an AX3 spin system. This significantly 
complicates the relaxation mechanism. For experimental simplicity, the spin systems of methyl 
groups are reduced to an AXY2 spin system. In the case of 2H relaxation, the CH2D isotopomer is 
selectively enriched (A=13C,X=2H, Y=1H).  In this case, the underlying relaxation mechanism is 
dominated by the quadrupolar relaxation, with very minor (~2.5%) contributions from dipole-dipole 
relaxation from the 1H atoms in the methyl group [24]. Because of the simplicity of analysis and 
relative affordability of reagents, 2H relaxation is often the ideal method for measuring side chain 
dynamics of proteins. These experiments, however, are quite sensitive to the macromolecular 
tumbling of the molecule. For molecules with a molecular tumbling time longer than ~20ns, 
INEPT-based coherence transfers in these experiments compete strongly with the rapid T2 
relaxation that is characteristic of slowly tumbling molecules. This leads to a severe degradation 
of the signal. For this reason, 13C relaxation methods can be employed for large proteins [25]. 
These experiments rely on the relaxation properties of the CHD2 isotopomer (AX2Y; 
A=13C,X=2H,Y=1H). In this case, the relaxation mechanism of the 13C-H spin pair is dominated by 
dipolar and CSA interactions. The bonded 2H nuclei do not significantly affect the dipolar 
reactions of the 13C spin. A detailed review of these and other methods for measuring side chain 
dynamics can be found elsewhere [16].  
The order parameters of methyl groups are often considered with respect to the methyl symmetry 
axis (O2axis) [16].  It has been shown that, in contrast to the backbone, the methyl side chains 
display a manifold of order parameters (Figure 1-4). One might intuit that methyl order 
parameters show a correlation to metrics such as crystallographic B-factor or burial depth. 
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Igumenova et al. have examined several factors such as this and no correlation has been 
observed [16]. Thus the motions of protein methyl side chains have been shown to be quite non-
intuitive. 
The distribution of methyl order parameters across a protein has been shown to be tri-Gaussian 
[26]. This observation was recently corroborated by using a Bayesian approach to show that 
methyl order parameters segment into three 
distinct dynamic “bands” [27].  The so-called J-
class is distinguished by extensive rotamer 
interconversion on the ps-ns timescale that 
results in O2axis values centered on ~0.35, while 
the ω-class corresponds to highly restricted 
motion within a single and likely narrower 
rotameric well potential that gives rise to O2axis 
values centered on ~0.8 [16, 27]. An 
intermediate class, with O2axis values centered 
on ~0.5, involves larger amplitude motion within 
a rotamer well that is accompanied by limited rotameric barrier crossing [27]. The relative 
population of each class varies significantly across proteins, even for the same protein involved in 
various complexes [10, 16, 27] (Figure 1-5). This dynamic banding can be rationalized in terms of 
packing interactions, which naturally lead to a segregation of order parameters. 
Measurement of conformational entropy from protein dynamics 
 As the order parameter reports on localized bond fluctuations, there is an intuitive 
connection between the order and the conformational entropy of a protein. Different approaches 
have been taken to establish a relationship between the order parameter and conformational 
entropy. Various motional models including a harmonic oscillator and an infinite square well 
potential have been invoked, leading to initial quantifications of the conformational entropy [28-
29]. These theoretical measurements laid the groundwork for quantification of protein entropy 
7	  
	  
using NMR dynamics as a proxy for conformational entropy. This relationship was first explored 
by Frederick et al., who used the harmonic oscillator model to determine  
	  
changes in conformational entropy for the binding of Calmodulin (CaM) to CaM-binding peptides 
[10]. It was demonstrated that there was a linear relationship between the change in total binding 
entropy measured from calorimetry and the change in conformational entropy deduced from NMR 
relaxation measurements (Figure 1-5). This was an unprecedented and unanticipated result, 
strongly suggesting that conformational entropy was a significant contributor to the total binding 
entropy and could no longer be ignored in macromolecular interactions. It should be noted that 
the use of a specific potential function has several criticisms. Among them are the effects of 
correlated motions and the completeness of the oscillator count [30]. This warranted an empirical 
calibration. Using the CaM data set and estimating the solvent entropy based on the burial of 
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surface area [31], a linear relationship was assumed between ΔO2axis and ΔSconf in the following 
form: 
( ) ( )⎡ ⎤Δ −Δ = Δ + Δ +Δ +Δ⎢ ⎥⎣ ⎦2 2
protein ligandprotein ligand




It was anticipated from Equation 1-4 that if no such linear relationship exists, it would be readily 
apparent in this analysis. However, the results showed a very clear linear relationship between 
the measured ΔO2axis and ΔSconf (Figure 1-6).  
 
A similar linear relationship was demonstrated with the catabolite activator protein binding to 
double-stranded DNA [13]. It should be noted that in this study, the contribution from ΔSsolvent was 
found to be identical between the 11 CAP-DNA complexes. This implies that the differences in 
total binding entropy can be reflected almost exclusively in the changes in conformational entropy 
measured by NMR. Taken together, these studies combine to suggest not only that 
conformational entropy plays an important role in macromolecular interactions, but also that it can 
be effectively quantified by NMR relaxation methods.  
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Measurement of methyl dynamics by solid state NMR spectroscopy 
 While the focus of this dissertation will be protein dynamics derived from solution state 
NMR, analogous studies of protein dynamics have been performed using solid state NMR [32]. In 
one such study, deuterium spin echo NMR was used to probe the dynamics of the 36-residue 
subdomain of the villin headpiece [33]. Applying a specific model for the motion, conformational 
entropies were determined for individual methyl groups. This suggests an additional technique for 
probing conformational entropy, but does warrant some degree of caution. It is clear that solid 
state NMR generally offers one advantage over solution state NMR in that protein dynamics can 
be observed over a wider temperature range. This allows the energy functions underlying 
biophysical phenomena such as entropy and heat capacity to be more robustly defined. One 
must consider, however, that physiological relevance must always be held paramount when 
exploring the intricacies of protein thermodynamics. Typically, solid state NMR studies are 
performed on hydrated protein powders, which may not be fully analogous to the fully hydrated 
state. Recently, studies on the SH3 domain of α-spectrin compared protein dynamics in the 
solution and solid states. Their results suggested that the internal ps-ns motions of this protein 
are essentially identical [34-35]. However, we believe that additional studies are needed on how 
observations observed in the solid state translate to the solution state. Of particular interest here 
is the relationship between solution state and solid state dynamics in the context of measuring 
protein conformational entropy. This will be addressed in Chapter 2 of this dissertation.     
Drug discovery and the potential role of conformational entropy  
 The ultimate goal of drug design is to identify compounds that bind with high affinity and 
specificity to a protein target of interest. This is a multi-step process. Typically, the structure of the 
target protein is determined experimentally, though homology modeling can be used for proteins 
that resist structural characterization [36]. To identify initial "hits" for binding, libraries of small 
molecules, often numbering in the millions, are tested against a protein target of interest [37]. 
These molecules typically bind with low to mid µM affinity. Their affinities are further optimized to 
produce a “lead compound” which will often bind with low nM affinity [38]. The process of lead 
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optimization is essential to early stage drug development. It is essential to identify a molecule that 
is both potent and selective for the protein target of interest. Several approaches are available to 
the drug designer in this regard. 
The simplest and most economical approaches are computational methods to aid in lead 
generation and optimization. This involves the computational design and screening of compounds 
based on the known structure of the protein target [39]. In such approaches, molecules are 
typically "docked" to a protein structure of interest in silico and the affinity is calculated to identify 
potential leads [40]. One must make a trade-off between computational rigor and the size of the 
screen. Many computational methods that are used to rapidly screen a number of drug 
candidates employ static structures in their calculations. This completely neglects the role of 
conformational entropy. These methods are seldom successful in identifying potent drug 
candidates, as they are plagued with false negatives in which potential drug candidates are lost in 
the vast expanse of the library [41]. The importance of accounting for both protein and ligand 
flexibility for a robust calculation is well established [42-43], highlighting the need to account for 
conformational entropy in such calculations. However, attempts to computationally calculate 
conformational entropy in a robust manner would require unrealistic computational expense [44]. 
Thus, despite advances in computing such as GPU technology [45], successful computational 
approaches to drug design still seem out of reach.  
In practice, many of these computational approaches also rely solely on free energy calculations 
and cannot reliably discern the thermodynamic signature (i.e., the relative contributions of 
enthalpy and entropy to the free energy). This is primarily a result of convergence issues in the 
molecular simulation [38]. Knowledge of the thermodynamic signature is far more valuable than 
simply knowing the overall affinity, as it allows one to optimize the affinity in a rational way [44]. It 
should be noted that being able to determine the thermodynamic signature of binding does not 
deem the process of drug optimization “rational,” as the interplay between enthalpy and entropy is 
poorly understood. Attempts to optimize one aspect of the thermodynamics (e.g., the enthalpy) 
often results in a penalty in the other (e.g., the entropy). This results in optimization attempts to 
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thermodynamically “break even” and not lead to an increase in affinity. This is often attributed to 
enthalpy-entropy compensation [46-47] and appears to be a major barrier for lead optimization 
[48]. 
In this regard, biocalorimetric techniques have proven valuable in the optimization of lead 
compounds [49]. Recently, Freire and colleagues demonstrated a framework for lead optimization 
that allows one to semi-rationally overcome the barrier of enthalpy-entropy compensation [50]. In 
their approach, both the affinity and thermodynamic signature of a compound are determined. All 
chemical modifications to a compound are then benchmarked for both affinity and thermodynamic 
signature. This method, while very powerful, is essentially a means of guess and check with 
respect to the underlying thermodynamics of binding. While one can retroactively rationalize the 
thermodynamic effects, it is advantageous to gain a deeper understanding of the subcomponents 
of enthalpy and entropy. In general, the goal of the drug designer is to optimize the enthalpy 
without a consequent entropic penalty [51]. The contribution from conformational entropy in drug 
design is considered to almost always be unfavorable [52]. While this seems intuitive, it has not 
been experimentally validated. Furthermore, the relative contribution of conformational entropy to 
the overall binding thermodynamics is not known, as conformational entropy has resisted 
experimental measurement. Of particular interest in this dissertation is an experimental measure 
of conformational entropy to assess its potential role in the drug design process. 
Dissertation objectives 
 This dissertation explores the role protein dynamics and conformational entropy play in 
the native state and in protein-ligand interactions. First, we compare protein methyl dynamics in 
the solid state and in the solution state using the 36-residue villin headpiece subdomain (Chapter 
2). We find a poor correlation between methyl dynamics measured in the two states. More 
interestingly, we discover that the native state dynamic of the protein display a remarkable spatial 
segmentation of different classes of motion which has not been observed previously with NMR 
relaxation techniques. Next, we establish a strong empirical relationship between solution NMR-
derived protein dynamics and conformational entropy. The relationship is shown to apply to a 
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wide variety of protein-ligand interactions. It not only allows for a measurement of the 
conformational entropy, but also establishes an empirical relationship between solvent entropy 
and burial of polar and nonpolar surface area (Chapter 3). Finally, with an experimental readout 
of conformational entropy, we examine its potential role in the drug design process. Here we find 
that conformational entropy may be an additional parameter that can be tuned during the process 
of lead optimization, potentially leading to a new and distinct class of pharmaceutical drugs 
(Chapter 4). Together, this work represents a large step forward for the use of NMR relaxation to 
not only characterize the dynamics of proteins, but also to probe protein thermodynamics, 
especially in the context of protein-ligand binding.
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CHAPTER 2: The unusual internal motion of the villin headpiece 
subdomain 
	  
Contributions	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  S.	  O'Brien,	  a	  
graduate	  student	  in	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  Wand	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Abstract 
 The thermostable 36-residue subdomain of the villin headpiece (HP36) is the smallest 
known cooperatively folding protein. Though the folding and internal dynamics of HP36 and close 
variants have been extensively studied there has not been a comprehensive investigation of side-
chain motion in this protein. Here, the fast motion of methyl-bearing amino acid side chains are 
explored over a range of temperatures using site-resolved solution NMR deuterium relaxation.  
The squared generalized order parameters of methyl groups extensively spatially segregate 
according to motional classes. This has not been observed before in any protein studied using 
this methodology. The class segregation is preserved from 275K to 305K. Motions detected in 
helix 3 suggest a fast timescale of conformational heterogeneity that has not been previously 
observed but is consistent with a range of folding and dynamics studies. Finally, a comparison 
between the order parameters in solution with previous results based on solid-state NMR 
deuterium line shape analysis of HP36 in partially hydrated powders shows a clear disagreement 
for half of the sites. This result has significant implications for the interpretation of data derived 
from a variety of approaches that rely on partially hydrated protein samples. 
Introduction 
 Recent advances in experiment and simulation have begun to indicate that the internal 
motion of proteins and the entropy that it represents can significantly impact the thermodynamics 
underlying various functions and states of proteins [11] . NMR spectroscopy has contributed 
centrally to this effort and has revealed previously unrecognized physical attributes and patterns 
of internal motion within the three-dimensional structure of the protein native state [16]. Methyl-
bearing amino acid side chains have been comprehensively examined in several dozen protein 
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systems using deuterium or carbon relaxation methods [16]. These studies have shown that 
many proteins display three classes of motion that involve various degrees of rotameric 
interconversion on the picosecond-nanosecond timescale	  [27]. Of particular interest is that these 
motions appear to report on the changes in conformational entropy associated with a change in 
protein functional state	   [10,	   28-­‐29]. Indeed, recent advances indicate that appropriate use of 
NMR relaxation methodologies can quantitatively access this important thermodynamic feature of 
protein molecules [30, 53]. These types of investigations have been carried out almost exclusively 
in the solution state. However, protein powders hydrated to various degrees are often employed 
in biophysical investigations using techniques such as neutron scattering [54-55]. Thus it is of 
interest to compare the internal dynamics of fully solvated and partially hydrated protein 
molecules. Here we use a small subdomain of the villin headpiece (HP36) and employ deuterium 
relaxation to illuminate the dynamics of the protein in free aqueous solution and compare them to 
those observed in a partially hydrated powder. 
HP36 is comprised of residues 791-825 of 
the intact chicken villin protein and is the 
smallest known cooperatively folding protein 
domain [56]. The protein is comprised of 
three short helices stabilized by a well 
packed hydrophobic core [57] (Figure 2-1). 
HP36 has been extensively studied using a 
variety of techniques [58-68]. While much is 
known about the folding and conformational 
dynamics of HP36 including the dynamics of 
the backbone, site-specific information at 
side-chains locations remains somewhat 
limited.  Many site-resolved experimental studies of the dynamics of HP36 have hitherto been 
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primarily confined to solid-state NMR. While several NMR dynamics studies have been performed 
to characterize the conformational distribution and thermodynamics of HP36, [33, 59, 66, 69-72] 
no comprehensive study of side chain motion has been performed in solution. Here we further 
characterize the native state ensemble of HP36 by probing the sub-ns methyl dynamics in 
solution across a wide range of temperatures. We then compare these results to those obtained 
from a partially hydrated powder across a comparable temperature range to determine if the 
underlying thermodynamics based on NMR observables are translatable from the partially 
hydrated solid state to the solution state.  
Results and Discussion 
Methyl-bearing side chain dynamics in solution 
 The fast dynamics of the methyl-bearing residues in HP36 were characterized at six 
temperatures ranging from 275K to 305K. Lipari-Szabo [21] squared generalized order 
parameters for the methyl symmetry axis (O2axis) and the associated effective correlation time (τe) 
were determined for the 18 methyl groups of HP36. The N-terminal methionine residue (M41) 
was omitted from further analysis, as it displayed O2axis values around 0.05, suggesting it is 
entirely disordered. It should be noted that 
this residue is a result of recombinant protein 
expression and is not present in the native 
sequence of the protein.  At the lower 
temperatures examined, the methyl groups 
of one Alanine and one Threonine display 
O2axis values near the theoretical limit of 1 
indicating that they are essentially rigid within 
the molecular frame. The remaining methyl 
groups show O2axis values over nearly the full 
theoretical range. The temperature 
16	  
	  
dependences of the O2axis and τe parameters display a clear linear trend. The plots of dO2axis/dT 
for the methyl groups of HP36 are shown in Figure 2-2. In contrast to previous studies of methyl 
dynamics across different temperatures [26, 73-74], a particularly sharp temperature dependence 
of O2axis is observed, with an average value of  -5.9 ± 1.5 x 10-3 K-1 across methyl residues. This 
value is significantly larger than previous studies on ubiquitin and a calmodulin-peptide complex 
where the observed dO2axis/dT values were  -2.3 x 10-3 K-1 and -2.5 x 10-3 K-1, respectively [26, 
73]. The distribution of these residues is shown in Figure 2-3. The reason for this difference is not 
clear, but has implications for the heat capacity 
of the protein.  A linear trend in τe values is 
also seen (not shown), though this parameter 
is complex as it involves convolved motions of 
the methyl axis as well as methyl rotation 
motions and is also scaled by the order 
parameter [21]. 
Banding of O2axis parameters 
 As outlined in Chapter 1, methyl-
bearing amino acid side chains undergo three 
classes of motion that are often manifested as 
a tri-modal distribution or banding of the amplitude of motion represented by the O2axis parameter 
[16] . The banding can be rationalized in terms of simple packing interactions that naturally lead 
to a segregation of order parameters	  [27]. The so-called J-class is distinguished by extensive 
rotamer interconversion while the ω-class corresponds to highly restricted motion within a single 
and likely narrower rotameric well potential [27]. An intermediate class involves larger amplitude 
motion within a rotamer well that is accompanied by limited rotameric barrier crossing	  [27]. The 
relative population of each class varies significantly across proteins, even for the same protein 
involved in various complexes [10, 16, 27]. To determine the presence of banding of the 
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distribution of O2axis parameters within HP36, we used a Bayesian statistical analysis that is 
described in detail elsewhere [27]. This approach makes no assumptions about the presence of 
distinct classes of motions. We applied this approach to each set of methyl order parameters at 
each temperature at which data was determined, i.e. the presence and number of dynamic bands 
was determined independently for each temperature. We observe two roughly equally populated 
bands are maintained at each temperature across the entire temperature range (Figure 2-2). At 
295K, the two band centers correspond to O2axis values of 0.35 and 0.78, which conform to the 
previously described J- and ω-bands, respectively [16, 27]. Most residues do not move to 
different bands over this temperature range ,i.e., they qualitatively maintain the same character of 
motion. The sole exception is M53Cε, which is in between the band centers at higher temperature 
and falls statistically into the ω-band at 284K and again at 305K. Visually, there appears to be a 
spatial gap between the M53Cε (the most dynamic ω-band residue) and L69Cδ2 (the least 
dynamic J-band residue) that separates the two bands of motion in Figure 2-2. Despite this, 
M53Cε statistically into different bands across the temperature range. It is unclear if this has any 
physical significance or is merely a consequence of having a methyl order parameter that falls 
roughly between the two band centers. Mapping the distribution of the various classes of motion 
onto the structure of HP36 reveals that they are spatially segmented and are separated by the 
three aromatic residues (F47, F51 and F58) that comprise the hydrophobic core of this protein 




The bulk of the J-band is found in helix 3, whereas the ω-band is centered on helices 1 and 2. 
Such distinct spatial clustering of dynamic motion has not been observed previously. Though 
some spatial clustering of O2axis values is seen within protein molecules it is generally obscure 
and limited [16, 27]. In this regard, the spatial distribution of internal motion of the methyl-bearing 
side chain dynamics seen for HP36 is quite striking. It must be noted that the low number of 
methyl-bearing residues in HP36 may bias the banding by amino acid type [16, 75-76]. For 
example, the J-band is comprised entirely of leucines. However, the ω-band contains both a 
leucine (L61) and a methionine residue (M53), which are often associated with relatively low 
order parameters due to a higher number of side chain degrees of freedom. Thus, the spatial 
clustering of these bands seems to have significance beyond the degrees of freedom offered by 
the side chain of a particular amino acid type.  
The spatial clustering of the J- and ω-bands in the structure of HP36 is consistent with the 
proposed energy landscape of the protein. The three helices of HP36 are all known to be 
unstructured in isolation [60]. However, a construct that comprised both helix 1 and 2 was shown 
to have significant secondary structure by both CD and NMR [60, 62]. Furthermore, triplet-triplet 
energy transfer (TTET) and 2D IR experiments have unveiled conformational heterogeneity in the 
C-terminal helix 3 [63-64, 67]. This manifests itself in what is described as a reversible “unlocking” 
of helix 3 from the helices 1 and 2, followed by large structural fluctuations of helix 3. TTET 
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experiments have shown that these motions occur on the ns-us timescale and are considered to 
be on the native side of the major folding barrier of HP36.  Cross-correlated NMR relaxation 
measurements have also indicated enhanced motions in the backbone of helix 3 [70]. The ω-
band encompasses helices 1 and 2, which is consistent with them forming the core structural unit 
of this protein. In contrast, the J-band is localized almost entirely to helix 3. This suggests that in 
addition to more global fluctuations within the helix, there are also large side chain fluctuations 
occurring on a timescale several orders of magnitude faster than what has been previously 
observed. Taken together, the segregation of methyl dynamics in HP36 into spatially distinct 
bands provide additional insight into the native state ensemble of the protein. 
Comparison of solution state and solid state dynamics 
 Recently, Vugmeyster and colleagues performed a study of the dynamics of a partially 
hydrated powder of HP36 across a wide range of temperature using deuterium spin echo NMR 
[33]. They performed deuterium line shape analysis and fit the data to a motional model 
containing three contributions that describe fast 3-site jumps of the methyl group, restricted 
diffusion along on an arc, and rotameric jumps. There are two important distinctions between the 
solution and solid-state studies: the level of hydration and the broader sensitivity of the averaging 
of the deuterium quadrupolar tensor into the microsecond time regime.  The level of hydration 
(h=0.4g H2O/g protein) used for the solid state studies corresponds to partial hydration – the 
roughly 100 water molecules per protein molecule will cover only about half of the molecular 
surface of the folded protein – while the solution studies employ a fully hydrated protein. 
Deuterium lineshape analysis is sensitive to motion on the order of and faster than the breadth of 
methyl deuterium quadrupolar tensor, with the motionally averaged values of one third of 167 
kHz,[75] or on the order of 20 µs. In contrast, deuterium relaxation in solution will report only on 
internal motion that are faster than overall tumbling, which in this case is on the order of 3 ns. 
Thus, even if motion in the solid state sample is identical on the nanosecond timescale, order 
parameters derived from deuterium lineshape analysis can potentially be smaller than those seen 
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by classical relaxation due to contributions from motions in the µs to ns time regime. However, 
they cannot be larger in this situation. The O2axis values obtained from these studies are 
compared to the solution O2axis values at 295K for the partially hydrated powder (h ≈ 0.4 grams 
H2O/gram protein) (Figure 2-5). The pro-chiral isopropyl methyls of Val and Leu are not resolved 
in the solid state data allowing comparison of only six methyl groups, which yielded a quite poor 
correlation (R2 = 0.003, RMSD = 0.172). Of the 6 methyl groups compared, only those of L42, 
V50 and L75 display a reasonable correlation between the solution and solid states. These 
residues are spatially clustered. The remaining methyl groups do not show a systematically 
higher O2axis values in the solution state as would be expected if the solid state analysis was 
reporting on motions on a slower timescale.  L63 is the only side-chain probed in the solid-state 
that is not buried in the hydrophobic core and, thus, its higher value of the order parameter in the 
powder state could be caused by inter-molecular contacts. The only hydrophobic core residues 
for which the values of the order parameter are larger in the solid-state is L69. The temperature 
dependence of the O2axis parameters is also shown in Figure 2-5. The average temperature 
derivative of the O2axis values obtained in the solid state data is -2.2 ± 1.2 x10-3 K-1 and compares 
to -5.9±1.5 x10-3 K-1 obtained in solution. Interestingly, the slope of the solid-state data correlates 







Vugmeyster and coworkers[59] have developed an analytical parameter (Λ) to help characterize 
the underlying energy potential governing the temperature dependence: 
      Equation 3-1 
Λ is ≤ 1 for a simple harmonic oscillator. Both amide N-H and methyl groups are generally found 
to have a non-harmonic component to their temperature dependent motion. For example, 
ubiquitin has average Λ values of 7.1 and 2.3 for the backbone and side chain atoms, 
respectively [73]. Higher values of lambda (Λ > ~5) were ascribed to highly restricted angular 
motions and barrier heights on the order of 5 kcal/mol. Lower values of lambda were inferred to 
typify large angular excursions with low 
barrier heights, i.e., consistent with 
rotameric interconversion. The correlation 
plot for solution and solid-state lambda 
values for HP36 are shown in Figure 2-6. 
Once again, we note that the timescale 
and/or level of hydration may explain the 
differences in the temperature dependence 
of the dynamics. Comparison of dynamics in 
solid and solution states is a topic of active 
investigation. Most studies focus on 
hydrated proteins in micro-crystalline state 
and show general correspondence between 
dynamics in solution and solid-state when probed by relaxation measurements [34].   However, 
mobile regions of the proteins can be affected by crystalline environments and display differences 
in ns-ms time scale dynamics when probed by dipolar coupling measurements [77]. Our work 









and various levels of hydration in the solid 
state using a variety of techniques that can 
match the time scales probed in the two 
phases. 
Molecular dynamics simulation of HP36 
 The accuracy of simulations of 
internal protein motion continues to improve 
and now provides generally semi-quantitative 
and, in some cases, quantitative prediction of 
experimentally obtained measures of side 
chain motion. [53, 78-80] In an effort to 
illuminate the origins of the apparent 
discrepancy between the view of methyl-
bearing side chain motion in the solution and 
solid-state studies, we carried out a 120 ns 
molecular dynamics simulation of HP36 in 
explicit solvent (Figure 2-7). The order 
parameters predicted by the simulation 
correlate well with solution state data (R2 = 
0.86) but poorly with those obtained in the 
partially hydrated solid-state sample (R2 = 
0.24). 
Implications for studies involving partially hydrated proteins 
 A protein hydration level of h ~ 0.4 has been the widely accepted level at which protein 
internal motions closely resemble native motions [81]. Previous studies utilizing neutron 
scattering as well as solid state NMR have shown that hydration has a very large effect on protein 
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dynamics in the range of h between 0 and around 0.4, after which most dynamic changes plateau 
[81-82]. In one such study, however, the quasielastic neutron scattering of lysozyme in the 2-6 
GHz (ps-ns) range showed a hydration dependence that continued to increase up to at least 
h=0.8 [83], suggesting that perhaps not all dynamic processes of proteins are activated at the 
level of 40% hydration. It should be noted that a hydration level of h ~ 0.8 would constitute one 
full hydration layer of HP36. The data presented in this work further supports the idea that some 
native state motions may require a greater level of hydration than has been previously shown.  
Conclusions 
 The side chain methyl dynamics of Villin HP36 have been measured across a wide range 
of temperatures. Curiously, the methyl dynamics of HP36 reside in spatially distinct bands of 
motion. While such a clear clustering of dynamics has not been previously observed to our 
knowledge, these dynamics are consistent with the proposed native state ensemble.  Our results 
also point to conformational heterogeneity of side chains of helix 3 occurring at a sub-ns 
timescale, which has not been observed previously. The majority of methyl-bearing residues 
show clear differences in dynamics in fully hydrated aqueous solution from that observed in 
partially hydrated powders.  These differences may be partially explained by a difference in 
timescales that are represented within the order parameters as well as by inter-molecular 
contacts for solvent-exposed side chains, but also suggest that there may be inherent differences 
between partially hydrated proteins and proteins in free aqueous solution. This has implications 
for the interpretation of many neutron scattering and solid-state NMR studies that utilize partially 
hydrated protein samples.  This suggests that the dynamical proxy to be discussed in the 




CHAPTER 3: Development of a universal entropy meter 
This	  chapter	  represents	  a	  curation	  and	  analysis	  of	  a	  large	  pool	  of	  experimental	  data.	  While	  all	  of	  
the	  final	  data	  analysis	  and	  fitting	  were	  performed	  by	  this	  author,	  earlier	  contributions	  to	  the	  
data	  analysis	  were	  made	  by	  Vignesh	  Kasinath,	  former	  graduate	  student	  of	  the	  Wand	  Lab.	  
Additionally,	  experimental	  data	  pertaining	  to	  the	  HBP(D24R)-­‐Histamine	  and	  	  Barnase-­‐dCGAC	  
complexes	  were	  contributed	  by	  Jack	  Wee	  Lim	  and	  Vignesh	  Kasinath,	  respectively.	  	  
Abstract 
 Molecular recognition by proteins is fundamental to molecular biology. Dissection of the 
thermodynamic landscape governing protein-ligand interactions has proven difficult[84]. 
Determination of the individual entropic contributions is particularly elusive. Recently, NMR 
relaxation based measurements have suggested that changes in conformational entropy can be 
quantitatively obtained through a dynamical proxy [11, 30, 53]. Here we use 32 different protein-
ligand complexes to show a general relationship between measures of fast side chain motion and 
the underlying conformational entropy. We find that the contribution of conformational entropy can 
range from favorable to unfavorable, which demonstrates the potential of this key thermodynamic 
variable to modulate protein-ligand interactions. The dynamical “entropy meter” also refines our 
understanding of the contributions of solvent entropy [31] and directly determines the loss in 
rotational-translational entropy [85] that occurs upon formation of high affinity complexes. 
Collectively, these results provide a comprehensive and unified view of the role of entropy in high 
affinity molecular recognition by proteins. 
Introduction 
 At the most fundamental level biological processes are controlled using molecular 
recognition by proteins. Protein-ligand interactions impact critical events ranging from the catalytic 
action of enzymes, assembly of macromolecular structures, complex signaling and allostery, 
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transport phenomena, force generation and so on. Indeed, efforts at pharmaceutical intervention 
in disease have largely centered on the manipulation of molecular recognition by proteins. 
The physical origin of high affinity interactions involving proteins has been the subject of intense 
investigation for decades. Structural analysis at atomic resolution has helped illuminate in great 
detail the role played by enthalpy in molecular recognition by proteins. Of interest here is the role 
of the entropy, in particular the protein conformational entropy, in modulating the free energy of 
association of protein with a ligand. Because this entropy arises from the distribution between 
different conformational states of the protein, it is effectively invisible in a static, structure based 
view of proteins. Moreover, the recognition and binding of ligands by proteins often involves 
dozens of amino acids and thousands of square Ångstroms of contact area [86]. The contribution 
of a particular amino acid residue to the affinity varies greatly from complex to complex, and also 
within each complex, which greatly hinders the computation of the free energy of binding by 
taking inventory of interactions or from analysis of static structures alone [84, 87]. While potential 
roles for conformational entropy in protein function have been speculated about and simulated for 
some time [84, 88-92], a comprehensive quantitative experimental demonstration of the extent 
and variation of its importance has been lacking.  
Experimental insight into entropy generally begins from a calorimetric perspective where the heat 
or enthalpy (ΔHtotal) and free energy (ΔGtotal) are measured and the total binding entropy (ΔStotal) 
is determined by:  
( )protein proteintotal total total total conf conf solvent RT otherG H T S H T S S S S SΔ = Δ − Δ = Δ − Δ +Δ +Δ +Δ +Δ Equation 3-1 
The challenge is to quantify the various microscopic contributions to the free energy of binding. 
Detailed atomic resolution structural models provide great insight into the origins of the enthalpy 
of binding. Much less certain are the various contributions to the total binding entropy. In 
principle, several types of entropy are potentially important (see right side of Equation 3-1). 
Historically, entropy has most often entered the discussion in terms of the changes in the entropy 
of solvent water (ΔSsolvent) and framed in terms of the so-called “hydrophobic effect” [31, 93]. 
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ΔSsolvent has, with some success, been related empirically to changes in accessible surface area 
(ΔASA) of the protein and ligand upon complexation [94]. Changes in the conformational entropy 
(ΔSconf) and the rotational-translation entropy (ΔSRT) of the interacting species have received far 
less attention, presumably because they have resisted experimental measurement. Contributions 
to binding entropy from unrecognized sources (ΔSother) are also included in Equation 3-1 for 
purposes of experimental validation (see below).  
Some time ago it was recognized that fast sub-nanosecond timescale motion between 
conformational states might provide access to various thermodynamic features [95], especially 
conformational entropy [28-29]. Application of this idea has been thwarted by a number of 
technical limitations [11, 16], but has nevertheless led to the strong suggestion that dynamical 
proxies made available by NMR relaxation measurements could provide access to measures of 
conformational entropy [10]. More recently, efforts have been taken to overcome these technical 
barriers and limitations and render this approach to protein entropy quantitative [30, 53]. The 
resulting NMR-based “dynamical proxy” for conformational entropy or “entropy meter” takes a 
simple form that requires few assumptions, particularly about the nature of the underlying motion 
[53]: 
( ) ( )χ χ⎡ ⎤Δ −Δ = Δ + Δ +Δ +Δ⎢ ⎥⎣ ⎦2 2
protein ligandprotein ligand
total solvent d axis axis RT otherS S s N O N O S S
 
Equation 3-2 
where ΔO2axis is a measure of the degree of spatial restriction of the methyl group symmetry axis 
and varies between 0, which represents complete isotropic disorder and 1, which corresponds to 
no internal motion within the molecular frame [21] and is measured in various ways [16]. 
Δ<O2axis> is the change in order parameter averaged over all the methyl groups in the protein. sd 
is the sought after relationship (conversion) between measures of fast internal motion and 
conformational entropy [30, 53]. To avoid issues associated with statements about absolute 
entropy we restrict this treatment to changes in entropy upon a perturbation ,e.g,. binding of a 
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ligand. In principle all internal degrees of freedom of the protein contribute to ΔSconf, namely bond 
lengths, angles and torsions. In practice, 
empirical and computational studies show 
that changes upon binding are largely 
restricted to the softer, torsional modes [14, 
96]. Thus Eqn. 2 contains just the total 
number of torsion angles in the molecule 
(Nχ). Scaling Δ<O2axis> by the total number of 
torsions essentially projects the entropy 
change detected via the motion of methyl-
bearing amino acid side chains across the 
entire protein molecule. ΔSsolvent is generally 
calculated from the structures of the free and 
complexed states using empirically 
determined scaling of changes in apolar and 
polar accessible surface area [94].  The 
conformational entropy meter approach has 
thus far been applied to two protein-ligand 
systems: calcium activated calmodulin 
binding peptides representing the domains of 
regulated proteins [30] and a series of 
mutants of the catabolite activator protein 
binding DNA [13]. Here, we expand this initial 
set of protein-ligand interactions to 32 
protein-ligand complexes that span a broad 
range of binding affinities (Kd : 10-4 to 10-10 M) 
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and ligand types (nucleic acids, enzyme substrates & cofactors, carbohydrates, peptides & 
proteins) (Figure 3-1: Table C-1). We set out to test the hypothesis that the “entropy meter” is 
universally applicable ,i.e., that the scaling (sd) between changes in fast motion and changes in 
conformational entropy is constant. There are now roughly two-dozen published studies of the 
change in methyl-bearing side chain dynamics that are sufficiently complete to use to test this 
idea (Tables C-9 through C-70). We have complemented several of these by measuring the 
binding thermodynamics using isothermal titration calorimetry. A number of new examples, 
including additional variants of calmodulin in complex with a peptide corresponding to the 
calmodulin-binding domain of the smooth muscle myosin light chain kinase, were also examined. 
The curated data set is summarized in Tables C-1 and C-2. 
Results and discussion 
Simultaneous calibration of conformational entropy and solvent entropy 
 Usually the contribution of solvent entropy to the thermodynamics of an equilibrium is 
calculated using empirically determined coefficients relating changes in accessible polar and 
apolar surface area [94]. These coefficients have been derived with various assumptions about 
the nature of conformational entropy. In addition, these coefficients were determined in the 
context of protein-unfolding, where conformational entropy may behave different. This suggests 
that the previously determined coefficients for determining solvent entropy may be inappropriate 
in the context of protein-ligand binding. Fortunately, the unprecedented extent of the dynamical 
dataset used here allowed us to fit directly for these solvent entropy coefficients. In addition, the 
intercept of Equation 3-2 contains the loss in rotational-translational entropy upon formation of the 
complex. We therefore recast Equation 3-2 as: 
( ) ( )χ χ⎡ ⎤Δ = Δ + Δ⎢ ⎥⎣ ⎦
⎡ ⎤+ Δ + Δ +Δ +Δ⎣ ⎦
2 2
1 2( ) ( )
protein ligandprotein ligand
total d axis axis
apolar polar RT other
S s N O N O
a T ASA a T ASA S S




Should unaccounted contributions to the binding entropy be insignificant (i.e., <ΔSother> ~ 0) then 
ΔSRT will dominate the ordinate intercept. Violations of the few assumptions used to construct the 
calibration line for the entropy meter will result in deviation from linearity. These include the 
assumptions that methyl-groups are sufficiently numerous, are well distributed and are 
adequately coupled to non-methyl bearing amino acids that their motions provide comprehensive 
coverage of internal motion in the protein. These assumptions are strongly supported by 
simulation [96]. Fitting of Equation 3-3 to the dynamical data summarized in Table C-1 gives an 








The parameter of central interest (sd) is well determined and provides for the first time a robust 
and apparently general means to experimentally obtain the change in conformational entropy 
upon protein-ligand association. In this treatment we have ignored the contribution to the binding 
entropy from the backbone of the protein.  Recent simulations suggest that the binding of ligands 
by structured proteins will involve little contribution from the polypeptide chain [23]. Unfortunately, 
only six of the complexes used in Figure 3-2 have sufficiently characterized dynamics to allow 
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backbone motion be included in our analysis. We have attempted to fit these data to a 
modification of Equation 3-3 that includes the contribution of backbone entropy: 
( ) ( )
{ }( ) { }( )
χ χ
Δ − + Δ −
⎡ ⎤Δ = Δ + Δ⎢ ⎥⎣ ⎦
⎡ ⎤+ ⎢ ⎥⎣ ⎦




.  log 1 .  log 1
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protein ligandprotein ligand
res res
protein ligandsc protein ligand
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bb
d NH NH
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a T ASA a T ASA S S       Equation 3-4
 
However, when analyzed in a similar fashion this subset cannot be reliably fit. Upon globally 
fitting this equation in a similar manner to Equation 3-3 (see appendix C), the backbone sd value 
is of the wrong sign, erroneously suggesting a decrease in dynamics is entropically favorable. 
Employing a number of reasonable constraints on the fitting parameters does not alter this result, 
supporting the idea that the contribution by the backbone to the binding entropy is indeed small. 
Utilizing the determined value of sd we can establish that the contribution of conformational 
entropy to molecular recognition by proteins is quite variable between complexes. Conformational 
entropy can highly disfavor, have no effect, or strongly favor association, and is often a large 






Other entropic contributions to protein-ligand associations are also made accessible by the 
approached summarized by Figure 3-2 and Equation 3-3. Equation 3-3 allows that there may be  
other unknown sources of entropy. These might include, for example, (de)protonation events 
associated with binding [97]. Clearly, if ΔSother is both significant and varies between complexes 
then the linearity of Equation 3 will be degraded. The observed linear correlation strongly 
suggests that this is not the case. Thus, if ΔSother is small relative to ΔSconf and ΔSsolvent then the 
ordinate intercept represents the loss in rotational-translational entropy (ΔSRT) upon formation of 
high affinity complexes. ΔSRT has been the subject of extensive theoretical debate but, like 
conformational entropy, has resisted experimental definition. Here we find that the apparent ΔSRT 
is -0.10 ± 0.1 kJ mol-1K-1, which compares quite well to that recently obtained through molecular 
dynamics simulations [9]. Finally, prior to this work, the contribution of solvent entropy to 
processes involving proteins has been empirically derived from changes in solvent accessible 
surface area. Underlying such approaches have been strong assumptions regarding 
conformational entropy [94], which are not required here. We find that burial of apolar and polar 
surfaces upon binding both produce a positive (favorable) change in entropy. This is because 
hydration of polar groups, like that of apolar groups, has a negative entropy of hydration at 
physiological temperatures, in agreement with a wide range of thermodynamic data on solute, ion 
and protein hydration [98-100]. We determined the surface area coefficients for apolar (a1) and 
polar (a2) desolvation entropy at 298 K to be +0.081 ± 0.022 J mol-1K-1 Å-2 and +0.033 ± 0.0026 J 
K-1 Å-2, respectively (Table 3-1). The corresponding hydration heat capacity surface area 
coefficients are also listed in Table 3-1. Burial of hydrophobic area stabilizes the complex through 
the usual hydrophobic effect. Concomitantly, burial of polar area also stabilizes the complex via 
release of its hydrating water into the bulk, less ordered state. These coefficient values are 
markedly different from those obtained previously. This is unsurprising, as the contributions to 
conformational entropy were explicitly accounted for in this fit. 
35	  
	  
Implications for the heat capacity of proteins 
 Several fundamental properties of protein molecules in solution are related to their heat 
capacity (Cp). The most pertinent definition of Cp here is the derivative of the entropy with respect 
to the natural logarithm of the temperature: 









         Equation 3-5
 
Thus, establishment of the “entropy meter” along with suitable temperature dependence data 
allows the protein conformational contribution to Cp changes to be determined. The relative 
importance of conformational and solvation contributions to ΔCp of binding, like that of ΔS,, has 
been the subject of considerable debate [101], because previously there was no experimental 
way to isolate the different contributions.  The temperature dependence of fast methyl-bearing 
side chain motion has been examined for only two proteins, ubiquitin [73, 102] and a calmodulin-
peptide complex[26]. By combining Equations 3-5 and 3-3, we can probe the contribution of 
amino acid side chains to the overall protein heat capacity as: 








                                   Equation 3-6
 
From Equation 3-6, we find that the amino acid side chains contribute only a small fraction (~5-
6%) to the total heat capacity measured by differential scanning calorimetry (Table C-8). This 
reinforces the expectation that the vast majority of heat capacity comes from solvent-protein 
interactions [93, 101, 103]. 
Conformational entropy of mutant calmodulin-peptide complexes 
 As part of the entropy meter calibration, we have fully characterized both the dynamics 
and thermodynamics of binding of three previously studied CaM mutants (D58N, D95N and 
E84K) [104] in complex with target peptides by ITC and NMR.  Specifically, we have measured 
the binding of smMLCK(p) to D58N and D95N as well as the binding of nNOS(p) to E84K. The 





We find that despite the fact that D58N and D95N mutants are pseudo-symmetric, the dynamic 
response of smMLCK(p) binding varies for these two mutants. While D58N displays nearly 
identical conformational entropy of binding with respect to wild type, D95N displays a notably 
smaller value upon binding. In both cases, the smMLCK(p) peptide displays a larger entropic 
penalty upon binding than the wild-type complex, suggesting that perhaps the entropic penalty of 
peptide binding is increased when mutant CaM binds a native CaM binding domain. In the case 
of E84K binding the nNOS(p), E84K experiences a significantly smaller entropic penalty upon 
binding with respect to wild-type. Curiously, this is partially compensated for by a much larger 
entropic penalty observed in nNOS(p) upon binding. Looking at the overall conformational 
entropy change upon binding of these three mutant complexes, we see that calorimetric data 
correlates well with our observations in changes in dynamics and conformational entropy. In the 
case of D58N:smMLCK(p), the binding is less favorable entropically but more favorable 
enthalpically with respect to wild-type. The increased entropic penalty upon binding is consistent 
with the large decrease in conformational entropy as measured by the dynamical proxy. The 
opposite trend is observed in D95N:smMLCK(p), where the decreased entropic penalty agrees 
with the lower conformational entropy of binding. Curiously, E84K:nNOS(p) follows the same 
qualitative trends as D95N:smMLCK(p) with respect to its wild-type complex, but results in a 
notable loss of binding affinity. It is also interesting to note that the affinity of all three mutant 
protein-ligand complexes is nearly identical (Kd ≈ 40nM). These results together with previously 
characterized CaM-peptide complexes [30] suggest that CaM has evolved to bind different 
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targets with fairly similar affinity even in the presence of perturbing mutations by simultaneously 
modulating the changes in enthalpy and conformational entropy, portraying a robust 
thermodynamic landscape. 
Conclusions 
 The range of ligand types employed here suggest that the relationship between fast 
internal side chain motion and the underlying conformational entropy documented in Fig. 3-2 is 
universal and represents a fundamental property of proteins. There is no apparent structural 
relationship for the dynamical (entropic) response to molecular recognition by proteins. The 
connection between structure, and the enthalpy that it represents, and the conformational entropy 
and dynamics presents an immediate challenge to our current understanding of protein 
thermodynamics and function. The experimental approach presented here provides a means to 
quantify the role of protein conformational entropy and will hopefully both guide refinement of 
computational approaches and allow experimental access to this crucial component underlying 
















CHAPTER 4: Conformational entropy of p38α-inhibitor binding: 
Implications for drug design 
 
This chapter makes extensive use of non-uniformly sampled NMR pulse sequences. These 
experiments were written by Matthew Stetz, graduate student in the Wand lab. 
Abstract 
In silico drug discovery has long held the promise to revolutionize the way drugs are designed,  
but has largely failed to deliver. Historically inhibitors were designed based mainly on static  
structures that emphasized interaction energetics but ignored potential contributions from  
conformational entropy. This issue has been difficult to address experimentally. Recently, we  
have developed an NMR-based approach that employs measures of motion as a proxy for the  
conformational entropy. Using an empirical calibration, we have shown that the resulting  
"entropy meter" is both robust and general. We hypothesize that conformational entropy  
represents a critical "missing piece" in rational drug design. Using the "entropy meter," we  
examine the effect of conformational entropy on protein-inhibitor interactions using the drug  
target mitogen-activated protein kinase (MAPK) p38α as a model system. We have assigned the 
majority of methyl resonances and measured the methyl dynamics of this protein both in the apo 
state and bound to either a competitive or a non-competitive (allosteric) inhibitor. Using NMR 
methods, the structural and dynamic effects of inhibitor binding were examined. The effects of 
binding were found to be structurally localized to the binding sites as well as the so-called 
catalytic spine region of the protein. In contrast, dynamic perturbations occurred on a much more 
global scale across the protein. We then applied our dynamical proxy to determine the role of 
conformational entropy in the binding of both inhibitors. Intriguingly, the conformational entropy 
change upon binding was found to roughly scale with the total  binding entropy. This suggests 
that conformational entropy may be a tunable parameter in the drug design process. These 
results promote further studies to understand how small molecule inhibitors may modulate the 
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dynamics and entropy of protein targets, and how this information can be used to design better 
lead compounds  
Introduction 
 Protein kinases perform the simple yet essential task of phosphorylating macromolecules 
in the cell. This task is essential in nearly all processes in the cell, from regulation of cell 
proliferation to stress responses [105-106]. To date, over 6000 kinase have been added to the 
PDB database [107]. The structures of these proteins are highly conserved, consisting of N and C 
terminal lobes connected by a hinge region [108]. Taylor and Kornev have shown that two 
structurally conserved “spines” play an essential role on the catalytic activity of kinases [109]. 
While a wealth of structural information exists, numerous studies have demonstrated that protein 
kinases are highly dynamic molecules with multitudes of complexity in their regulation [110-115]. 
The majority of studies that have been performed address only the dynamics of the protein in the 
native state or in the context of native substrates, and most focus on the dynamics of the 
backbone or on µs-ms timescales typically associated with catalysis. Few studies have dealt with 
the dynamic effects of the binding of kinase inhibitors.  
Because of their roles in several cellular processes, kinases are often sought after drug targets 
for a wide range of diseases ranging from cancer to inflammatory diseases to hypertension to 
Parkinson’s disease [116]. Design of both potent and selective inhibitors for such structurally 
conserved proteins represents a challenge [117]. Thus the ability to design and optimize such 
inhibitors of protein kinases is of considerable interest.  As discussed in Chapter 1, “rational” 
design of inhibitors has proven difficult, as such design efforts cannot sufficiently address the role 
of entropy, particularly conformational entropy. The contribution of conformational entropy is often 
assumed to be almost always unfavorable [52] , yet its contribution has been difficult to address 
experimentally. Furthermore, computational methods are not able to robustly determine the 
conformational entropy of protein-ligand binding due to the inability to sample the vast degrees of 
freedom of a protein-ligand complex [43]. We seek to examine the effect of conformational 
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entropy on protein ligand binding using our NMR-based approach. Here we use the drug target 
mitogen-actived protein kinase (MAPK) p38α to explore the role of conformational entropy in drug 
design.  
p38α MAPK is involved in inflammation pathways [118] and is a current drug target for 
inflammatory diseases such as COPD and Rhematoid Arthritis [119-121]. p38α is activated by 
dual phosphorylation in the TGY motif of the activation loop [122]. Here we examine the binding 
of the resting state (non-phosphorylated) p38α to two potent inhibitors with distinct binding modes 
to determine if conformational entropy plays an appreciable role in the energetics of binding. The 
first of these inhibitors is the pyridinyl imidazole inhibitor SB203580, which is known to be a type I 
(ATP competitive) inhibitor of p38α [123]. The second inhibitor, the diaryl urea compound 
BIRB796, is an allosteric inhibitor of p38α, binding to an inactive conformation of the kinase and 
resulting in a conformational change in the conserved DFG loop of the kinase [124]. This ligand 
has previously been shown by NMR to bind with a conformational selection mechanism [125]. 
The structures of these complexes are shown in Figure 4-1. We first perform calorimetry to 
determine the overall thermodynamic of binding of two inhibitors with distinct binding modes. We 
then assess the structural and dynamic changes that occur upon inhibitor binding in the context of 
knowledge of these highly tuned molecular machines. Finally, we consider the observed dynamic 
changes in the context of the ‘entropy meter’ to determine if conformational entropy plays a 
significant role in protein-inhibitor interactions and thus may be a tunable parameter in drug 
design. 
Results and discussion 
Overall thermodynamics of binding 
We first determined the overall binding thermodynamics of p38α to the two inhibitors using ITC 
(Figure 4-2). We find that both molecules bind with low nM affinity (Kd=17.6 ± 8.5nM and 1.9 ± 
4.2nM for SB203580 and BIRB796, respectively. These numbers are in general agreement with 
the literature [125]. Unsurprisingly, the affinity of each compound is driven almost entirely by 









optimized drug will display a favorable enthalpy [52].  The binding entropy of these two 
compounds differs, with SB203580 binding being associated with a slightly favorable binding 
entropy (-TΔS= -0.48kcal/mol), whereas BIRB 796 is associated with a slightly unfavorable 
entropy of binding (-TΔS= +1.11 kcal/mol). The latter is more than compensated by a largely 
favorable enthalpy of binding, resulting in a roughly 10-fold higher affinity for BIRB 796 than for 
SB203580. It is notable that the total binding entropies of these two compounds differ in sign. The 
available thermodynamic data suggest that the difference in binding modes does not display a 
general trend in terms of thermodynamic signature [126-127]. Furthermore, no information is 
available on the contributions of the various components of the binding entropy, namely the 
solvent entropy or conformational entropy. It is well established that the burial of both polar and 
apolar surface area is entropically favorable [128], but the magnitude of this contribution is 
unclear. Could this partially explain the difference in binding entropy? The contribution of 
conformational entropy is also unclear.  To address the role of the entropic subcomponents in 
these binding interactions, we employ NMR relaxation techniques and our recently established 
dynamical proxy. 
Resonance assignments 
 Assignments of the backbone and ILV methyl side chains of resting state apo p38α 
MAPK have been reported previously[129-130]. We have largely confirmed these assignments 
using a suite of backbone and side chain experiments. Backbone assignments of the apo protein 
were confirmed using TROSY HNCA and agree very well with previously published assignments. 
Backbone assignments of the drug-bound complexes were performed using non-uniform sampled 
(NUS) [131] versions of the TROSY HNCA and HN(CA)CB. More information about non-uniform 
sampling is provided in Appendix D. 
ILV methyl side chain assignments of all three states were performed using either Cartesian or 
NUS versions of the methyl “Divide and Conquer” experiments [132-133] as well as Cartesian 4D 
13C/13C and in the case of the apo protein 13C/15N  -HSQC-NOESY-HSQC experiments.  Methyl 







Structural changes upon inhibitor binding 
 With a significant portion of the backbone and methyl resonances assigned in both the 
apo and inhibitor bound states, we can assess the site-specific structural perturbations that occur 
upon binding these inhibitors. The methyl and backbone chemical shift perturbations (CSPs) are 
mapped onto the structure of the inhibitor-bound complexes in Figure 4-3. Unsurprisingly, a large 
amount of chemical shift perturbations (CSPs) occurred near the inhibitor binding sites. Both 
inhibitors exhibit large chemical shift perturbations in the proximity of the αD helix and the β7-β8 
region of the protein. This region of the protein has been shown to be a docking site for both 
upstream and downstream substrates of p38α [134]. This region of the protein is also notable, as 
several residues in this region comprise one of two “hydrophobic spines” that are conserved 
across protein kinases [108]. These spines are proposed to be regions of the protein that allow 
communication between the N and C lobes. Regions of αD and β7-β8 comprise the catalytic 
spine (C-spine). This spine is not structurally contiguous in the apo protein and is completed by 
the binding of ATP into the active site. Analyzing the structures of p38α, we observe several 
residues both within and directly surrounding the C-spine experience very large CSPs, 
corresponding to Δδweighted >0.4ppm, where: 
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Δ = Δ + Δ⎜ ⎟
⎝ ⎠
        Equation 4-1  
In Equation 4-1, X corresponds to either 13C or 15N and γ corresponds to the gyromagnetic ratio. 
The resulting CSPs suggest a localized structural rearrangement of the residues around this 
conserved structural unit. Recently, Shimada and colleagues showed that essentially no spectral 
change occurs when the native substrate, ATP,  binds to inactive p38α [130]. This suggests that 
the structural rearrangement we observe is not simply a result of the completion of the C-spine by 
a ligand. It is curious to note that no significant structural differences are observed between the 
crystal structures of the apo and inhibitor-bound states (Backbone RMSD <0.8 Å). Concomitantly, 




the order of 60-95 Å2  and in the BIRB796 bound structure, this region is entirely unresolved. This 
suggests a large degree of conformational equilibrium in this region, which may be perturbed or 
disrupted by inhibitor binding. To further address this, we have determined dynamic perturbations 
of the protein by NMR relaxation methods. 
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Characterization of macromolecular tumbling 
 We have used NUS-sampled [131] versions of standard TROSY-detected 15N backbone 
relaxation experiments to determine the overall tumbling of resting state p38α both in its apo and 
inhibitor bound states[135]. The rotational correlation times and backbone dynamics of all three 
states were determined from 15N T1 and T2 measurements at 14.1T and 17.6T. Data were fit to 
the Lipari-Szabo model free formalism[21]. For each complex, a data set of approximately 115 
resonances was used to calculate τm values. Full details can be found in appendix D.  
It should be noted that one would not expect a priori for the macromolecular tumbling of the 
protein to change significantly when binding a small molecule drug. High-resolution crystal 
structures show minimal structural perturbation in both the absence and presence of ligand [123-
124, 136]. Based on analysis of the 15N relaxation, all three states were found to tumble 
isotropically. The tumbling times were determined to be 32.5ns, 30.8ns, and 33.0ns for apo, 
SB203580-bound, and BIRB796-bound p38, respectively. These molecular tumbling times are all 
notably longer than what has been previously observed for the activated form of p38α [137]. This 
is not surprising, given a difference in experimental temperature and the consequent difference in 
the viscosity of the solvent. While the BIRB 796 complex displays a comparable τm to the apo 
state, SB203580 shows a notably lower (~7%) tumbling time than apo p38. The reasons for this 
are not clear. One potential cause of the different τm values could be related to the fidelity of the 
NUS reconstruction of data (see Appendix D), which is a source of controversy in the literature 
[138]. It has been noted in particular, that a higher peak density may warrant the need for a 
higher sampling percentage than is employed in this study. To confirm that this confounding issue 
does not significantly distort the τm , it was recalculated using a sparse set of peaks that excluded 
any 15N resonances within two times the line width of one another in the NUS (15N) dimension. If 
significant NUS reconstruction artifacts were present, we would expect a significant impact on the 
experimentally determined τm using this subset of our data. However, the resulting τm values were 
within 1% of the original value. This confirms that the NUS sampling schedule and sampling 
density employed here can be used to determine a τm value of a moderately sized (40kDa) 
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protein. Unfortunately, this does not resolve the issue of deviant macromolecular tumbling. 
Furthermore, we speculate that the presence of slower timescale motions may also distort the τm 
of the p38-SB203580 complex. These motions can be detected through the T1T2 product for 15N 
relaxation peaks [139], though  no deviant behavior was detected in this case. The notably lower 
τm in the p38-SB203580 complex remains quite puzzling and is not supported by theoretical 
hydrodynamic calculations such as the boundary element method or HYDRONMR [140-143]. We 
speculate that another factor not detectable by our NMR relaxation data may be contributing to 
the deviant τm. This prevents a robust analysis of site-specific dynamic perturbations of the amide 
backbone, and the backbone dynamics will not be explored further. As notable differences in the 
τm are not anticipated, we have used the average τm value for all three complexes (32.1ns) for 
analysis of side chain relaxation. 
Methyl dynamics of p38a  
Carbon methyl axis generalized order 
parameters (O2axis) of ILV methyl resonances 
were calculated from the 13CHD2 isotopomer 
from 13C T1 and T2 relaxation rates at 14.1T 
and 17.6T. Additional details are available in 
appendix D. A large degree of spectral 
degeneracy is present in the methyl spectra, 
and several functionally interesting residues 
are obscured. Approximately 100 (74%) of 
the 135 observed methyls are resolved in 
each of the three states. Despite this, we are still able to make pairwise comparisons of O2axis for 
80 methyl sites in p38α upon binding these inhibitors. Plots for Δ O2axis can be found in Figure 4-4.   
A number of residues display large changes in Δ O2axis upon binding. Surprisingly, these dynamic 
changes do not correspond to an increase in rigidity as is often thought intuitively in protein-drug 
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interactions.  Instead, both increases and decreases in dynamics are observed near the active 
site (Figure 4-5).  Furthermore, propagation of dynamic changes throughout the protein is 
apparent in both states. If we examine the spatial distribution of dynamic changes as a function of 
proximity to the inhibitor, we find that there are several significant changes in regions of the 
protein in the C lobe, quite distal to the active site (Figure 4-6). This suggests a complex network 
of dynamics across the protein. It is also interesting to note that the extent of overall dynamic 
perturbation is larger for BIRB796, supporting the fact that an allosteric inhibitor will, by definition, 




As we observed with the structural perturbations, a large deal of dynamic perturbations occur in 
the "peri-spinal region" (Figure 4-6). Several residues on the αE helix flanking the base of the C-
spine become more dynamic, while other residues, namely Leu 113, display differential dynamic 
trends between binding of the competitive and allosteric inhibitor. This residue is one of two 
hydrophobic residues that faces downward to contact residues on the αF helix at the "base" of 
the C-spine. Upon binding SB203580, Leu 113 becomes very rigid (O2axis ≈0.9) and is flanked by 
several residues which become dynamic. Curiously, upon binding BIRB796, the Leu 113 
becomes notably more dynamic and the residues flanking it become more rigid. This result 
suggests that this residue, as part of the hydrophobic spine, displays dynamics that report on the 
overall state of the protein. We speculate that in the case of the ATP-competitive inhibitor, the 
 enzyme may not be able to fully distinguish a native substrate from its inhibitor and rigidifies the 
hydrophobic spine in preparation for catalysis. A similar result has been observed with the binding 
of the enzyme dihydrofolate reductase to a folate-competitive inhibitor, where the protein displays 
some motions typically associated with native substrate binding [144]. We must note, however, 
that we do not have any information regarding dynamic pertubations that occur upon native 
substrate binding. Such studies would be valuable in distinguishing dynamic perturbations that 
are associated with substrate binding from those that are associated with potential dynamic 
modes of inhibition. Outside of the "peri-spinal region," several changes in dynamics are 
observed in both the N and C lobes upon inhibitor binding. On the whole, it seems that significant 
dynamic changes are well dispersed across the protein. Several more subtle dynamic changes 
occur in the C lobe of the protein, quite far from the binding site (Figure 4-6). For both inhibitors, 
the overall change in methyl dynamics across the protein is small (Δ<O2axis>= +0.004±0.036 and 
+0.012±0.037 for SB203580 and BIRB796, respectively).  It appears that, in this regard, the 
binding of these inhibitors does not greatly affect the dynamics of the protein. This has interesting 








Conformational entropy of binding: implications for drug design 
 As described in Chapter 3, we developed a conformational “entropy meter” to discern 
conformational entropy changes from NMR dynamics. This method employed a data set of 32 
protein-ligand complexes with a manifold of binding partners to empirically calibrate not only the 
change in conformational entropy, but also the change in solvent entropy derived from changes in 
polar and apolar surface area. Combining the NMR and ITC data collected here with changes in 
acessible surface area from the published 
crystal structures, we find that both p38-
inhibitor complexes fit on the entropy meter 
(Figure 4-7), suggesting that we can use it to 
dissect the ΔStotal measured from NMR 
relaxation. Analyzing the crystal structures of 
the apo and p38-inhibitor complexes, we 
determine that the changes in solvent entropy 
are almost identical (-TΔSsolv=-5.1 ±0.6 
kcal/mol and =-5.1 ±0.8 kcal/mol for SB203580 
and BIRB796, respectively). This implies that 
solvent entropy does not explain the difference in ΔStotal observed from ITC. This is somewhat 
surprising given the changes in conformation of the DFG loop between the two inhibitors. It has 
been suggested that the change in ΔSRT is essentially constant for tight-binding macromolecular 
interactions [9] . The 'entropy meter' outlined in Chapter 3 supports this. Could conformational 
entropy be a differentiating factor?  
Using the measured changes in dynamics, we can apply the dynamical proxy to determine the 
conformational entropy of binding of these two complexes. It must be noted that the methyl 
coverage for the protein is somewhat low (~65%). This might suggest that our NMR-derived order 
parameters may not be able to appropriately represent the overall dynamic state of the protein.  
The Δ<O2axis> values may be biased by the lack of available probes in the analysis. This has 
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implications for the conformational entropy of the protein, as larger proteins are more sensitive to 
errors in the measurement of ΔO2axis. This is due to the fact that the observed dynamic change is 
scaled by Nχ,, which increases with increasing size. The sensitivity of the measurement to limited 
methyl coverage  is highlighted by calculating the dynamic changes in another way, namely the 
average of the pairwise changes in O2axis, or  <ΔO2axis> instead of Δ<O2axis>. The results are 
shown in Table 4-2.  
 
Note that the two methods result in opposite signs for dynamic changes, but the trend of BIRB 
796 having a larger dynamical penalty upon binding is upheld. It should be noted that a pairwise 
comparison (<ΔO2axis>) omits more methyl probes and thus exacerbates the issue of methyl 
coverage across the protein. The pairwise comparison of methyl probes is a function of the 
overlap of the NMR spectrum, which we assume is essentially random. Thus the difference 
between <ΔO2axis> and Δ<O2axis> may then be due simply to omission of an additional 20% of the 
data. To address this, we pseudorandomly omitted up to 25% of methyl probes for both the free 
and bound states and calculated the resulting Δ<O2axis>. The results of this simulation are shown 
in Figure 4-8. Indeed, we find that the value of <ΔO2axis> (pairwise) is almost precisely one 







This suggests that the observed difference between <ΔO2axis> and Δ<O2axis> is simply due to a 
decrease in effective methyl coverage. The issue of the precision of Δ<O2axis> remains. We make 
the conservative assumption that the error can be reflected with respect to the difference between 
Δ<O2axis>  and < Δ O2axis> . For both inhibitors, this corresponds to an error in Δ<O2axis> of 0.015. 
In this regard, we acknowledge that propagation of the error will consequently lead to large errors 
in conformational entropy, which will be 
reflected in our analysis.  
Using the entropy meter, we find that the 
conformational entropy of inhibitor binding is 
appreciable (-TΔSconf=0.9 ± 3.7 kcal/mol and 
2.9 ± 3.7 kcal/mol for SB203580 and 
BIRB796 respectively). It is interesting to 
note that despite the large uncertainties 
outlined above, the differences in ΔSconf 
between the two inhibitors appears to scale 
roughly with the differences in ΔStotal from 
ITC (Figure 4-9). This suggests that 
conformational entropy accounts for the difference in binding entropy for the two inhibitors. This is 
supported by the fact that the solvent entropy, often a major contributor in the total binding 
entropy, does not vary between the two inhibitors. Taken together, these results provide evidence 
that while conformational entropy is often unfavorable as observed here, it may be a tunable 
parameter in drug design. 
Conclusions 
 We have found that in the case of p38α MAPK, dynamic changes that occur across the 
protein can lead to a more shallow conformational entropy change upon binding than one might 
expect a priori. In some regard, this is encouraging to the drug designer, as conformational 
entropy may be less of a threat to high affinity binding. Concomitantly. this also adds to the 
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complexity of considerations in drug design. The “rules” for tuning conformational entropy have 
not yet been established, and thus an “entropically optimized” compound cannot yet be designed.  
A study of two notably different compounds with distinct binding modes cannot provide a 
thorough prescriptive knowledge of how to optimize conformational entropy. Follow-up studies will 
be needed to determine if the addition of a given functional group can significantly affect the 
overall conformational entropy of binding of a compound. Given this, it is curious to speculate that 
conformational entropy may be an important consideration in overcoming the barrier of enthalpy-
entropy compensation often encountered in drug design [50, 145].  
In summary, conformational entropy presents yet another layer of complexity with respect to lead 
optimization in drug discovery, but also opens the possibility of a new class of drugs whose 




CHAPTER 5: Conclusions 
Summary 
 The goal of this work was to establish the relationship between protein dynamics and 
conformational entropy and apply this relationship in the context of rational drug design. Chapter 
2 demonstrated the curious nature of protein side chain dynamics. In the case of the villin 
headpiece subdomain, spatially segregated classes of motions can occur. This unprecedented 
result demonstrates an interesting case study for the spatial distribution of different motional 
classes in proteins. It also provides further insight into the native state conformational ensemble 
of the highly studied protein, and may have interesting implications for the thermodynamics of 
folding of this protein. Furthermore, it highlights the need for a full hydration layer to recapitulate 
the native state dynamics of proteins, and precludes its analysis using the dynamical proxy 
between NMR dynamics and entropy. Chapter 3 demonstrated that solution state methyl 
dynamics can reliably report on the conformational entropy. This has allowed for the calibration of 
an ‘entropy meter’ that provides a quantitative estimate of both the conformational entropy and 
solvent entropy of a binding event. Furthermore, it provides insight into the relative distribution of 
protein heat capacity from the protein, which challenges previous calculations [146]. This 
demonstrates the power of the entropy meter to provide a deeper understanding of the underlying 
thermodynamics of proteins. Chapter 4 demonstrated that the binding of inhibitors to p38a MAPK 
have distinct structural and dynamic effects on the kinase, particularly in the structurally 
conserved hydrophobic spine regions. It also demonstrated that two different classes of p38α 
kinase inhibitors exhibit differential dynamic changes upon binding. These dynamic changes are 
not uniformly unfavorable, as traditional drug design efforts might assume. Instead, the protein 
appears to adapt to the binding of inhibitors through a complex dynamic network that exists 
across this protein. This likely diminishes the entropic penalty of binding. Furthermore, the total 
binding entropy of these two compounds appears to roughly scale with the calculated 
conformational entropy determined from NMR dynamics. This suggests that conformational 
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entropy may represent an additional tool in the toolbox for the drug designer. Taken together, this 
work further demonstrates the complexity of protein dynamics and their implications in the 
underlying thermodynamics of protein-ligand interactions. 
Future Directions 
	   The relationship between solution NMR-derived dynamics and conformational entropy 
has been shown to be both robust and general. However, the relationship is purely empirical and 
as such offers a means of further exploration. The ordinate intercept of the entropy meter 
represents the quantity (ΔSRT+ΔSother), where ΔSother represents contributions to the entropy that 
have not been accounted for, such as the entropy of (de)protonation upon binding[97]. As 
highlighted in Chapter 3, if ΔSother represents a significant contribution to the overall binding 
entropy the linear relationship will be degraded. We have clearly demonstrated this is not the 
case. It is curious to note that the value of (ΔSRT+ ΔSother ) across the data set agrees very well 
with an approximation of the RT entropy alone from molecular dynamics. This quantity was 
argued to be constant for high-affinity protein-ligand complexes [9]. Therefore one could interpret 
the ordinate intercept of the entropy meter as the constant ΔSRT and the observed "scatter" in the 
entropy meter containing information about ΔSother. We expect that as various theoretical and 
experimental determinations of the various terms of ΔSother are more robustly defined, this 
observed scatter will further decrease for our data set. The work presented in Chapter 3 provides 
an excellent benchmark to account for additional entropic terms in the context of the full entropic 
equation. 
 The application of the entropy meter to drug design presents an exciting line of inquiry, as 
we have shown conformational entropy may be a tunable parameter in this context. The work 
presented here provides preliminary evidence of conformational entropy's role in lead 
optimization, but further work will be required to begin to understand the "rules of the game" with 
respect to entropic optimization. Of particular interest would be to explore the consequences of 
the addition of functional groups to a lead candidate by both biocalorimetry and NMR relaxation 
methods similar to those employed in Chapter 4. This would complement previous studies only 
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employing the former [50] by allowing a deeper understanding of the entropic side of binding. 
Such work would begin to allow the drug designer to more deeply understand the consequences 
of given functional groups at the interface of structure and dynamics to ultimately begin to 
"rationalize" rational drug design.  
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Where	  	  μo	  is	  the	  permeability	  of	  free	  space,	  γH	  	  and	  γX	  are	  the	  gyromagnetic	  ratios	  of	  H	  and	  X	  (15N	  
or	  13C)	  respectively,	  h is	  Planck's	  constant	  divided	  by	  2π,	  r	  is	  the	  effective	  bond	  length,	  and	  Δσ	  is	  
the	  chemical	  shift	  anisotropy	  in	  ppm.	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  is	  the	  quadrupolar	  coupling	  constant	  and	  h	  is	  Planck's	  constant	  ( 2h π= h ).	  It	  has	  
been	  suggested	  that	  the	  dipolar	  contribution	  to	  the	  relaxation	  mechanism	  will	  contribute	  less	  
than	  2.5%	  to	  the	  relaxation	  mechanism	  as	  is	  neglected	  here	  [24].	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APPENDIX B: Chapter 2 
	  
Materials and methods 
 
Sample preparation:  
 The experiments were performed on homogenously 13C/15N –labeled and partially 
deuterated sample stemming from expression in 65% D2O/35% H2O. This leads to methyl group 
isotopomers distribution with the CH2D isotopomer detected by the relaxation experiments.  The 
expression, according to the method of Bi. et al., relies on a fusion of HP36 via a factor Xa 
cleavage sequence to the C-terminus of the N-terminal domain of the ribosomal protein L9.[147]  
As described by Marley et al., BL21 (DE3) cells were transformed with the L9-HP36 fusion 
plasmid were grown in 4 L of Luria Broth to an OD600 of 0.8, then harvested by centrifugation and 
washed once with M9 salts.[148]  The resulting pellet was re-suspended in 1 L M9T minimal 
media with 0.8 g/L 15NH4Cl, 3 g/L 13C-glucose and in 65% D2O/35% H2O.  Cells were allowed 1 
hour to recover, then protein expression was induced by addition of Isopropyl β-D-1-
thiogalactopyranoside to a final concentration of 1 mM.  The cells were harvested after 12 hrs.  
The cells were lysed with lysozyme treatment and sonication and the spun at 300,000 g for 1hr.  
The supernatant was applied to a Sephadex G75 column (2 cm x 100 cm) run in 20 mM 
tris(hydroxymethyl)aminomethane, 100 mM NaCl, 5 mM CaCl2, and 0.01% azide, pH 7.5 
(cleavage buffer) at 0.5 – 1 ml/min.  Fractions containing the L9-HP36 fusion protein were pooled 
and lyophilized.  The lyophilized powder was resuspended in water and further purified by high 
performance liquid chromatography (HPLC) and a C18 column (Vydac) eluted with a linear water-
acetonitrile gradient with 0.1% trifluoroacetic acid throughout.  Fractions containing the fusion 
protein were pooled and lyophilized.  The fusion protein was resuspended in cleavage buffer and 
treated with 8 units of factor Xa per mg of protein at room temperature overnight.  The cleaved 
HP36 was then purified by HPLC.  The HP36 fractions were lyophilized and stored at -20 oC. The 
identity and purity of the sample was confirmed by mass spectroscopy, 15N NMR HSQC 
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spectrum, and reverse- phase high performance liquid chromatography. The sample was 
resuspended in 90%:10% H2O:D2O. The resulting buffer conditions were 50 mM Sodium Acetate-
d3, pH 5.4.  A 4 mM HP36 sample was used for collecting NMR assignments, which was adjusted 
to 2 mM HP36 for collection of relaxation experiments. 
NMR Spectroscopy  
 All NMR experiments were collected using Bruker Avance III NMR spectrometers 
equipped with cryogenic probes. Assignments of the methyl groups in HP36 were determined by 
collection of a (H)CC(CO)NH-TOCSY[149] and a 2D H-H NOESY[150] experiments. Our 
assignments are in good agreement with the previously published assignments for a similar 
construct, HP67.[151] NMR relaxation data of methyl side chain CH2D isotopomers were 
collected at 14.1T and 17.6T using the IzCz-compensated IzCzDz and IzCzDy experiments.[24, 
152] These experiments were carried out at 275, 279, 284, 289, 295, and 305K. Temperatures 
were calibrated before each set of experiments using a methanol-d3 standard sample. For each 
pseudo-3D relaxation experiment, nine delays were collected with three duplicate points to 
estimate the error in the decay rates. The relaxation delays for these experiments ranged from 
1.5 – 60 ms and 0.6 – 27.5 ms for IzCzDz and IzCzDy , respectively.  
Relaxation Data Analysis 
 The rotational correlation time of HP36 at each temperature was calculated using the 
boundary element method, which has been described elsewhere and has been shown to be a 
robust method for determination of macromolecular tumbling [140-142]. The molecular surface of 
Villin HP36 (1VII) was constructed using in-house software.[153] The viscosity of the solution was 
determined from standard values of water at each experimental temperature.[154] The resulting 
rotational correlation times at 275, 279, 284, 289, 295, and 305K were 5.40 ns, 4.68 ns, 3.96 ns, 
3.40 ns, 2.87 ns, and 2.22 ns, respectively.  The N-terminal methionine residue was removed for 
these calculations as it is known to be unstructured in solution and its inclusion leads to large 
(~10%) biases in the macromolecular tumbling time. Exponential decays were fit using in-house 
software to determine T1 and T1p rates. Model free parameters (O2 and τe ) were determined 
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using a grid search approach[155] utilizing software and parameters as described 
elsewhere.[156] Errors were determined using the Monte Carlo method. O2axis values were 
obtained by division by 0.111, which assumes a tetrahedral geometry of the methyl groups.   
Banding analysis 
 To determine the "banding" of the O2axis parameters at each temperature, a Bayesian 
approach was used as described previously [27] using in-house software. The approach was 
performed separately for a data set of all methyl order parameters at each temperature. No 
assumptions about the number (or even existence) of bands was made. In each case, a two-band 
model was the best fit to the data set. The N-terminal residue, Met41, was excluded from this 
analysis. If included, the Bayesian approach identified three bands, with the population of the 
third band having a band center near the theoretical lower limit of O2axis and populated only by 
Met41. 
Molecular dynamics simulation and determination of in silico order parameters  
 A molecular dynamics simulation of the villin headpiece (PDB: 1VII) was performed using 
NAMD2[157] with the CHARMM27 [158] all-atom parameters and an explicit TIP3P water 
potential.[159] Hydrogen atoms were added to the villin headpiece crystal structure with 
VMD.[160] The protein was centered in a TIP3P water box such that the initial minimum protein-
boundary distance was 6 Å. The simulation was conducted with a 2 fs timestep. Bonds to 
hydrogen atoms were constrained with the SHAKE algorithm.[161] A switching distance of 10 Å 
and cutoff distance of 12 Å were used for nonbonded interactions, along with a particle mesh 
Ewald summation (1 Å grid spacing) for long-range electrostatic interactions. The simulation 
utilized the Langevin method to ensure constant temperature and pressure (1 atm). The 
simulation was performed at 295K to match experimental conditions of the solution state 
measurements. Following a 200 ps equilibration run, a production run of 120 ns was performed. 





Data tables and figures 








275K 279K 284K 289K 295K 305K 
Met41Cε 0.062±0.02 0.049±0.019 0.065±0.024 0.067±0.003 0.105±0.012 0.216±0.007 
Leu42Cδ1 0.539±0.02 0.49±0.014 0.469±0.016 0.412±0.002 0.337±0.006 0.232±0.008 
Leu42Cδ2 0.418±0.066 0.469±0.037 0.493±0.026 0.472±0.004 0.418±0.032 0.278±0.032 
Ala49Cβ 1.013±0.013 0.992±0.008 0.954±0.01 0.927±0.002 0.897±0.011 0.838±0.01 
Val50Cγ1 0.849±0.002 0.819±0.001 0.787±0.007 0.763±0.001 0.706±0.002 0.649±0.001 
Val50Cγ2 0.822±0.007 0.792±0.005 0.76±0.006 0.728±0.001 0.698±0.007 0.641±0.008 
Met53Cε 0.711±0.016 0.671±0.012 0.644±0.015 0.62±0.002 0.544±0.019 0.488±0.014 
Thr54Cγ2 0.93±0.003 0.905±0.002 0.873±0.009 0.849±0.001 0.822±0.002 0.773±0.012 
Ala57Cβ 0.897±0.001 0.868±0.001 0.857±0.006 0.814±0.001 0.787±0.001 0.752±0.003 
Ala59Cβ 0.913±0.012 0.889±0.008 0.862±0.017 0.846±0.001 0.795±0.009 0.752±0.007 
Leu61Cδ1 0.752±0.004 0.722±0.003 0.701±0.014 0.666±0.001 0.641±0.003 0.587±0.011 
Leu61Cδ2 0.808±0.029 0.79±0.018 0.754±0.016 0.695±0.003 0.663±0.018 0.609±0.018 





275K 279K 284K 289K 295K 305K 
Leu63Cδ2 0.337±0.007 0.315±0.005 0.304±0.005 0.28±0.001 0.253±0.003 0.207±0.004 
Leu69Cδ1 0.461±0.008 0.45±0.007 0.418±0.005 0.38±0.001 0.364±0.004 0.307±0.007 
Leu69Cδ2 0.577±0.013 0.566±0.011 0.55±0.009 0.488±0.001 0.463±0.009 0.407±0.011 
Leu75Cδ1 0.35±0.008 0.321±0.008 0.283±0.009 0.264±0.001 0.213±0.005 0.135±0.015 
Leu75Cδ2 0.407±0.021 0.383±0.017 0.348±0.012 0.31±0.001 0.291±0.001 0.245±0.001 
	  




275K 279K 284K 289K 295K 305K 
Met41Cε 10±4.3 10±3.6 7.5±3.6 7.5±4.5 5±3.1 2.5±3 
Leu42Cδ1 112.5±3.4 102.5±1.8 90±2 80±2.8 70±1.6 60±1.1 
Leu42Cδ2 57.5±1.2 50±1.7 45±0.8 40±1.6 37.5±0.3 35±0.2 
Ala49Cβ 65±2.1 57.5±1.1 52.5±1.4 47.5±1.3 42.5±0.9 37.5±0.5 
Val50Cγ1 37.5±4.5 35±2.3 32.5±2.1 30±2.8 30±2.1 27.5±1.5 
Val50Cγ2 97.5±5.7 87.5±3 80±2.9 72.5±4.1 65±3.2 55±2.4 
Met53Cε 7.5±2.5 7.5±1.6 7.5±3.8 7.5±4.1 10±1.5 10±1 
Thr54Cγ2 42.5±2.6 40±1.4 37.5±1.7 35±1.9 32.5±1.4 30±1.2 
Ala57Cβ 75±2.7 70±1.5 62.5±2 60±2.1 55±1.4 47.5±1.1 
Ala59Cβ 40±0.4 37.5±0.2 35±1.3 32.5±1.5 32.5±0.2 30±0.7 
Leu61Cδ1 45±1.1 42.5±0.7 40±1 37.5±0.9 35±0.7 32.5±0.5 
Leu61Cδ2 62.5±0.5 57.5±0.5 55±0.8 50±0.7 47.5±0.5 42.5±0.8 
Leu63Cδ1 62.5±0.4 57.5±0.3 52.5±1.8 47.5±0.3 42.5±0.1 35±0.3 
Leu63Cδ2 70±0.8 65±0.6 57.5±1.2 52.5±0.4 47.5±0.2 40±0.3 
Leu69Cδ1 57.5±6.4 52.5±3.4 50±2.5 47.5±3.3 42.5±2.4 37.5±1.7 
Leu69Cδ2 152.5±4.7 137.5±4.7 120±1.9 107.5±4.1 92.5±1.9 75±2.1 





275K 279K 284K 289K 295K 305K 
Leu75Cδ2 47.5±1.8 42.5±1.6 40±1.2 37.5±1.2 32.5±0.1 27.5±0.9 
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APPENDIX C: Chapter 3 
 
Materials and Methods 
Sample preparation  
 
 Calmodulin mutants and target peptides and complexes were prepared in 20 mM 
imidazole (pH 6.5), 100 mM KCl, 6 mM CaCl2 and 0.02% (w/v) NaN3 as described elsewhere [30, 
162]. The SAP SH2 domain was prepared as described[163]. The pY281 (Ac-RKSLTIYAQVQK-
COOH) and pY281 (Ac-KKSLTIpYAQVQK-COOH) peptides were obtained from Genscript 
(Piscataway, NJ). The ecDHFR:folate binary complex was prepared as described previously and 
refolded to remove endogenous ligands[164]. The genes coding for both barnase and barstar 
were cloned into a pETDUET vector with both barnase and barstar under the control of their own 
T7 promoter. Barnase contained a N-terminal His6x-tag followed by a Factor Xa cleavage site 
while Barstar remained untagged.  Barstar was also expressed separately from a pET-15b vector 
containing N-terminal His6x-tag. The barnase-barstar complex was isolated by Ni-NTA affinity 
chromatography and further purified by size-exclusion chromatography. Free barnase was 
isolated from the purified barnase-barstar complex by denaturation in 9 M urea pH 7.4 at 25°C for 
4 hours and purification on a DEAE anion exchange column equilibrated at pH 7.4. Barnase (pI 
9.0) was collected from the flow through and subjected to multiple rounds of dialysis followed by 
size-exclusion chromatography. dCGAC was purchased from Integrated DNA Technologies 
(Coralville, IA) . NMR and calorimetry experiments with barnase and its complex were done with 
samples prepared in 20 mM potassium phosphate pH 6.6, 1 mM DTT, 10% D2O and 0.02% NaN3 
(azide). Histamine-binding protein (HBP) with a D24R mutation (to abolish the second histamine 
binding site) was expressed from pET-15b vector with an N-terminal His6x-tag followed by a 
thrombin cleavage site. HBP(D24R) was isolated using a cobalt resin column with a pH gradient 
from 7.5 to 5.0 using 50 mM sodium phosphate with 300 mM NaCl further purified using size-
exclusion chromatography. NMR and calorimetry experiments with HBP(D24R)  and its complex 
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with histamine were done with samples prepared in 50 mM potassium phosphate pH 7.3, 5% D2O 
and 0.02% NaN3 (azide).  
 
Isothermal Titration Calorimetry 
Isothermal titration calorimetry (ITC) measurements were carried out on a VP-ITC instrument 
(Microcal) at the same temperature and buffer conditions as the corresponding NMR relaxation 
data. In cases where DTT is present in the buffer (SAP SH2-Y281/pY281 and DHFR:Folate-
NADP+), The DTT concentration was lowered to 0.1-0.2mM. All samples were prepared as 
described above and centrifuged at 4000 RPM for 10 mins to remove precipitate. ITC 
experiments of Calmodulin Mutant-peptide binding were performed as described previously [30]. 
For SAP SH2-peptide binding, samples were centrifuged at 4000 RPM for 10 minutes to remove 
any precipitate. 5-25µM SAP SH2 domain was titrated with 265-365µM peptide. For 
ecDHFR:Folate-NADP+ binding, 60uM ecDHFR pre-bound to 360uM folate was titrated with 935-
995µM NADP+ . 4-6µL injections were used. Data analysis was performed using the Origin 
software. Data were corrected for the heat of dilution as necessary. Example thermograms and 
fits of all protein-ligand complexes described above can be found in Figure C-1. 
 
NMR Spectroscopy  
 Free proteins and their complexes were assigned using standard triple resonance 
strategies. The resonance assignments have been deposited in the BMRB under accession 
numbers 25727, 25728, 26619 and 26620. Barnase relaxation studies employed 13C-relaxation 
using the 13CHD2 isotopomer [165] essentially as described elsewhere[166]. Calmodulin and 
histamine binding protein relaxation studies utilized deuterium relaxation [24] essentially as 
described elsewhere [156]. O2axis parameters were determined from T1 and T1ρ relaxation 
measured at two magnetic fields. Rotational correlation times and O2NH were determined from 15N 






grid search approach using a quadrupolar coupling constant of 167 kHz, an effective N-H bond 
length of 1.04 Å and a general 15N tensor breadth of 170 p.p.m. O2axis and O2NH parameters have 
been deposited in the BMRB under accession numbers 26619, 26620, 26621 and 26622. The 
appropriate tumbling model was identified through statistical analysis.  
Fitting of the entropy meter  
 The optimization and statistical analysis of the parameters obtained for the empirical 
calibration of the entropy meter (Table 3-1) was performed using nonlinear least-squares 
regression analysis by fitting to Equation 3-3. The errors in the fitted parameters were estimated 
using Monte Carlo sampling (N=100,000) where the fitting procedure was repeated taking into 
account the errors in Δ<O2axis>. This error was assumed to be 10%. Changes in polar and apolar 
accessible surface area were calculated using AREAIMOL[167] as described previously [30]. 




Table C-1: Protein-Ligand Complexes Used 
Index Protein:Ligand Kd (M)§ PDB Code          Reference 
1 CaM:CaMKKα(p) 3.6 ± 0.7 x10-9 1XO2, 1CKK [10, 30] 
2 CaM:smMLCK(p) 1.3 ± 0.5 x10-8 1XO2, 1CDL [10, 30]
 CaM(E84K):smMLCk(p) 4.1 ± 0.8 x10-8 1XO2, 1CDL [10, 30] 
4 CaM:CaMKI(p) 4.1 ± 0.8 x10-9 1XO2, 1MXE [10, 30] 
5 CaM:eNOS(p) 4.6 ± 0.5 x10-9 1XO2, 1NIW [10, 30] 
6 CaM:nNOS(p) 1.7 ± 0.4 x10-9 1XO2, 2O60 [10, 30] 
7 CAP:cAMP2:DNA 3.6x10-7 ± NA 1G6N, 1CGP [13] 
8 CAP(D53H):cAMP2:DNA 4.2x10-7 ± NA 1G6N, 1CGP [13] 
9 CAP(S62F):cAMP2:DNA 4.2x10-7 ± NA 1G6N, 1CGP [13] 
10 CAP(T127LS128I):DNA 4.2x10-7 ± NA 1G6N, 1CGP [13] 
11 CAP(T127LS128I):cAMP2:DNA 4.2x10-7 ± NA 1G6N, 1CGP [13] 
12 CAP(G141S):DNA 5.9x10-6 ± NA 1G6N, 1CGP [13] 
13 CAP(G141S):cAMP2:DNA 3.6x10-7 ± NA 1G6N, 1CGP [13] 
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14 CAP(G141S):cGMP2:DNA 3.6x10-7 ± NA 1G6N, 1CGP [13] 
15 CAP(A144T):DNA 1.6x10-5 ± NA 1G6N, 1CGP [13] 
16 CAP(A144T):cAMP2:DNA 2.2x10-7 ± NA 1G6N, 1CGP [13] 
17 CAP(A144T):cGMP2:DNA 2.2x10-7 ± NA 1G6N, 1CGP [13] 
18 Galectin:L2 1.8 ± 0.1 x10-5 1A3Kc, 2XG3 [168] 
19 Galectin:L3 3.3 ± 0.1 x10-6 1A3K c, 1KJR [168] 
20 Galectin:Lactose 2.3 ± 0.2 x10-4 1A3K c, 2NN8 [168] 
21 HEWL:Chitotriose 1.5 ± 0.0 x10-5 1LZA, 1LZB [156, 169] 
22 PDZ3:CRIPT 1.2 ± 0.1 x10-6 1BFE, 1BE9 [170] 
23 PDZ3Δ7:CRIPT 2.6 ± 0.4 x10-5 1BFE, 1BE9 [170] 
24 DHFR:NADP:Folatef 3.8 ± 0.4 x10-6 1RX7, 1RX2 [171],a 
25 SAP SH2:Y281 3.4 ± 0.4 x10-8 1D1Z, 1D4T [163],a 
26 SAP SH2:pY281 3.8 ± 5.5 x10-10 1D1Z, 1D4W [163],a 
27 PDZ2:RA-GEF2 5.1 ± 0.2 x10-6 3LNX, 3LNY [172-173]e 
28 CaM(D58N):smMLCK(p) 4.0 ± 0.9 x10-8 1XO2, 1CDLd [104],a,b 
29 CaM(D95N ):smMLCK(p) 2.7 ± 0.5 x10-8 1XO2, 1CDLd a,b 
30 CaM(E84K):nNOS(p) 3.3 ± 0.8 x10-8 1XO2, 2O60d a,b 
31 Barnase-dCGAC 5.0 ± 0.6 x10-5 1BNI,1BRN a,b 
32 HBP(D24R):Histamine 3.2 ± 0.7 x10-9 3GAQ,3G7X a,b 
 
§  For some complexes information regarding the precision of the determined Kd was not available from the cited literature 
and is indicated by “NA”. 
a  The calorimetric measurements were carried out in this study 
b  The NMR relaxation measurements were carried out in this study 
c  The unliganded structure of this protein is not available. The ligand was manually removed from the indicated 
coordinates of the complex and used for accessible surface area calculations without further adjustment. 
d  Structures were not available for these mutant calmodulin-peptide complexes. The corresponding structures of wild-
type calmodulin were used for accessible surface area calculations. 
e  The RA-GEF2 peptide used in the calorimetric study (Ac-YADSEADENEQVSAV-COOH) is longer than that used in the 
NMR relaxation study (Ac-ENEQVSAV-COOH). The solution structure of the complex with the longer peptide (PDB 
code: 1D5G [174]) shows that only the five C terminal residues of the peptide contact the protein.  Accessible surface 
area calculations used the shorter peptide. 
f  The "free state" is the DHFR:folate binary complex and the binding of  NADP+ to form a ternary complex that is the 
“bound” state. 
	  
Table C-2: Summary of the thermodynamic association of protein complexes 
Index totalbindingGΔ   Δ
total
bindingH  − Δ totalbindingT S  T (K) Ref 
 (kJ/mol) (kJ/mol) (kJ/mol) 
1 -49.8 ± 0.5 -140.0 ± 0.9 +90.0 ± 1.0 308 [10]  
2 -46.6 ± 0.1 -124.7 ± 0.2 +75.0 ± 0.3 308 [10] 
3 -43.6 ± 0.5 -84.3 ± 0.8 +40.7 ± 0.9 308 [30] 
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4 -49.5 ± 0.5 -119 ± 0.6 +69.6 ± 0.9 308 [10] 
5 -49.2 ± 0.3 -74.9 ± 0.4 +25.7 ± 0.8 308 [10] 
6 -51.7 ± 0.6 -49.9 ± 0.3 -1.9 ± 0.7 308 [10] 
7 -37.7 ± NA -92.0 ± NA +54.4 ± NA 305 [13] 
8 -37.2 ± NA -51.5 ± NA +14.2 ± NA 305 [13] 
9 -37.2 ± NA +19.2 ± NA -56.5 ± NA 305 [13] 
10 -37.2 ± NA +15.9 ± NA -49.8  ± NA 305 [13] 
11 -37.2 ± NA -45.6 ± NA +8.4 ± NA 305 [13] 
12 -30.5 ± NA -18.8 ± NA -11.7 ± NA 305 [13] 
13 -37.7 ± NA -55.2 ± NA +17.6 ± NA 305 [13] 
14 -37.7 ± NA +18.4± NA -51.9 ± NA 305 [13] 
15 -28.0 ± NA -12.1 ± NA -15.9 ± NA 305 [13] 
16 -38.9 ± NA +7.1 ± NA -44.4 ± NA 305 [13] 
17 -38.9 ± NA +44.4 ± NA -80.3 ± NA 305 [13] 
18 -27.3 ± 0.1 -49.3 ± 0.8 +22.0 ± 0.8 301 [168]  
19 -31.6 ± 0.1 -57.7 ± 0.5 +26.1 ± 0.5 301 [168] 
20 -21.0 ± 0.2 -50.6 ± 1.4 +30.0 ± 1.0 301 [168] 
21 -28.5 ± 0.04 -63.6 ± 0.4 +35.1 ± NA 308 [169] 
22 -34 ± 0.2 -40.6 ± 0.5 +6.9 ± 0.3 298 [170] 
23 -26.2 ± 0.3 -43.0 ± 2.8 +16.7 ± 2.5 298 [170] 
24 -31.3 ± 0.3 -37.0 ± 3.0 +6.4 ± 2.9 302 a 
25 -43.3 ± 0.3 -98.1 ± 3.2 +55.4 ± 3.5 303 a 
26 -54.7 ± 2.9 -81.2 ± 6.4 +27.5 ± 4.3 303 a 
27 -30.2 ± 0.1 -39.6 ± 0.9 +9.4 ± 0.9 298 [173] 
28 -43.7 ± 0.6 -129.4 ± 2.1 +85.7 ± 1.9 308 a 
29 -44.6 ± 0.4 -118.1 ± 0.2 +73.4 ± 0.4 308 a 
30 -44.1 ± 0.6 -41.2 ± 2.7 -2.9 ± 3.1 308 a 
31 -24.6 ± 0.3 -4.2 ± 1.5 -20.4 ± 2.7 298 a 
32 -48.5 ± 0.5 -69.5 ± 3.7 +21.0 ± 3.1 298 a 
 
§  Precision listed as the standard deviation between experiments. In some cases, the precision of the 
measurements was not available from the literature and is indicated as "NA." 
a  This work.  
Table C-3: Effective rotational correlation times for calcium-saturated calmodulin mutants 
and their complexes at 308K 
Protein Domaina τm (ns)b 
Free CaM (D58N) N-term 8.9   
Free CaM (D58N) C-term 7.8 
Free CaM (D95N) N-term 9.5 
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Free CaM (D95N) C-term 8.9 
Free CaM (E84K)c,d N-term 9.5 
Free CaM (E84K)c,d C-term 8.5 
CaM (D58N):smMLCK(p) N/A 7.7 
CaM (D95N):smMLCK(p) N/A 8.2 
CaM (E84K):nNOS(p)d N/A 9.4 
 
a   The rotational correlation times for the individual domains of free (calcium-saturated) calmodulin were analyzed 
separately. The N-terminal domain was defined as residues 1-79 and the C-terminal domain was defined as residues 
80-148. For the complexes, rotational correlation times considered all residues.  All proteins were found to tumble 
isotropically. 
b  Tumbling model selected from isotropic, axially symmetric and fully anisotropic models using standard statistical tests. 
See Moorman et al[166] for further details. Monte Carlo analysis indicated that the error in τm is 0.2 ns. 
c  These data were recollected for this study. 
d   These data were collected using mixed 15N/14N-13C-55%2H samples. The overall concentration of the samples was 1.4 
mM and contained 1 mM of 14N-13C-55%2H labeled protein and 55% fractionally deuterated protein and 0.4 mM 15N 
labeled protein, allowing for measurement of both backbone and side chain relaxation on the same sample. 
 
Table C-4: <O2axis> of mutant calmodulin-peptide complexes at 308K 
 
Complex Free CaM Bound CaM Bound Target  
CaM:smMLCK(p)b 0.439 ± 0.010 0.543 ± 0.014 0.634 ± 0.042c 
CaM(D58N):smMLCK(p) 0.465 ± 0.023 0.569 ± 0.015c 0.687 ± 0.013 
CaM(D95N):smMLCK(p) 0.474 ± 0.030 0.557 ± 0.031c 0.629 ± 0.012 
CaM:nNOS(p)b 0.439 ± 0.010 0.526 ± 0.010 0.628 ± 0.032d 
CaM(E84K):nNOS(p) 0.435 ± 0.022 0.461 ± 0.028 0.543 ±  0.011 
    Alanines were not included in the calculation of <O2axis> since they do not have a meaningful side chain χ angle. Errors 
were determined using Monte Carlo sampling. 
b  Data from Frederick et al. 2007 [10].  
c  Data from Igumenova et al. 2005[104].  
d  Data from Marlow et al. 2010[30].  
 
 
Table C-5: Effective rotational correlation times for barnase and histamine binding protein 
(D24R) and their complexes at 298 K. 
 
Protein isomτ
a Tumblingb Davg     φ   θ   ψ   












 (deg) (deg) (deg) 
 
Barnase (Bn) (1mM) 8.0 Axial 2.00 1.17 1.00 76 10 - 
Bn-dCGAC (0.7mM) 7.9 Axial 2.11 1.16 1.00 1 4 11 
HBP(D24R) apo 9.2 Axial 1.82 1.11 1.00 68 1 - 




a Monte Carlo analysis indicated that the error is 0.2 ns. 
b Tumbling model selected from isotropic, axially symmetric and fully anisotropic models using standard statistical tests. 
See Moorman et al[166] for further details. 
 
Table C-6: Dynamics of barnase and histamine binding protein and their complexes at  
298 K. 
Protein <Oaxis2 >  a  
Barnase 0.745 ± 0.025 
Barnase-dCGAC 0.645 ± 0.020 
HBP(D24R) 0.559 ± 0.036 
HBP(D24R):histamine 0.549 ± 0.029 
a  Alanines were not included in the calculation of <O2axis> since they do not have a meaningful side chain χ angle. Errors 
were determined using Monte Carlo sampling. 
	  
Table C-7: Entropy and NMR relaxation parameters for the calibration of the entropy 
meter§. 
Index totalSΔ   
a
polarASAΔ   Δ
a
apolarASA  bsolventSΔ   2axisN Oχ c Δ confS  
 (J mol-1 K-1) (Å2) (Å2) (J mol-1 K-1) (J mol-1 K-1) 
1 -290 ± 3 -1778 -1965 193 ± 29 +52.7 ± 5.7 f -269 ± 18 
2 -240 ± 1 -1824 -2433 213 ± 28 +57.1 ± 5.1 f -292 ± 20 
3 -130 ± 3 -1867 -2386 214 ± 29 +51.6 ± 7.6 f -264 ± 18 
4 -230 ± 3 -1836 -2421 213 ± 28 +60.2 ± 6.8 f -308 ± 21 
5 -83 ± 3 -1661 -2248 195 ± 26 +51.9 ± 5.0 f -265 ± 18 
6 + 6.2 ± 2 -1618 -2000 183 ± 25 +46.4 ± 4.0 f -237 ± 16 
7 -180 ± N/A -745d -3070 d 160 ± 6 +30.7 ± 24.5 -157 ± 11 
8 -47 ± N/A -745 d -3070 d 160 ± 6 +19.2 ± 22.1 -98 ± 7 
9 +190 ± N/A -745 d -3070 d 160 ± 6 -19.5 ± 25.2 +100 ± 7 
10 +160 ± N/A -745 d -3070 d 160 ± 6 -17.3 ± 30.6 +88 ± 6 
11 -27 ± N/A -745 d -3070 d 160 ± 6 +14.8 ± 28.8 -76 ± 5 
12 +38 ± N/A -745 d -3070 d 160 ± 6 -6.1 ± 40.5 +31 ± 2 
13 -58 ± N/A -745 d -3070 d 160 ± 6 +11.9 ± 46.3 -61 ± 4 
14 +170 ± N/A -745 d -3070 d 160 ± 6 -12.8 ± 56.8 +65 ± 4 
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15 +52 ± N/A -745 d -3070 d 160 ± 6 +3.3 ± 35.0 -17 ± 1 
16 +150 ± N/A -745 d -3070 d 160 ± 6 -6.7 ± 28.6 +34 ± 2 
17 +260 ± N/A -745 d -3070 d 160 ± 6 -26.8 ± 26.4 +137 ± 9 
18 -73 ± 3 -113 -471 24 ± 1 -15.6 ± 9.3 +79 ± 5 
19 -87 ± 2 -272e -368 e 33 ± 5 -9.6 ± 9.7 +49 ± 3 
20 -100± 3 -95 -304 18 ± 1 -17.7 ± 10.3 +91 ± 6 
21 -110 ± N/A -342 -445 39 ± 5 +2.6 ± 7.7 -14 ± 1 
22 -23 ± 1 -442 -271 44 ± 9 +9.1 ± 14.4 f -46 ± 3 
23 -56 ± 8 -451 -212 43 ± 9 +31.8 ± 16.5 f -162 ± 11 
24 -21 ± 10 -524 -903 71 ± 9 +11.3 ± 15.2 -58 ± 4 
25 -183 ± 12 -731 -842 83 ± 13 +7.4 ± 22.2 f -38 ± 3 
26 -91 ± 14 -833 -967 95 ± 15 +2.6 ± 24.4 f -13 ± 1 
27 -32 ± 3 -539 -509 60 ± 11 +4.5 ± 12.8 f -23 ± 2 
28 -280 ± 6 -1824 -2433 213 ± 28 +59.2 ± 8.2 f -302 ± 21 
29 -240 ± 1 -1824 -2433 213 ± 28 +50.2 ± 12.7 f -256 ± 18 
30 +9 ± 10 -1618 -2000 183 ± 25 +33.6 ± 10.8 f -172 ± 12 
31 +68 ± 9 -436 -636 56 ± 8 -8.9 ± 8.1g +45 ± 3 
32 -70 ± 10 -351 -318 39 ± 7 -3.04 ± 14.1 +16 ± 1 
§  In some cases, the error value was not available in the cited literature and is indicated as "NA." 
a  The change in accessible surface areas (ASA) was calculated for both the protein and the ligand using 
AREAIMOL[167]. For cases where the residues within the deposited crystal structure had two 
conformations, the "A" conformer was always used. For non-peptide ligands the free ligand ASA was 
determined using the structure of the ligand in the complex.  For peptide ligands (index # 1-6, 22, 23, 25-
30), an extended structure was used to model the free ligand[175]. For double-stranded DNA ligands 
(index # 7-17), the DNA in the crystal structure (1CGP) is structurally distorted in the complex. To 
obtain an approximate model structure of the DNA in its free state, the DNA from the crystal structure 
was hydrated in silico and molecular dynamics simulations run using the CHARMM27ref. [158] standard 
nucleic acid parameters to allow the DNA to relax to a stable apo structure. The DNA reached a stable 
structure after 1.2 ns of simulation time and the total simulation was continued to 3.6 ns. The RMSD 
between the starting and final structure was 6.85 Å. 
b  The changes in solvent entropy were obtained by the simultaneous optimization of the conformational 
entropy and the solvent entropy using Equation 3-3 (see main text). 
c  Alanines were not included in the calculation of Nχ <O2axis> since they do not have a meaningful side 
chain χ angle. The Nχ values correspond to the species used in the NMR relaxation experiments. The 
effective error between experimental replicates of <O2axis> is generally less (± 0.01) than that calculated 
in quadrature from error estimated by Monte Carlo analysis of individual order parameters. An additional 
uncertainty is introduced by the nature of the ligand (see legend to Figure 1 in main text and footnote f 
below). 
d  The CAP complexes were found experimentally to not involve a change in solvent entropy[13], which 
implies that they also have identical changes in accessible surface area upon binding. 
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e  The ligand in this complex contains fluorine atoms, which are not recognized by AREAIMOL. To 
accommodate this the fluorine atoms were changed to oxygen atoms, which have nearly identical atomic 
radii. 
f   These complexes contain a peptide ligand. In all cases the dynamics of the free peptide were not 
characterized. As discussed elsewhere[175], < O2axis > for the free peptide is taken as 0.05, which is 
reflective of the disorder of small unstructured peptides. In some cases, the dynamics of the peptide in the 
complex was measured (Index # 1-6,28-30) but in other cases not (Index # 22,23,25-27). In the latter 
situation, the contribution of the peptide to Δ<O2axis> was conservatively taken to range between 0 
(corresponding to the peptide maintaining the disorder of the free peptide while in the bound state) and 
0.9 (corresponding to the attaining an average order parameter in the bound state of 0.95). The midpoint 
of this range was used for the contribution of the peptide to Nχ <O2axis>. The reported error in these 
complexes combines the error of the measured <O2axis> and the uncertainty arising from the peptide 
contribution. In the former situation (the CaM-peptide complexes), the <O2axis> in the bound state is 
known and thus the error is treated in quadrature for both the protein and the peptide.  
g  This complex contains a small single-stranded DNA, which has not been dynamically characterized. The 
contribution of the DNA to Δ<O2axis> was conservatively taken to range between 0 (corresponding to the 
DNA maintaining the disorder of the free DNA while in the bound state) and 0.9 (corresponding to the 
attaining an average order parameter in the bound state of 0.95). Nχ was derived as 1 angle per 
nucleotide, corresponding to that between the base and the sugar-phosphate backbone. 
 
Table C-8: Contribution of amino acid side chains to the heat capacity of protein solutions. 
 
 Ubiquitin CaM:smMLCK(p) 
dOaxis2 d lnT
a
 -0.80 ± 0.15 b -0.96 ± 0.09c 
Nres 76 170 
Nχ 161 343 
Cpsc  (J/mol/K) 680 ± 130 1750 ± 170 
Cpsc  (J/g/K) 0.080 ± 0.014 0.091± 0.009 
 (cal/g/K) 1.47d 1.46e 
a Only residues whose linear fit displayed an R2  > 0.7 were included in this analysis. Alanines were excluded  
since they do not have a meaningful side chain χ angle. The error in <dO2axis/dlnT> is the average of the regression errors 
for each probe. 
b Data taken from Song et al. (2007) [73].  
c Data taken from Lee et al. (2001)[26]. Data for the smMLCK(p) peptide was not collected in this study, so it is assumed 
that the peptide methyls display the identical <dO2axis/dlnT> value. 
d Wintrode et al.[176] 










Table C-9: Methyl Order Parameters of Ca2+-bound CaM  
ID	   O2axis Err	  
l4d1 0.412 0.018 
i9d1 0.39 0.007 
i9g2 0.786 0.018 
a10b 0.793 0.016 
a15b 0.934 0.042 
l18d1 0.171 0.004 
l18d2 0.256 0.004 
t26g2 0.489 0.008 
i27g2 0.617 0.021 
t29g2 0.376 0.006 
l32d1 0.32 0.006 
l32d2 0.256 0.012 
v35g2 0.687 0.017 
m36e 0.249 0.002 
m51e 0.171 0.005 
i52d1 0.334 0.006 
i52g2 0.673 0.017 
v55g1 0.567 0.013 
v55g2 0.567 0.013 
t62g2 0.793 0.033 
i63d1 0.504 0.012 
i63g2 0.715 0.021 
l69d1 0.355 0.017 
t70g2 0.595 0.012 
m71e 0.164 0.004 
m72e 0.277 0.003 
m76e 0.094 0.003 
ID	   O2axis Err	  
i85d1 0.32 0.005 
i85g2 0.553 0.009 
a88b 0.836 0.029 
v91g1 0.68 0.015 
v91g2 0.68 0.012 
i100g2 0.737 0.022 
a102b 0.949 0.025 
m109e 0.136 0.005 
l116d1 0.285 0.01 
l116d2 0.299 0.005 
v121g1 0.553 0.008 
v121g2 0.553 0.009 
m124e 0.186 0.001 
i125d1 0.207 0.003 
i125g2 0.567 0.008 
a128b 0.779 0.018 
i130d1 0.327 0.005 
i130g2 0.489 0.006 
v136g2 0.723 0.018 
v142g1 0.715 0.014 
v142g2 0.61 0.011 
m144e 0.115 0 
m145e 0.2 0.001 
t146g2 0.433 0.005 
a147b 0.327 0.005 
	  
Table C-10: Methyl Order Parameters of CaM bound to CaMKKα(p) 
ID	   O2axis Err	  
l4d1 0.341 0.01 
l4d2 0.348 0.007 
i9d1 0.405 0.006 
i9g2 0.708 0.011 
a10b 0.871 0.016 
a15b 0.899 0.044 
ID	   O2axis Err	  
l18d1 0.313 0.006 
l18d2 0.299 0.022 
i27d1 0.751 0.048 
i27g2 0.843 0.034 
t28g2 0.829 0.027 
t29g2 0.306 0.005 
77	  
	  
ID	   O2axis Err	  
l32d1 0.666 0.039 
l32d2 0.659 0.051 
t34g2 0.595 0.013 
v35g1 0.793 0.028 
v35g2 0.744 0.024 
m36e 0.39 0.004 
l39d1 0.553 0.027 
l39d2 0.595 0.024 
t44g2 0.369 0.006 
a46b 0.786 0.011 
l48d1 0.68 0.047 
m51e 0.652 0.009 
i52d1 0.263 0.006 
i52g2 0.786 0.018 
v55g1 0.602 0.026 
v55g2 0.779 0.03 
a57b 0.864 0.016 
i63d1 0.602 0.029 
i63g2 0.786 0.036 
l69d1 0.228 0.012 
l69d2 0.171 0.009 
t70g2 0.553 0.008 
m71e 0.39 0.005 
m72e 0.383 0.004 
a73b 0.864 0.018 
m76e 0.285 0.004 
i85d1 0.617 0.014 
i85g2 0.8 0.022 
v91g2 0.814 0.022 
i100d1 0.829 0.048 
ID	   O2axis Err	  
i100g2 0.836 0.031 
a102b 0.885 0.022 
a103b 0.885 0.019 
l105d1 0.108 0.004 
l105d2 0.186 0.004 
v108g1 0.313 0.006 
v108g2 0.292 0.004 
m109e 0.595 0.005 
t110g2 0.433 0.004 
l112d1 0.426 0.018 
l112d2 0.398 0.012 
l116d1 0.518 0.013 
l116d2 0.574 0.016 
v121g1 0.758 0.016 
v121g2 0.779 0.023 
m124e 0.878 0.023 
i125d1 0.277 0.005 
i125g2 0.843 0.018 
a128b 0.963 0.045 
i130d1 0.32 0.005 
i130g2 0.525 0.005 
v136g1 0.504 0.013 
v136g2 0.546 0.011 
v142g1 0.532 0.008 
v142g2 0.546 0.009 
m144e 0.504 0.005 
m145e 0.348 0.005 
t146g2 0.511 0.008 
a147b 0.412 0.005 
	  
Table C-11: Methyl Order Parameters of CaM bound to smMLCK(p) 
ID	   O2axis Err	  
l4d1 0.304 0.011 
l4d2 0.579 0.021 
i9d1 0.516 0.008 
i9g2 0.77 0.014 
a10b 0.823 0.017 
ID	   O2axis Err	  
a15b 0.83 0.032 
l18d1 0.682 0.061 
l18d2 0.354 0.011 
t26g2 0.604 0.011 
i27d1 0.749 0.033 
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ID	   O2axis Err	  
i27g2 0.735 0.021 
t28g2 0.801 0.01 
t29g2 0.548 0.012 
t34g2 0.632 0.013 
v35g1 0.66 0.015 
v35g2 0.632 0.012 
m36e 0.301 0.003 
l39d1 0.442 0.022 
l39d2 0.329 0.019 
t44g2 0.766 0.01 
a46b 0.823 0.015 
l48d1 0.449 0.018 
l48d2 0.738 0.03 
m51e 0.269 0.003 
i52d1 0.318 0.006 
i52g2 0.749 0.018 
v55g1 0.438 0.006 
v55g2 0.389 0.008 
i63d1 0.724 0.018 
i63g2 0.745 0.021 
l69d1 0.265 0.016 
t70g2 0.639 0.012 
m71e 0.378 0.004 
m72e 0.72 0.013 
a73b 0.78 0.017 
m76e 0.117 0.002 
t79g2 0.396 0.005 
i85d1 0.301 0.006 
i85g2 0.615 0.012 
a88b 0.798 0.028 
v91g1 0.699 0.017 
ID	   O2axis Err	  
v91g2 0.844 0.015 
i100d1 0.922 0.036 
a102b 0.935 0.024 
a103b 0.875 0.017 
l105d1 0.59 0.023 
l105d2 0.551 0.025 
v108g1 0.466 0.009 
v108g2 0.449 0.007 
m109e 0.315 0.003 
t110g2 0.622 0.012 
l112d2 0.604 0.022 
l116d1 0.199 0.007 
l116d2 0.223 0.006 
v121g1 0.639 0.011 
v121g2 0.509 0.006 
m124e 0.837 0.018 
i125d1 0.407 0.007 
i125g2 0.798 0.018 
a128b 0.922 0.033 
i130d1 0.347 0.005 
i130g2 0.569 0.007 
v136g1 0.791 0.026 
v136g2 0.826 0.013 
v142g1 0.604 0.01 
v142g2 0.558 0.011 
m144e 0.354 0.005 
m145e 0.283 0.004 
t146g2 0.512 0.008 
a147b 0.378 0.004 
	  
Table C-12: Methyl Order Parameters of CaM bound to CaMKI(p) 
ID	   O2axis Err	  
l4d1 0.475 0.031 
l4d2 0.489 0.014 
i9d1 0.553 0.012 
i9g2 0.765 0.02 
ID	   O2axis Err	  
a10b 0.934 0.018 
a15b 0.8 0.05 
l18d1 0.482 0.047 
l18d2 0.171 0.007 
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ID	   O2axis Err	  
t26g2 0.595 0.018 
i27d1 0.744 0.045 
i27g2 0.906 0.047 
t29g2 0.624 0.022 
l32d1 0.525 0.032 
l32d2 0.751 0.058 
t34g2 0.638 0.021 
v35g1 0.822 0.038 
m36e 0.341 0.006 
l39d1 0.249 0.008 
l39d2 0.659 0.032 
m51e 0.285 0.004 
i52d1 0.256 0.006 
i52g2 0.758 0.026 
v55g1 0.412 0.009 
v55g2 0.383 0.009 
a57b 0.864 0.03 
t62g2 0.914 0.028 
i63d1 0.723 0.023 
i63g2 0.786 0.028 
l69d1 0.39 0.036 
m71e 0.383 0.006 
m72e 0.595 0.012 
m76e 0.101 0.004 
t79g2 0.61 0.014 
i85d1 0.567 0.016 
i85g2 0.715 0.023 
a88b 1 0.085 
v91g1 0.61 0.021 
ID	   O2axis Err	  
v91g2 0.737 0.022 
i100g2 0.899 0.043 
a102b 0.906 0.033 
a103b 0.885 0.03 
l105d1 0.602 0.032 
l105d2 0.624 0.059 
v108g1 0.496 0.014 
v108g2 0.518 0.017 
m109e 0.419 0.005 
t110g2 0.659 0.019 
l116d1 0.292 0.014 
l116d2 0.313 0.012 
v121g1 0.645 0.018 
v121g2 0.504 0.01 
m124e 0.906 0.026 
i125d1 0.362 0.008 
i125g2 0.829 0.031 
a128b 0.405 0.016 
i130d1 0.327 0.006 
i130g2 0.581 0.009 
v136g1 0.412 0.008 
v136g2 0.751 0.02 
v142g1 0.645 0.018 
v142g2 0.652 0.018 
m144e 0.285 0.005 
m145e 0.341 0.006 
t146g2 0.617 0.014 
a147b 0.447 0.007 
	  
Table C-13: Methyl Order Parameters of CaM bound to eNOS(p) 
ID	   O2axis Err	  
l4d1 0.39 0.011 
l4d2 0.525 0.006 
i9g2 0.694 0.01 
a10b 0.836 0.013 
a15b 0.793 0.022 
l18d1 0.178 0.002 
ID	   O2axis Err	  
l18d2 0.178 0.003 
t26g2 0.489 0.007 
i27d1 0.602 0.022 
i27g2 0.715 0.019 
t29g2 0.348 0.004 
l32d1 0.44 0.012 
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ID	   O2axis Err	  
l32d2 0.44 0.018 
t34g2 0.673 0.011 
v35g1 0.666 0.014 
l39d1 0.723 0.117 
l39d2 0.56 0.021 
a46b 0.772 0.011 
l48d1 0.588 0.04 
l48d2 0.511 0.008 
i52d1 0.242 0.005 
i52g2 0.68 0.011 
v55g1 0.567 0.009 
v55g2 0.581 0.009 
a57b 0.08 0 
t62g2 0.779 0.02 
i63d1 0.518 0.007 
i63g2 0.617 0.01 
l69d1 0.433 0.015 
l69d2 0.496 0.018 
t70g2 0.624 0.01 
m71e 0.15 0.004 
m72e 0.482 0.004 
a73b 0.723 0.011 
m76e 0.143 0 
i85g2 0.765 0.014 
a88b 0.871 0.025 
v91g1 0.758 0.019 
ID	   O2axis Err	  
i100d1 0.885 0.033 
i100g2 0.864 0.023 
a102b 0.906 0.017 
l105d1 0.489 0.009 
l105d2 0.44 0.016 
v108g1 0.723 0.016 
v108g2 0.723 0.013 
m109e 0.383 0.004 
t110g2 0.327 0.005 
l112d1 0.398 0.02 
v121g1 0.595 0.006 
v121g2 0.652 0.012 
i125d1 0.341 0.005 
i125g2 0.701 0.013 
a128b 0.878 0.021 
i130d1 0.313 0.004 
i130g2 0.532 0.006 
v136g2 0.765 0.018 
v142g1 0.56 0.007 
v142g2 0.539 0.007 
m144e 0.553 0.006 
m145e 0.383 0.003 
t146g2 0.588 0.008 
a147b 0.461 0.004 
	  
Table C-14: Methyl Order Parameters of CaM bound to nNOS(p) 
ID	   O2axis Err	  
l4d1 0.362 0.003 
l4d2 0.744 0.017 
i9d1 0.419 0.003 
i9g2 0.715 0.01 
a10b 0.822 0.013 
l18d1 0.221 0.002 
l18d2 0.27 0 
t26g2 0.553 0.003 
i27d1 0.8 0.034 
ID	   O2axis Err	  
i27g2 0.8 0.026 
t29g2 0.355 0.005 
l32d1 0.433 0.007 
t34g2 0.581 0.007 
v35g1 0.758 0.02 
m36e 0.249 0.004 
l39d2 0.779 0.034 
l48d1 0.602 0.027 
l48d2 0.631 0.015 
81	  
	  
ID	   O2axis Err	  
m51e 0.285 0.002 
i52d1 0.242 0.005 
i52g2 0.645 0.009 
v55g1 0.489 0.002 
v55g2 0.419 0.005 
a57b 0.051 0.005 
t62g2 0.871 0.009 
i63d1 0.652 0.015 
i63g2 0.744 0.018 
l69d1 0.376 0.009 
t70g2 0.532 0.006 
m71e 0.193 0 
m72e 0.348 0.003 
a73b 0.772 0.016 
m76e 0.178 0 
t79g2 0.32 0 
i85d1 0.433 0.005 
i85g2 0.723 0.014 
a88b 0.885 0.026 
v91g1 0.793 0.019 
i100d1 0.708 0.024 
i100g2 0.793 0.027 
a102b 0.906 0.02 
ID	   O2axis Err	  
l105d1 0.285 0.004 
l105d2 0.256 0.002 
v108g1 0.595 0.008 
v108g2 0.56 0.007 
m109e 0.334 0 
t110g2 0.624 0.007 
l112d2 0.482 0.009 
l116d1 0.235 0.009 
l116d2 0.263 0.004 
v121g2 0.511 0.005 
m124e 0.383 0.005 
i125d1 0.306 0.002 
a128b 0.963 0.022 
i130d1 0.306 0 
i130g2 0.518 0.004 
v136g2 0.814 0.025 
v142g1 0.574 0.005 
v142g2 0.574 0.007 
m144e 0.68 0.009 
m145e 0.454 0.004 
t146g2 0.56 0.005 
a147b 0.433 0.002 
	  
Table C-15: Methyl Order Parameters of CaMKKα(p) bound to CaM 
ID	   O2axis Err	  
l3d1 0.133 0.004 
l3d2 0.155 0.003 
i4d1 0.252 0.005 
i4g2 0.341 0.007 
t8g2 0.587 0.022 
t9g2 0.888 0.073 
v10g1 0.608 0.029 
v10g2 0.621 0.024 
i11d1 0.349 0.013 
ID	   O2axis Err	  
i11g2 0.697 0.029 
l12d1 0.273 0.016 
l12d2 0.265 0.011 
v13g1 0.786 0.034 
v13g2 0.723 0.038 
m16e 0.252 0.004 
l17d1 0.667 0.119 





Table C-16: Methyl Order Parameters of smMLCK(p)bound to CaM 
ID	   O2axis Err	  
a1b 0.693 0.033 
t8g2 0.583 0.028 
a11b 0.667 0.046 
v12g1 0.744 0.054 
v12g2 0.744 0.034 
ID	   O2axis Err	  
a14b 0.693 0.048 
i15d1 0.358 0.011 
i15g2 0.646 0.023 
l18d1 0.578 0.051 
l18d2 0.782 0.094 
	  
Table C-17: Methyl Order Parameters of CaMKI(p) bound to CaM 
ID	   O2axis Err	  
a3b 0.693 0.027 
a10b 0.922 0.059 
a13b 0.947 0.051 
t14g2 0.561 0.02 
a15b 0.875 0.05 
v16g1 0.744 0.024 
ID	   O2axis Err	  
v16g2 0.256 0.005 
v17g1 0.837 0.04 
v17g2 0.744 0.029 
m20e 0.248 0.002 
l23d1 0.723 0.038 
l23d2 0.316 0.02 
	  
Table C-18: Methyl Order Parameters of eNOS(p) bound to CaM 
ID	   O2axis Err	  
t4g2 0.854 0.017 
v8g1 0.574 0.008 
v8g2 0.557 0.007 
a9b 0.723 0.025 
a11b 0.837 0.022 
v12g1 0.765 0.03 
v12g2 0.829 0.02 
ID	   O2axis Err	  
i14d1 0.578 0.01 
i14g2 0.879 0.018 
a16b 0.934 0.023 
l18d1 0.405 0.006 
l18d2 0.434 0.005 
m19e 0.324 0.002 
	  
Table C-19: Methyl Order Parameters of nNOS(p) bound to CaM 
ID	   O2axis Err	  
a1b 0.905 0.057 
a4b 0.485 0.007 
i5d1 0.358 0.008 
i5g2 0.417 0.008 
l10d1 0.587 0.028 
l10d2 0.782 0.072 
a13b 0.863 0.044 
ID	   O2axis Err	  
v14g1 0.782 0.055 
v14g2 0.812 0.041 
a18b 0.918 0.036 
l20d1 0.451 0.019 
l20d2 0.481 0.041 




Table C-20: Methyl Order Parameters of Ca2+-bound CaM(E84K) for comparison to 
CaM(E84K):smMLCK(p) 
ID	   O2axis Err	  
l4d1 0.464 0.013 
i9d1 0.426 0.004 
i9g2 0.778 0.009 
a10b 0.782 0.009 
a15b 0.939 0.025 
l18d1 0.188 0.002 
l18d2 0.273 0.003 
m26e 0.252 0.002 
t26g2 0.468 0.006 
i27g2 0.723 0.017 
t29g2 0.375 0.005 
l32d1 0.324 0.005 
l32d2 0.43 0.015 
v35g2 0.706 0.011 
m51e 0.18 0.001 
i52d1 0.333 0.004 
i52g2 0.655 0.009 
v55g1 0.591 0.008 
v55g2 0.553 0.008 
t62g2 0.867 0.027 
i63d1 0.502 0.007 
i63g2 0.735 0.013 
l69d1 0.409 0.012 
t70g2 0.553 0.01 
m71e 0.155 0 
m72e 0.252 0.003 
m76e 0.095 0 
ID	   O2axis Err	  
i85d1 0.341 0.003 
i85g2 0.583 0.006 
a88b 0.816 0.014 
v91g1 0.706 0.009 
v91g2 0.697 0.007 
i100g2 0.756 0.013 
a102b 0.931 0.015 
m109e 0.163 0.003 
l116d1 0.328 0.009 
l116d2 0.299 0.004 
v121g1 0.557 0.005 
v121g2 0.519 0.005 
m124e 0.121 0.001 
i125d1 0.21 0.003 
i125g2 0.587 0.006 
a128b 0.765 0.01 
i130d1 0.324 0.003 
i130g2 0.502 0.004 
v136g2 0.714 0.011 
v142g1 0.735 0.009 
v142g2 0.617 0.007 
m144e 0.201 0.003 
m145e 0.197 0.001 
t146g2 0.422 0.003 
a147b 0.328 0.003 
	  
Table C-21: Methyl Order Parameters of CaM(E84K) bound to smMLCK(p) 
ID	   O2axis Err	  
l4d1 0.349 0.019 
i9d1 0.471 0.011 
i9g2 0.748 0.018 
a10b 0.857 0.022 
a15b 0.883 0.052 
l18d1 0.241 0.017 
ID	   O2axis Err	  
l18d2 0.209 0.009 
t26g2 0.612 0.026 
i27d1 0.794 0.05 
i27g2 0.862 0.037 
t29g2 0.533 0.022 
l32d1 0.544 0.053 
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ID	   O2axis Err	  
t34g2 0.603 0.019 
v35g2 0.7 0.029 
l39d1 0.615 0.052 
l39d2 0.641 0.039 
t44g2 0.818 0.027 
a46b 0.795 0.023 
l48d1 0.66 0.097 
l48d2 0.741 0.041 
i52g2 0.737 0.023 
v55g1 0.456 0.013 
v55g2 0.437 0.016 
i63d1 0.71 0.026 
i63g2 0.803 0.031 
l69d1 0.348 0.03 
l69d2 0.372 0.053 
t70g2 0.632 0.017 
m71e 0.257 0.004 
m72e 0.554 0.01 
a73b 0.837 0.031 
m76e 0.169 0.002 
t79g2 0.328 0.007 
i85g2 0.642 0.02 
a88b 0.871 0.046 
v91g1 0.604 0.014 
v91g2 0.591 0.017 
i100d1 0.785 0.048 
ID	   O2axis Err	  
i100g2 0.83 0.039 
a102b 0.925 0.029 
a103b 0.889 0.029 
l105d1 0.524 0.039 
l105d2 0.53 0.031 
v108g2 0.503 0.015 
m109e 0.363 0.004 
t110g2 0.635 0.017 
l112d1 0.523 0.05 
l116d1 0.285 0.02 
l116d2 0.3 0.014 
v121g2 0.604 0.015 
m124e 0.865 0.018 
i125d1 0.335 0.009 
i125g2 0.813 0.024 
a128b 0.886 0.051 
i130d1 0.324 0.007 
i130g2 0.53 0.008 
v136g2 0.848 0.049 
v142g1 0.571 0.014 
v142g2 0.581 0.016 
m144e 0.329 0.005 
m145e 0.416 0.005 
t146g2 0.515 0.014 
a147b 0.41 0.007 
	  
Table C-22: Methyl Order Parameters of smMLCK(p) bound to CaM(E84K) 
ID	   O2axis Err	  
   L18d1 0.379 0.006 
   L18d2 0.32 0.016 
   v12g1/g2 0.723 0.01 
   v12g1/g2 0.718 0.01 
     t8g 0.638 0.016 
ID	   O2axis Err	  
     a1b 0.723 0.01 
    a11b 0.769 0.011 
    a14b 0.863 0.013 
   i15g2 0.676 0.008 





Table C-23: Methyl Order Parameters of Ca2+-bound CaM(E84K) for comparison to 
CaM(E84K):nNOS(p)
ID	   O2axis Err	  
LEU4CD1 0.388 0.016 
LEU4CD2 0.373 0.007 
THR5CG2 0.731 0.036 
ILE9CG2 0.775 0.042 
ILE9CD1 0.353 0.036 
ALA10CB 0.82 0.019 
ALA15CB 0.994 0.072 
LEU18CD1 0.199 0.066 
LEU18CD2 0.273 0.036 
THR26CG2 0.477 0.021 
ILE27CG2 0.224 0.011 
THR29CG2 0.383 0.016 
LEU32CD1 0.497 0.03 
VAL35CG2 0.711 0.035 
MET36CE 0.244 0.031 
LEU48CD2 0.368 0.033 
MET51CE 0.184 0.024 
ILE52CG2 0.567 0.02 
ILE52CD1 0.333 0.036 
VAL55CG1 0.547 0.009 
VAL55CG2 0.582 0.036 
THR62CG2 0.86 0.038 
ILE63CD1 0.497 0.024 
ILE63CG2 0.746 0.013 
LEU69CD1 0.408 0.009 
LEU69CD2 0.343 0.043 
THR70CG2 0.621 0.025 
MET71CE 0.154 0.017 
MET72CE 0.253 0.051 
ALA73CB 0.775 0.053 
MET76CE 0.089 0.005 
ID	   O2axis Err	  
THR79CG2 0.298 0.06 
ILE85CG2 0.557 0.013 
ILE85CD1 0.338 0.042 
ALA88CB 0.785 0.007 
VAL91CG1 0.716 0.004 
VAL91CG2 0.666 0.009 
ILE100CG2 0.75 0.019 
ALA102CB 0.91 0.04 
LEU105CD1 0.373 0.005 
LEU105CD2 0.234 0.011 
VAL108CG2 0.512 0.012 
MET109CE 0.169 0.019 
LEU112CD1 0.422 0.005 
LEU116CD1 0.308 0.004 
LEU116CD2 0.298 0.008 
VAL121CG1 0.527 0.002 
VAL121CG2 0.542 0.015 
MET124CE 0.189 0.038 
ILE125CG2 0.596 0.019 
ILE125CD1 0.209 0.053 
ALA128CB 0.77 0.021 
ILE130CG2 0.507 0.01 
ILE130CD1 0.343 0.039 
VAL136CG2 0.696 0.003 
VAL142CG1 0.701 0.006 
VAL142CG2 0.631 0.021 
MET144CE 0.119 0.001 
MET145CE 0.179 0.021 
THR146CG2 0.408 0.005 
ALA147CB 0.313 0.001 
 
Table C-24: Methyl Order Parameters of CaM(E84K) bound to nNOS(p) 
ID	   O2axis Err	  
ALA1CB 0.06 0.05 
LEU4CD1 0.318 0.007 
ID	   O2axis Err	  
LEU4CD2 0.343 0.017 
ILE9CG2 0.621 0.02 
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ID	   O2axis Err	  
ILE9CD1 0.388 0.044 
ALA10CB 0.8 0.051 
LEU18CD1 0.239 0.015 
LEU18CD2 0.244 0.039 
THR26CG2 0.467 0.019 
ILE27CD1 0.83 0.012 
ILE27CG2 0.83 0.057 
THR29CG2 0.308 0.007 
THR34CG2 0.512 0.005 
VAL35CG1 0.671 0.015 
MET36CE 0.288 0.059 
LEU39CD2 0.621 0.033 
LEU48CD1 0.442 0.021 
MET51CE 0.288 0.04 
ILE52CD1 0.244 0.027 
VAL55CG1 0.502 0.014 
VAL55CG2 0.442 0.022 
THR62CG2 0.741 0.043 
ILE63CD1 0.616 0.036 
ILE63CG2 0.686 0.018 
LEU69CD1 0.333 0.024 
MET71CE 0.219 0.056 
MET72CE 0.249 0.049 
ALA73CB 0.785 0.026 
MET76CE 0.194 0.045 
ILE85CG2 0.651 0.043 
ID	   O2axis Err	  
ILE85CD1 0.408 0.044 
ALA88CB 0.989 0.032 
VAL91CG1 0.716 0.025 
ILE100CG2 0.825 0.025 
ILE100CD1 0.741 0.027 
ALA102CB 0.934 0.022 
LEU105CD1 0.333 0.04 
LEU105CD2 0.273 0.05 
VAL108CG1 0.646 0.017 
MET109CE 0.328 0.055 
LEU112CD2 0.427 0.01 
LEU116CD1 0.224 0.028 
LEU116CD2 0.249 0.045 
VAL121CG2 0.462 0.016 
MET124CE 0.343 0.012 
ILE125CD1 0.293 0.028 
ALA128CB 0.77 0.051 
ILE130CD1 0.318 0.02 
VAL142CG1 0.552 0.02 
VAL142CG2 0.542 0.026 
MET144CE 0.785 0.031 
MET145CE 0.398 0.012 
THR146CG2 0.527 0.007 
ALA147CB 0.398 0.016 
	  
Table C-25: Methyl Order Parameters of nNOS(p) bound to CaM(E84K) 
ID	   O2axis Err	  
ALA4CB 0.492 0.005 
ILE5CG2 0.432 0.006 
ILE5CD1 0.343 0.02 
LEU10CD1 0.562 0.012 
LEU10CD2 0.686 0.019 
ALA11CB 0.87 0.002 
ALA13CB 0.885 0.012 
ID	   O2axis Err	  
VAL14CG1 0.785 0.005 
VAL14CG2 0.8 0.017 
ALA18CB 0.919 0.043 
LEU20CD1 0.462 0.002 
LEU20CD2 0.462 0.009 





Table C-26: Methyl Order Parameters of Ca2+-bound CaM(D58N)  
ID	   O2axis Err	  
LEU4CD1 0.403 0.022 
LEU4CD2 0.358 0.036 
ILE9CG2 0.726 0.028 
ILE9CD1 0.378 0.045 
ALA10CB 0.741 0.028 
ALA15CB 0.954 0.052 
LEU18CD1 0.174 0.038 
LEU18CD2 0.239 0.049 
THR26CG2 0.696 0.025 
ILE27CD1 0.721 0.027 
THR29CG2 0.413 0.017 
LEU32CD2 0.472 0.016 
THR34CG2 0.517 0.019 
VAL35CG1 0.676 0.021 
VAL35CG2 0.681 0.033 
MET36CE 0.229 0.028 
LEU39CD1 0.502 0.016 
LEU39CD2 0.467 0.018 
LEU48CD1 0.497 0.022 
LEU48CD2 0.681 0.026 
MET51CE 0.154 0.062 
ILE52CG2 0.716 0.03 
ILE52CD1 0.512 0.017 
VAL55CG1 0.646 0.016 
VAL55CG2 0.651 0.017 
ALA57CB 0.785 0.025 
THR62CG2 0.83 0.031 
ILE63CD1 0.616 0.023 
ILE63CG2 0.775 0.036 
LEU69CD1 0.422 0.022 
LEU69CD2 0.393 0.023 
THR70CG2 0.557 0.024 
MET71CE 0.129 0.05 
MET72CE 0.219 0.03 
MET76CE 0.075 0.044 
THR79CG2 0.234 0.028 
ID	   O2axis Err	  
ILE85CG2 0.572 0.015 
ILE85CD1 0.343 0.038 
ALA88CB 0.77 0.008 
VAL91CG1 0.681 0.005 
VAL91CG2 0.641 0.012 
ILE100CG2 0.78 0.013 
ILE100CD1 0.596 0.037 
ALA102CB 0.919 0.042 
LEU105CD1 0.343 0.006 
LEU105CD2 0.268 0.025 
VAL108CG1 0.557 0.008 
VAL108CG2 0.462 0.021 
MET109CE 0.134 0.028 
THR110CG2 0.482 0.007 
LEU112CD1 0.373 0.003 
LEU112CD2 0.398 0.007 
LEU116CD1 0.293 0.003 
LEU116CD2 0.298 0.017 
VAL121CG1 0.522 0.009 
VAL121CG2 0.517 0.026 
MET124CE 0.109 0.031 
ILE125CG2 0.586 0.031 
ILE125CD1 0.199 0.032 
ALA128CB 0.741 0.029 
ILE130CG2 0.457 0.02 
ILE130CD1	   0.333	   0.051	  
VAL136CG1	   0.78	   0.009	  
VAL136CG2	   0.686	   0.002	  
VAL142CG1	   0.701	   0.007	  
VAL142CG2	   0.626	   0.03	  
MET144CE	   0.184	   0.007	  
MET145CE	   0.179	   0.019	  
THR146CG2	   0.413	   0.006	  





Table C-27: Methyl Order Parameters of CaM(D58N) bound to smMLCK(p) 
ID	   O2axis Err	  
ALA1CB 0.04 0.008 
LEU4CD1 0.338 0.006 
LEU4CD2 0.467 0.004 
ILE9CD1 0.532 0.025 
ALA10CB 0.8 0.006 
ALA15CB 0.87 0.025 
LEU18CD1 0.472 0.004 
LEU18CD2 0.408 0.021 
THR26CG2 0.681 0.011 
ILE27CD1 0.82 0.014 
ILE27CG2 0.919 0.022 
THR29CG2 0.606 0.005 
LEU32CD1 0.527 0.004 
LEU32CD2 0.477 0.02 
THR34CG2 0.671 0.002 
VAL35CG1 0.656 0.009 
VAL35CG2 0.76 0.022 
MET36CE 0.318 0.016 
LEU39CD1 0.616 0.005 
LEU39CD2 0.601 0.013 
ALA46CB 0.81 0.007 
LEU48CD2 0.726 0.019 
MET51CE 0.283 0.046 
ILE52CG2 0.81 0.021 
ILE52CD1 0.482 0.016 
VAL55CG1 0.686 0.006 
VAL55CG2 0.591 0.01 
ALA57CB 0.368 0.015 
ILE63CD1 0.542 0.025 
ILE63CG2 0.954 0.035 
LEU69CD1 0.318 0.021 
THR70CG2 0.691 0.013 
MET71CE 0.462 0.014 
MET72CE 0.721 0.009 
ID	   O2axis Err	  
ALA73CB 0.815 0.026 
MET76CE 0.08 0.016 
THR79CG2 0.363 0.021 
ILE85CG2 0.666 0.015 
ILE85CD1 0.323 0.021 
ALA88CB 0.994 0.021 
VAL91CG2 0.76 0.016 
ILE100CD1 0.939 0.003 
ALA102CB 0.929 0.003 
ALA103CB 0.929 0.027 
LEU105CD1 0.557 0.006 
LEU105CD2 0.656 0.009 
VAL108CG2 0.512 0.008 
MET109CE 0.338 0.019 
THR110CG2 0.611 0.003 
LEU112CD1 0.586 0.003 
LEU112CD2 0.606 0.014 
LEU116CD1 0.189 0.029 
VAL121CG2 0.621 0.02 
MET124CE 0.954 0.012 
ILE125CG2 0.81 0.023 
ILE125CD1 0.417 0.048 
ALA128CB 0.805 0.017 
ILE130CG2 0.582 0.009 
ILE130CD1 0.373 0.026 
VAL136CG2 0.736 0.008 
VAL142CG1 0.631 0.002 
VAL142CG2	   0.616	   0.011	  
MET144CE	   0.398	   0.003	  
MET145CE	   0.293	   0.015	  
THR146CG2	   0.527	   0.007	  





Table C-28: Methyl Order Parameters of smMLCK(p) bound to CaM(D58N) 
ID	   O2axis Err	  
ALA1CB 0.78 0.008 
THR8CG2 0.681 0.021 
ALA11CB 0.88 0.012 
VAL12CG1 0.765 0.005 
VAL12CG2 0.731 0.014 
ID	   O2axis Err	  
ALA14CB 0.87 0.018 
ILE15CG2 0.701 0.018 
ILE15CD1 0.427 0.019 
LEU18CD1 0.721 0.012 
LEU18CD2 0.785 0.004 
	  
Table C-29: Methyl Order Parameters of Ca2+-bound CaM(D95N)  
ID	   O2axis Err	  
LEU4CD1 0.472 0.032 
LEU4CD2 0.393 0.037 
THR5CG2 0.775 0.029 
ILE9CG2 0.78 0.021 
ILE9CD1 0.422 0.049 
ALA10CB 0.815 0.031 
ALA15CB 0.989 0.053 
LEU18CD1 0.209 0.035 
LEU18CD2 0.288 0.033 
THR26CG2 0.487 0.018 
ILE27CD1 0.721 0.026 
ILE27CG2 0.611 0.024 
THR29CG2 0.398 0.019 
LEU32CD1 0.611 0.025 
LEU32CD2 0.393 0.023 
THR34CG2 0.547 0.021 
VAL35CG2 0.75 0.04 
MET36CE 0.249 0.035 
LEU39CD2 0.482 0.023 
ALA46CB 0.825 0.042 
LEU48CD2 0.398 0.029 
MET51CE 0.189 0.044 
ILE52CG2 0.681 0.032 
ILE52CD1 0.338 0.028 
VAL55CG1 0.586 0.027 
VAL55CG2 0.557 0.028 
THR62CG2 0.895 0.04 
ILE63CD1 0.517 0.03 
ID	   O2axis Err	  
ILE63CG2 0.716 0.032 
LEU69CD1 0.427 0.026 
LEU69CD2 0.358 0.026 
THR70CG2 0.611 0.026 
MET71CE 0.159 0.042 
MET72CE 0.253 0.018 
MET76CE 0.089 0.026 
THR79CG2 0.249 0.027 
ILE85CG2 0.606 0.02 
ILE85CD1 0.363 0.035 
ALA88CB 0.81 0.032 
VAL91CG1 0.755 0.014 
VAL91CG2 0.731 0.023 
ILE100CG2 0.82 0.031 
ILE100CD1 0.661 0.028 
ALA102CB 0.994 0.059 
LEU105CD1 0.358 0.026 
LEU105CD2 0.278 0.031 
VAL108CG2 0.537 0.024 
MET109CE 0.154 0.044 
THR110CG2 0.532 0.015 
LEU112CD2 0.437 0.015 
LEU116CD1 0.348 0.023 
LEU116CD2 0.328 0.023 
VAL121CG1 0.562 0.02 
VAL121CG2 0.532 0.019 
MET124CE 0.194 0.051 
ILE125CG2 0.636 0.024 
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ID	   O2axis Err	  
ILE125CD1 0.219 0.058 
ALA128CB 0.81 0.042 
ILE130CG2 0.522 0.022 
ILE130CD1 0.318 0.051 
VAL136CG2 0.78 0.036 
VAL142CG1	   0.76	   0.034	  
ID	   O2axis Err	  
VAL142CG2	   0.651	   0.031	  
MET144CE	   0.124	   0.042	  
MET145CE	   0.194	   0.041	  
THR146CG2	   0.427	   0.024	  
ALA147CB	   0.343	   0.033	  
	  
Table C-30: Methyl Order Parameters of CaM(D95N) bound to smMLCK(p) 
ID	   O2axis Err	  
LEU4CD1 0.333 0.038 
ILE9CD1 0.532 0.04 
ALA10CB 0.915 0.047 
ALA15CB 0.994 0.051 
LEU18CD2 0.408 0.042 
THR26CG2 0.616 0.023 
ILE27CD1 0.8 0.028 
ILE27CG2 0.77 0.018 
THR29CG2 0.591 0.014 
THR34CG2 0.661 0.006 
VAL35CG1 0.641 0.014 
VAL35CG2 0.691 0.025 
MET36CE 0.313 0.033 
LEU39CD1 0.542 0.025 
LEU39CD2 0.522 0.034 
ALA46CB 0.84 0.038 
LEU48CD2 0.78 0.038 
MET51CE 0.288 0.042 
ILE52CD1 0.328 0.043 
ILE52CG2 0.775 0.041 
VAL55CG1 0.457 0.025 
VAL55CG2 0.422 0.036 
ILE63CD1 0.81 0.033 
ILE63CG2 0.845 0.033 
LEU69CD1 0.308 0.044 
THR70CG2 0.661 0.025 
MET71CE 0.422 0.036 
MET72CE 0.731 0.026 
ALA73CB 0.83 0.042 
ID	   O2axis Err	  
MET76CE 0.089 0.066 
THR79CG2 0.373 0.03 
ILE85CD1 0.303 0.042 
ILE85CG2 0.656 0.026 
VAL91CG2 0.76 0.024 
ILE100CD1 0.865 0.013 
ALA102CB 0.959 0.024 
ALA103CB 0.929 0.032 
LEU105CD2 0.636 0.027 
VAL108CG2 0.527 0.018 
MET109CE 0.353 0.033 
THR110CG2 0.681 0.028 
LEU112CD2 0.601 0.022 
LEU116CD1 0.189 0.056 
VAL121CG2 0.646 0.024 
MET124CE 0.835 0.032 
ILE125CD1 0.408 0.05 
ILE125CG2 0.805 0.027 
ALA128CB 0.924 0.036 
ILE130CD1 0.363 0.04 
ILE130CG2 0.596 0.029 
VAL136CG2 0.845 0.04 
VAL142CG1 0.611 0.015 
VAL142CG2 0.651 0.025 
MET144CE 0.398 0.021 
MET145CE 0.283 0.026 
THR146CG2 0.547 0.021 




Table C-31: Methyl Order Parameters of smMLCK(p) bound to CaM(D95N) 
ID	   O2axis Err	  
ALA1CB 0.731 0.011 
THR8CG2 0.626 0.041 
ALA11CB 0.83 0.003 
VAL12CG1 0.721 0.01 
VAL12CG2 0.706 0.012 
ID	   O2axis Err	  
ALA14CB 0.855 0.011 
ILE15CG2 0.656 0.009 
ILE15CD1 0.363 0.006 
LEU18CD1 0.661 0.004 
LEU18CD2 0.671 0.004 
	  
Table C-32: Methyl Order Parameters of WT CAP:cAMP2 
ID	   O2axis Err	  
LEU11d2 0.46 0.04 
LEU11d1 0.43 0.04 
LEU15d2 0.85 0.06 
LEU15d1 0.59 0.02 
ILE20d1 0.15 0.03 
LEU29d2 0.36 0.04 
LEU29d1 0.47 0.04 
ILE30d1 0.79 0.04 
LEU39d2 0.74 0.03 
LEU39d1 0.73 0.03 
ILE42d1 0.56 0.04 
VAL43g1 0.74 0.07 
VAL43g2 0.7 0.04 
VAL47g1 0.66 0.03 
VAL47g2 0.66 0.05 
VAL49g2 0.96 0.04 
VAL49g1 0.86 0.03 
LEU50d1 0.33 0.06 
LEU50d2 0.32 0.04 
ILE51d1 0.54 0.04 
ILE60d1 0.46 0.02 
LEU61d1 0.4 0.04 
LEU61d2 0.37 0.04 
LEU64d2 0.68 0.03 
LEU64d1 0.67 0.03 
ILE70d1 0.55 0.06 
LEU73d2 0.63 0.05 
ID	   O2axis Err	  
LEU73d1 0.57 0.03 
LEU75d2 0.52 0.04 
LEU75d1 0.47 0.04 
VAL86g1 0.66 0.09 
VAL86g2 0.63 0.05 
VAL94g1 0.63 0.04 
VAL94g2 0.56 0.03 
ILE97d1 0.52 0.02 
LEU105d1 0.56 0.03 
LEU105d2 0.55 0.03 
ILE106d1 0.36 0.04 
VAL108g2 0.52 0.03 
VAL108g1 0.46 0.03 
ILE112d1 0.55 0.07 
LEU113d2 0.44 0.07 
LEU113d1 0.54 0.06 
LEU116d1 0.27 0.05 
LEU116d2 0.24 0.04 
LEU124d2 0.29 0.03 
LEU124d1 0.29 0.02 
VAL126g2 0.52 0.04 
VAL126g1 0.49 0.03 
VAL131g2 0.45 0.05 
VAL131g1 0.51 0.05 
LEU134d1 0.54 0.05 
LEU134d2 0.51 0.07 
LEU137d2 0.55 0.07 
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ID	   O2axis Err	  
LEU137d1 0.45 0.04 
VAL139g1 0.5 0.04 
VAL139g2 0.49 0.04 
ILE143d1 0.44 0.04 
LEU147d1 0.62 0.08 
LEU147d2 0.56 0.08 
LEU148d2 0.35 0.04 
LEU148d1 0.34 0.07 
LEU150d1 0.44 0.14 
LEU150d2 0.49 0.06 
ILE165d1 0.44 0.05 
ILE167d1 0.29 0.06 
ILE172d1 0.42 0.05 
ILE175d1 0.54 0.05 
VAL176g2 0.52 0.05 
VAL176g1 0.37 0.05 
VAL183g1 0.44 0.07 
VAL183g2 0.17 0.05 
ILE186d1 0.23 0.04 
LEU187d1 0.44 0.06 
LEU187d2 0.54 0.05 
LEU190d1 0.63 0.05 
LEU190d2 0.44 0.09 
LEU195d1 0.48 0.05 
LEU195d2 0.32 0.06 
ILE196d1 0.3 0.1 
ID	   O2axis Err	  
ILE203d1 0.54 0.11 
VAL204g2 0.54 0.05 
VAL204g1 0.5 0.04 
VAL205g1 0.54 0.05 
VAL205g2 0.31 0.04 
ALA36 0.9 0.05 
ALA48 0.92 0.12 
MET59 0.13 0.04 
ALA84 0.66 0.19 
ALA88 0.86 0.2 
ALA91 0.9 0.22 
ALA95 0.71 0.22 
MET114 0.17 0.1 
ALA118 0.62 0.14 
MET120 0.24 0.07 
ALA121 0.87 0.22 
ALA135 0.85 0.2 
ALA144 0.93 0.23 
ALA151 0.93 0.19 
ALA156 0.81 0.17 
MET157 0.31 0.18 
MET163 0.4 0.19 
MET189 0.53 0.09 
ALA198 0.74 0.15 
	  
Table C-33: Methyl Order Parameters of CAP:cAMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.45 0.02 
LEU11d1 0.43 0.01 
LEU15d2 0.9 0.02 
LEU15d1 0.68 0.02 
ILE20d1 0.24 0.01 
LEU29d2 0.22 0.02 
LEU29d1 0.3 0.02 
ILE30d1 0.82 0.02 
LEU39d2 0.72 0.02 
ID	   O2axis Err	  
LEU39d1 0.8 0.02 
ILE42d1 0.72 0.03 
VAL43g1 0.86 0.02 
VAL43g2 0.71 0.02 
VAL47g1 0.88 0.04 
VAL47g2 0.7 0.03 
VAL49g2 0.79 0.02 
VAL49g1 0.72 0.02 
LEU50d1 0.27 0.01 
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ID	   O2axis Err	  
LEU50d2 0.26 0.01 
ILE51d1 0.61 0.01 
ILE60d1 0.61 0.01 
LEU61d1 0.32 0.01 
LEU61d2 0.32 0.02 
LEU64d2 0.87 0.02 
LEU64d1 0.7 0.03 
ILE70d1 0.49 0.03 
LEU73d2 0.9 0.04 
LEU73d1 0.69 0.02 
LEU75d2 0.63 0.02 
LEU75d1 0.6 0.02 
VAL86g1 0.9 0.04 
VAL86g2 0.67 0.02 
VAL94g1 0.5 0.02 
VAL94g2 0.67 0.02 
ILE97d1 0.64 0.02 
LEU105d1 0.39 0.02 
LEU105d2 0.36 0.02 
ILE106d1 0.48 0.02 
VAL108g2 0.54 0.02 
VAL108g1 0.52 0.02 
ILE112d1 0.48 0.01 
LEU113d2 0.46 0.02 
LEU113d1 0.4 0.02 
LEU116d1 0.46 0.02 
LEU116d2 0.36 0.02 
LEU124d2 0.35 0.02 
LEU124d1 0.34 0.01 
VAL126g2 0.49 0.02 
VAL126g1 0.49 0.01 
VAL131g2 0.48 0.02 
VAL131g1 0.47 0.02 
LEU134d1 0.33 0.01 
LEU134d2 0.48 0.02 
LEU137d2 0.48 0.01 
LEU137d1 0.32 0.02 
VAL139g1 0.52 0.02 
VAL139g2 0.5 0.02 
ID	   O2axis Err	  
ILE143d1 0.46 0.04 
LEU147d1 0.9 0.02 
LEU147d2 0.68 0.02 
LEU148d2 0.45 0.01 
LEU148d1 0.41 0.02 
LEU150d1 0.4 0.03 
LEU150d2 0.64 0.02 
ILE165d1 0.6 0.01 
ILE167d1 0.46 0.02 
ILE172d1 0.78 0.02 
ILE175d1 0.73 0.01 
VAL176g2 0.57 0.01 
VAL176g1 0.56 0.01 
VAL183g1 0.53 0.02 
VAL183g2 0.56 0.02 
ILE186d1 0.78 0.02 
LEU187d1 0.74 0.02 
LEU187d2 0.79 0.02 
LEU190d1 0.72 0.02 
LEU190d2 0.82 0.02 
LEU195d1 0.71 0.02 
LEU195d2 0.9 0.03 
ILE196d1 0.68 0.13 
ILE203d1 0.6 0.02 
VAL204g2 0.59 0.02 
VAL204g1 0.55 0.02 
VAL205g1 0.54 0.02 
VAL205g2 0.41 0.02 
ALA36 0.86 0.1 
ALA48 0.91 0.15 
MET59 0.29 0.02 
ALA84 0.72 0.11 
ALA88 0.94 0.08 
ALA91 0.71 0.12 
ALA95 0.81 0.1 
MET114 0.12 0.01 
ALA118 0.8 0.14 
MET120 0.24 0.03 
ALA121 0.86 0.19 
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ID	   O2axis Err	  
ALA135 0.95 0.15 
ALA144 0.92 0.18 
ALA151 0.92 0.2 
ALA156 0.88 0.1 
ID	   O2axis Err	  
MET157 0.38 0.16 
MET163 0.39 0.17 
MET189 0.62 0.12 
ALA198 0.79 0.12 
	  
Table C-34: Methyl Order Parameters of CAP(D53H):cAMP2 
ID	   O2axis Err	  
LEU11d2 0.24 0.03 
LEU11d1 0.23 0.03 
LEU15d2 0.47 0.04 
LEU15d1 0.48 0.02 
ILE20d1 0.13 0.02 
LEU29d2 0.35 0.03 
LEU29d1 0.3 0.02 
ILE30d1 0.64 0.03 
LEU39d2 0.72 0.02 
LEU39d1 0.65 0.02 
ILE42d1 0.7 0.03 
VAL43g1 0.78 0.04 
VAL43g2 0.77 0.02 
VAL47g1 0.76 0.02 
VAL47g2 0.74 0.03 
VAL49g2 0.82 0.02 
VAL49g1 0.88 0.02 
LEU50d1 0.25 0.04 
LEU50d2 0.25 0.03 
ILE51d1 0.61 0.03 
ILE60d1 0.24 0.01 
LEU61d1 0.34 0.03 
LEU61d2 0.34 0.02 
LEU64d2 0.77 0.02 
LEU64d1 0.76 0.02 
ILE70d1 0.64 0.04 
LEU73d2 0.71 0.03 
LEU73d1 0.7 0.02 
LEU75d2 0.57 0.03 
LEU75d1 0.47 0.02 
VAL86g1 0.75 0.06 
ID	   O2axis Err	  
VAL86g2 0.71 0.03 
VAL94g1 0.72 0.03 
VAL94g2 0.7 0.02 
ILE97d1 0.58 0.01 
LEU105d1 0.69 0.02 
LEU105d2 0.66 0.02 
ILE106d1 0.3 0.03 
VAL108g2 0.58 0.02 
VAL108g1 0.45 0.02 
ILE112d1 0.66 0.05 
LEU113d2 0.6 0.05 
LEU113d1 0.37 0.04 
LEU116d1 0.15 0.03 
LEU116d2 0.15 0.03 
LEU124d2 0.2 0.02 
LEU124d1 0.18 0.01 
VAL126g2 0.57 0.02 
VAL126g1 0.51 0.02 
VAL131g2 0.56 0.03 
VAL131g1 0.44 0.03 
LEU134d1 0.59 0.03 
LEU134d2 0.56 0.04 
LEU137d2 0.64 0.05 
LEU137d1 0.43 0.03 
VAL139g1 0.55 0.03 
VAL139g2 0.51 0.03 
ILE143d1 0.43 0.02 
LEU147d1 0.7 0.05 
LEU147d2 0.69 0.05 
LEU148d2 0.26 0.03 
LEU148d1 0.26 0.05 
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ID	   O2axis Err	  
LEU150d1 0.51 0.09 
LEU150d2 0.41 0.04 
ILE165d1 0.4 0.03 
ILE167d1 0.22 0.04 
ILE172d1 0.34 0.03 
ILE175d1 0.58 0.03 
VAL176g2 0.38 0.03 
VAL176g1 0.33 0.03 
VAL183g1 0.58 0.05 
VAL183g2 0.53 0.03 
ILE186d1 0.54 0.03 
LEU187d1 0.62 0.04 
LEU187d2 0.51 0.04 
LEU190d1 0.4 0.03 
LEU190d2 0.39 0.06 
LEU195d1 0.48 0.03 
LEU195d2 0.68 0.04 
ILE196d1 0.7 0.06 
ILE203d1 0.61 0.07 
VAL204g2 0.62 0.03 
VAL204g1 0.51 0.03 
ID	   O2axis Err	  
VAL205g1 0.61 0.03 
VAL205g2 0.46 0.03 
ALA36 0.88 0.2 
ALA48 0.94 0.1 
MET59 0.5 0.22 
ALA84 0.93 0.34 
ALA88 0.92 0.29 
ALA91 0.96 0.33 
ALA95 0.96 0.36 
MET114 0.54 0.1 
ALA118 0.89 0.24 
MET120 0.51 0.07 
ALA121 0.85 0.23 
ALA135 0.88 0.32 
ALA144 0.94 0.32 
ALA151 0.84 0.34 
ALA156 0.77 0.3 
MET157 0.27 0.18 
MET163 0.45 0.19 
MET189 0.33 0.06 
ALA198 0.76 0.16 
	  
Table C-35: Methyl Order Parameters of CAP(D53H):cAMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.23 0.03 
LEU11d1 0.21 0.02 
LEU15d2 0.5 0.03 
LEU15d1 0.52 0.02 
ILE20d1 0.14 0.01 
LEU29d2 0.41 0.03 
LEU29d1 0.34 0.02 
ILE30d1 0.71 0.02 
LEU39d2 0.73 0.03 
LEU39d1 0.72 0.03 
ILE42d1 0.72 0.03 
VAL43g1 0.83 0.03 
VAL43g2 0.86 0.02 
VAL47g1 0.84 0.05 
ID	   O2axis Err	  
VAL47g2 0.74 0.04 
VAL49g2 0.9 0.03 
VAL49g1 0.9 0.02 
LEU50d1 0.25 0.01 
LEU50d2 0.24 0.01 
ILE51d1 0.65 0.02 
ILE60d1 0.21 0.02 
LEU61d1 0.37 0.02 
LEU61d2 0.36 0.03 
LEU64d2 0.77 0.03 
LEU64d1 0.9 0.03 
ILE70d1 0.71 0.03 
LEU73d2 0.8 0.05 
LEU73d1 0.73 0.02 
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ID	   O2axis Err	  
LEU75d2 0.59 0.02 
LEU75d1 0.5 0.02 
VAL86g1 0.74 0.05 
VAL86g2 0.72 0.03 
VAL94g1 0.72 0.02 
VAL94g2 0.73 0.02 
ILE97d1 0.61 0.02 
LEU105d1 0.72 0.03 
LEU105d2 0.72 0.02 
ILE106d1 0.31 0.02 
VAL108g2 0.6 0.02 
VAL108g1 0.5 0.02 
ILE112d1 0.72 0.01 
LEU113d2 0.64 0.03 
LEU113d1 0.42 0.03 
LEU116d1 0.14 0.02 
LEU116d2 0.13 0.02 
LEU124d2 0.18 0.02 
LEU124d1 0.15 0.02 
VAL126g2 0.59 0.03 
VAL126g1 0.54 0.02 
VAL131g2 0.58 0.02 
VAL131g1 0.5 0.02 
LEU134d1 0.64 0.03 
LEU134d2 0.56 0.02 
LEU137d2 0.68 0.03 
LEU137d1 0.49 0.05 
VAL139g1 0.55 0.03 
VAL139g2 0.54 0.03 
ILE143d1 0.48 0.02 
LEU147d1 0.67 0.03 
LEU147d2 0.72 0.04 
LEU148d2 0.3 0.03 
LEU148d1 0.29 0.02 
LEU150d1 0.52 0.03 
LEU150d2 0.46 0.03 
ILE165d1 0.44 0.02 
ILE167d1 0.43 0.01 
ILE172d1 0.41 0.02 
ID	   O2axis Err	  
ILE175d1 0.61 0.02 
VAL176g2 0.61 0.02 
VAL176g1 0.59 0.02 
VAL183g1 0.73 0.02 
VAL183g2 0.71 0.02 
ILE186d1 0.68 0.03 
LEU187d1 0.67 0.03 
LEU187d2 0.72 0.03 
LEU190d1 0.52 0.03 
LEU190d2 0.5 0.17 
LEU195d1 0.75 0.02 
LEU195d2 0.71 0.02 
ILE196d1 0.77 0.02 
ILE203d1 0.66 0.02 
VAL204g2 0.66 0.02 
VAL204g1 0.54 0.02 
VAL205g1 0.65 0.04 
VAL205g2 0.5 0.03 
ALA36 0.95 0.12 
ALA48 0.9 0.16 
MET59 0.4 0.19 
ALA84 0.96 0.16 
ALA88 0.86 0.2 
ALA91 0.92 0.28 
ALA95 0.95 0.26 
MET114 0.59 0.24 
ALA118 0.87 0.24 
MET120 0.42 0.12 
ALA121 0.88 0.14 
ALA135 0.94 0.25 
ALA144 0.97 0.18 
ALA151 0.93 0.18 
ALA156 0.92 0.18 
MET157 0.32 0.04 
MET163 0.41 0.21 
MET189 0.39 0.16 





Table C-36: Methyl Order Parameters of CAP(S62F):cAMP2 
ID	   O2axis Err	  
LEU11d2 0.3 0.05 
LEU11d1 0.29 0.04 
LEU15d2 0.74 0.06 
LEU15d1 0.64 0.04 
ILE20d1 0.3 0.02 
LEU29d2 0.2 0.06 
LEU29d1 0.18 0.04 
ILE30d1 0.67 0.04 
LEU39d2 0.68 0.06 
LEU39d1 0.75 0.05 
ILE42d1 0.66 0.07 
VAL43g1 0.78 0.06 
VAL43g2 0.66 0.04 
VAL47g1 0.73 0.09 
VAL47g2 0.68 0.08 
VAL49g2 0.94 0.05 
VAL49g1 0.9 0.05 
LEU50d1 0.53 0.03 
LEU50d2 0.74 0.03 
ILE51d1 0.77 0.04 
ILE60d1 0.83 0.03 
LEU61d1 0.77 0.03 
LEU61d2 0.86 0.05 
LEU64d2 0.64 0.05 
LEU64d1 0.79 0.05 
ILE70d1 0.75 0.05 
LEU73d2 0.54 0.1 
LEU73d1 0.53 0.04 
LEU75d2 0.75 0.05 
LEU75d1 0.73 0.04 
VAL86g1 0.7 0.09 
VAL86g2 0.75 0.05 
VAL94g1 0.69 0.05 
VAL94g2 0.8 0.04 
ID	   O2axis Err	  
ILE97d1 0.66 0.05 
LEU105d1 0.62 0.05 
LEU105d2 0.51 0.04 
ILE106d1 0.52 0.04 
VAL108g2 0.43 0.04 
VAL108g1 0.36 0.05 
ILE112d1 0.21 0.03 
LEU113d2 0.71 0.06 
LEU113d1 0.72 0.06 
LEU116d1 0.44 0.04 
LEU116d2 0.43 0.04 
LEU124d2 0.58 0.04 
LEU124d1 0.56 0.03 
VAL126g2 0.43 0.05 
VAL126g1 0.58 0.04 
VAL131g2 0.58 0.04 
VAL131g1 0.37 0.04 
LEU134d1 0.49 0.05 
LEU134d2 0.48 0.04 
LEU137d2 0.37 0.05 
LEU137d1 0.28 0.09 
VAL139g1 0.63 0.06 
VAL139g2 0.62 0.06 
ILE143d1 0.8 0.04 
LEU147d1 0.69 0.06 
LEU147d2 0.86 0.08 
LEU148d2 0.56 0.05 
LEU148d1 0.58 0.04 
LEU150d1 0.72 0.05 
LEU150d2 0.69 0.05 
ILE165d1 0.39 0.03 
ILE167d1 0.5 0.03 
ILE172d1 0.8 0.03 
ILE175d1 0.96 0.04 
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ID	   O2axis Err	  
VAL176g2 0.6 0.04 
VAL176g1 0.46 0.04 
VAL183g1 0.59 0.04 
VAL183g2 0.84 0.04 
ILE186d1 0.83 0.05 
LEU187d1 0.75 0.06 
LEU187d2 0.64 0.05 
LEU190d1 0.63 0.07 
LEU190d2 0.56 0.33 
LEU195d1 0.56 0.05 
LEU195d2 0.53 0.04 
ILE196d1 0.52 0.04 
ILE203d1 0.4 0.04 
VAL204g2 0.56 0.04 
VAL204g1 0.43 0.04 
VAL205g1 0.48 0.08 
VAL205g2 0.5 0.06 
ALA36 0.66 0.14 
ID	   O2axis Err	  
ALA48 0.69 0.12 
MET59 0.28 0.07 
ALA84 0.98 0.1 
ALA88 0.89 0.14 
ALA91 0.9 0.15 
ALA95 0.94 0.15 
MET114 0.28 0.07 
ALA118 0.82 0.17 
MET120 0.45 0.05 
ALA121 0.88 0.17 
ALA135 0.76 0.18 
ALA144 0.99 0.11 
ALA151 0.85 0.1 
ALA156 0.84 0.16 
MET157 0.14 0.02 
MET163 0.2 0.05 
MET189 0.28 0.1 
ALA198 0.76 0.04 
	  
Table C-37: Methyl Order Parameters of CAP(S62F):cAMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.31 0.02 
LEU11d1 0.3 0.02 
LEU15d2 0.55 0.02 
LEU15d1 0.63 0.01 
ILE20d1 0.18 0.01 
LEU29d2 0.23 0.02 
LEU29d1 0.23 0.01 
ILE30d1 0.62 0.02 
LEU39d2 0.67 0.01 
LEU39d1 0.53 0.01 
ILE42d1 0.66 0.02 
VAL43g1 0.53 0.03 
VAL43g2 0.41 0.01 
VAL47g1 0.51 0.01 
VAL47g2 0.45 0.02 
VAL49g2 0.72 0.01 
VAL49g1 0.54 0.01 
ID	   O2axis Err	  
LEU50d1 0.35 0.02 
LEU50d2 0.42 0.02 
ILE51d1 0.53 0.02 
ILE60d1 0.4 0.01 
LEU61d1 0.39 0.02 
LEU61d2 0.55 0.01 
LEU64d2 0.63 0.01 
LEU64d1 0.62 0.01 
ILE70d1 0.55 0.02 
LEU73d2 0.69 0.02 
LEU73d1 0.68 0.01 
LEU75d2 0.6 0.02 
LEU75d1 0.51 0.01 
VAL86g1 0.62 0.04 
VAL86g2 0.62 0.02 
VAL94g1 0.45 0.02 
VAL94g2 0.54 0.01 
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ID	   O2axis Err	  
ILE97d1 0.44 0.01 
LEU105d1 0.67 0.01 
LEU105d2 0.58 0.01 
ILE106d1 0.32 0.02 
VAL108g2 0.28 0.01 
VAL108g1 0.33 0.01 
ILE112d1 0.24 0.03 
LEU113d2 0.71 0.03 
LEU113d1 0.62 0.02 
LEU116d1 0.37 0.02 
LEU116d2 0.37 0.02 
LEU124d2 0.75 0.01 
LEU124d1 0.72 0.01 
VAL126g2 0.37 0.01 
VAL126g1 0.51 0.01 
VAL131g2 0.49 0.03 
VAL131g1 0.42 0.03 
LEU134d1 0.61 0.02 
LEU134d2 0.58 0.02 
LEU137d2 0.57 0.02 
LEU137d1 0.3 0.01 
VAL139g1 0.73 0.03 
VAL139g2 0.69 0.03 
ILE143d1 0.78 0.02 
LEU147d1 0.76 0.03 
LEU147d2 0.67 0.05 
LEU148d2 0.71 0.02 
LEU148d1 0.55 0.02 
LEU150d1 0.47 0.02 
LEU150d2 0.46 0.02 
ILE165d1 0.35 0.02 
ILE167d1 0.62 0.02 
ILE172d1 0.67 0.02 
ILE175d1 0.9 0.03 
VAL176g2 0.78 0.02 
VAL176g1 0.56 0.02 
ID	   O2axis Err	  
VAL183g1 0.77 0.02 
VAL183g2 0.73 0.02 
ILE186d1 0.86 0.02 
LEU187d1 0.92 0.03 
LEU187d2 0.87 0.02 
LEU190d1 0.8 0.02 
LEU190d2 0.7 0.04 
LEU195d1 0.7 0.04 
LEU195d2 0.65 0.02 
ILE196d1 0.64 0.02 
ILE203d1 0.3 0.02 
VAL204g2 0.48 0.02 
VAL204g1 0.43 0.01 
VAL205g1 0.43 0.05 
VAL205g2 0.45 0.02 
ALA36 0.62 0.11 
ALA48 0.65 0.11 
MET59 0.27 0.12 
ALA84 0.91 0.09 
ALA88 0.75 0.25 
ALA91 0.92 0.11 
ALA95 0.95 0.09 
MET114 0.29 0.03 
ALA118 0.86 0.17 
MET120 0.43 0.3 
ALA121 0.89 0.56 
ALA135 0.55 0.11 
ALA144 0.9 0.11 
ALA151 0.86 0.32 
ALA156 0.82 0.14 
MET157 0.2 0.16 
MET163 0.25 0.19 
MET189 0.37 0.15 





Table C-38: Methyl Order Parameters of CAP(T127L/S128I) 
ID	   O2axis Err	  
LEU11d2 0.56 0.05 
LEU11d1 0.48 0.04 
LEU15d2 0.96 0.06 
LEU15d1 0.72 0.04 
ILE20d1 0.22 0.02 
LEU29d2 0.71 0.06 
LEU29d1 0.38 0.04 
ILE30 0.85 0.04 
LEU39d2 0.81 0.06 
LEU39d1 0.76 0.05 
ILE42d1 0.78 0.07 
VAL43g1 0.96 0.06 
VAL43g2 0.82 0.04 
VAL47g1 0.96 0.09 
VAL47g2 0.72 0.08 
VAL49g2 0.96 0.05 
VAL49g1 0.96 0.05 
LEU50d1 0.52 0.03 
LEU50d2 0.46 0.03 
ILE51d1 0.72 0.04 
ILE60d1 0.47 0.03 
LEU61d1 0.38 0.03 
LEU61d2 0.36 0.05 
LEU64d2 0.96 0.05 
LEU64d1 0.96 0.05 
ILE70d1 0.77 0.05 
LEU73d2 0.82 0.1 
LEU73d1 0.69 0.04 
LEU75d2 0.74 0.05 
LEU75d1 0.59 0.04 
VAL86g1 0.96 0.09 
VAL86g2 0.83 0.05 
VAL94g1 0.92 0.05 
VAL94g2 0.72 0.04 
ILE97d1 0.75 0.05 
LEU105d1 0.69 0.05 
LEU105d2 0.62 0.04 
ID	   O2axis Err	  
ILE106d1 0.61 0.04 
VAL108g2 0.75 0.04 
VAL108g1 0.73 0.05 
ILE112d1 0.87 0.03 
LEU113d2 0.96 0.06 
LEU113d1 0.92 0.06 
LEU116d1 0.36 0.04 
LEU116d2 0.3 0.04 
LEU124d2 0.55 0.04 
LEU124d1 0.34 0.03 
VAL126g2 0.96 0.05 
VAL126g1 0.76 0.04 
LEU127D1 0.78 0.05 
LEU127D2 0.67 0.04 
ILE128 0.71 0.04 
VAL131g2 0.79 0.04 
VAL131g1 0.74 0.04 
LEU134d1 0.84 0.05 
LEU134d2 0.66 0.04 
LEU137d2 0.96 0.05 
LEU137d1 0.92 0.09 
VAL139g1 0.96 0.06 
VAL139g2 0.89 0.06 
ILE143d1 0.59 0.04 
LEU147d1 0.95 0.06 
LEU147d2 0.95 0.08 
LEU148d2 0.8 0.05 
LEU148d1 0.65 0.04 
LEU150d1 0.94 0.05 
LEU150d2 0.91 0.05 
ILE165d1 0.51 0.03 
ILE167d1 0.28 0.03 
ILE172d1 0.62 0.03 
ILE175d1 0.69 0.04 
VAL176g2 0.72 0.04 
VAL176g1 0.66 0.04 
VAL183g1 0.45 0.04 
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ID	   O2axis Err	  
VAL183g2 0.37 0.04 
ILE186d1 0.52 0.05 
LEU187d1 0.96 0.06 
LEU187d2 0.86 0.05 
LEU190d1 0.95 0.07 
LEU190d2 0.92 0.33 
LEU195d1 0.79 0.05 
LEU195d2 0.59 0.04 
ILE196d1 0.58 0.04 
ILE203d1 0.96 0.04 
VAL204g2 0.79 0.04 
VAL204g1 0.75 0.04 
VAL205g1 0.94 0.08 
VAL205g2 0.9 0.06 
ALA36 0.62 0.16 
ALA48 0.91 0.09 
MET59 0.59 0.11 
ID	   O2axis Err	  
ALA84 0.94 0.14 
ALA88 0.8 0.16 
ALA91 0.79 0.15 
ALA95 0.85 0.13 
MET114 0.51 0.11 
ALA118 0.61 0.13 
MET120 0.48 0.1 
ALA121 0.95 0.2 
ALA135 0.6 0.16 
ALA144 0.94 0.11 
ALA151 0.68 0.15 
ALA156 0.62 0.11 
MET157 0.17 0.09 
MET163 0.38 0.09 
MET189 0.33 0.1 
ALA198 0.45 0.1 
	  
Table C-39: Methyl Order Parameters of CAP(T127L/S128I):DNA 
ID	   O2axis Err	  
LEU11d2 0.62 0.03 
LEU11d1 0.53 0.03 
LEU15d2 0.84 0.04 
LEU15d1 0.6 0.02 
ILE20d1 0.19 0.02 
LEU29d2 0.74 0.03 
LEU29d1 0.45 0.02 
ILE30 0.55 0.03 
LEU39d2 0.57 0.02 
LEU39d1 0.56 0.02 
ILE42d1 0.73 0.03 
VAL43g1 0.95 0.05 
VAL43g2 0.68 0.03 
VAL47g1 0.35 0.02 
VAL47g2 0.17 0.04 
VAL49g2 0.4 0.02 
VAL49g1 0.4 0.02 
LEU50d1 0.36 0.04 
ID	   O2axis Err	  
LEU50d2 0.3 0.03 
ILE51d1 0.45 0.03 
ILE60d1 0.19 0.01 
LEU61d1 0.56 0.03 
LEU61d2 0.49 0.03 
LEU64d2 0.5 0.02 
LEU64d1 0.49 0.02 
ILE70d1 0.72 0.04 
LEU73d2 0.6 0.03 
LEU73d1 0.48 0.02 
LEU75d2 0.65 0.03 
LEU75d1 0.5 0.03 
VAL86g1 0.96 0.06 
VAL86g2 0.93 0.03 
VAL94g1 0.71 0.03 
VAL94g2 0.48 0.02 
ILE97d1 0.62 0.02 
LEU105d1 0.6 0.02 
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ID	   O2axis Err	  
LEU105d2 0.26 0.02 
ILE106d1 0.77 0.03 
VAL108g2 0.53 0.02 
VAL108g1 0.52 0.02 
ILE112d1 0.67 0.05 
LEU113d2 0.96 0.05 
LEU113d1 0.82 0.04 
LEU116d1 0.77 0.03 
LEU116d2 0.72 0.03 
LEU124d2 0.55 0.02 
LEU124d1 0.45 0.02 
VAL126g2 0.62 0.03 
VAL126g1 0.55 0.02 
LEU127D1 0.76 0.03 
LEU127D2 0.68 0.04 
ILE128 0.76 0.03 
VAL131g2 0.96 0.05 
VAL131g1 0.96 0.05 
LEU134d1 0.83 0.03 
LEU134d2 0.73 0.03 
LEU137d2 0.93 0.03 
LEU137d1 0.83 0.03 
VAL139g1 0.96 0.06 
VAL139g2 0.89 0.06 
ILE143d1 0.68 0.03 
LEU147d1 0.92 0.05 
LEU147d2 0.96 0.09 
LEU148d2 0.87 0.04 
LEU148d1 0.79 0.03 
LEU150d1 0.83 0.04 
LEU150d2 0.79 0.03 
ILE165d1 0.62 0.03 
ILE167d1 0.63 0.03 
ILE172d1 0.68 0.03 
ILE175d1 0.74 0.05 
VAL176g2 0.89 0.04 
VAL176g1 0.77 0.03 
ID	   O2axis Err	  
VAL183g1 0.96 0.04 
VAL183g2 0.89 0.04 
ILE186d1 0.72 0.03 
LEU187d1 0.96 0.06 
LEU187d2 0.96 0.03 
LEU190d1 0.96 0.04 
LEU190d2 0.96 0.06 
LEU195d1 0.96 0.07 
LEU195d2 0.96 0.03 
ILE196d1 0.87 0.03 
ILE203d1 0.96 0.03 
VAL204g2 0.81 0.03 
VAL204g1 0.75 0.02 
VAL205g1 0.96 0.08 
VAL205g2 0.72 0.03 
ALA36 0.75 0.17 
ALA48 0.93 0.14 
MET59 0.44 0.22 
ALA84 0.95 0.24 
ALA88 0.83 0.19 
ALA91 0.85 0.11 
ALA95 0.9 0.12 
MET114 0.21 0.15 
ALA118 0.76 0.3 
MET120 0.23 0.54 
ALA121 0.7 0.2 
ALA135 0.79 0.2 
ALA144 0.81 0.12 
ALA151 0.82 0.56 
ALA156 0.31 0.06 
MET157 0.14 0.1 
MET163 0.49 0.16 
MET189 0.32 0.27 





Table C-40: Methyl Order Parameters of CAP(T127L/S128I):cAMP2 
	  
ID	   O2axis Err	  
LEU11d2 0.16 0.05 
LEU11d1 0.31 0.04 
LEU15d2 0.47 0.06 
LEU15d1 0.53 0.04 
ILE20d1 0.14 0.02 
LEU29d2 0.21 0.06 
LEU29d1 0.17 0.04 
ILE30 0.3 0.04 
LEU39d2 0.45 0.06 
LEU39d1 0.53 0.05 
ILE42d1 0.58 0.07 
VAL43g1 0.47 0.06 
VAL43g2 0.45 0.04 
VAL47g1 0.54 0.09 
VAL47g2 0.64 0.08 
VAL49g2 0.5 0.05 
VAL49g1 0.46 0.05 
LEU50d1 0.17 0.03 
LEU50d2 0.16 0.03 
ILE51d1 0.48 0.04 
ILE60d1 0.12 0.03 
LEU61d1 0.3 0.03 
LEU61d2 0.29 0.05 
LEU64d2 0.46 0.05 
LEU64d1 0.34 0.05 
ILE70d1 0.45 0.05 
LEU73d2 0.2 0.1 
LEU73d1 0.34 0.04 
LEU75d2 0.3 0.05 
LEU75d1 0.28 0.04 
VAL86g1 0.69 0.09 
VAL86g2 0.51 0.05 
VAL94g1 0.54 0.05 
VAL94g2 0.53 0.04 
ILE97d1 0.57 0.05 
ID	   O2axis Err	  
LEU105d1 0.45 0.05 
LEU105d2 0.43 0.04 
ILE106d1 0.47 0.04 
VAL108g2 0.34 0.04 
VAL108g1 0.47 0.05 
ILE112d1 0.45 0.03 
LEU113d2 0.51 0.06 
LEU113d1 0.53 0.06 
LEU116d1 0.19 0.04 
LEU116d2 0.23 0.04 
LEU124d2 0.31 0.04 
LEU124d1 0.3 0.03 
VAL126g2 0.56 0.05 
VAL126g1 0.56 0.04 
LEU127D1 0.67 0.04 
LEU127D2 0.57 0.04 
ILE128 0.66 0.05 
VAL131g2 0.51 0.04 
VAL131g1 0.44 0.05 
LEU134d1 0.67 0.09 
LEU134d2 0.54 0.06 
LEU137d2 0.22 0.06 
LEU137d1 0.21 0.04 
VAL139g1 0.43 0.06 
VAL139g2 0.29 0.08 
ILE143d1 0.27 0.05 
LEU147d1 0.47 0.04 
LEU147d2 0.43 0.05 
LEU148d2 0.53 0.05 
LEU148d1 0.37 0.03 
LEU150d1 0.42 0.03 
LEU150d2 0.51 0.03 
ILE165d1 0.37 0.04 
ILE167d1 0.43 0.04 
ILE172d1 0.35 0.04 
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ID	   O2axis Err	  
ILE175d1 0.27 0.04 
VAL176g2 0.56 0.04 
VAL176g1 0.52 0.05 
VAL183g1 0.51 0.06 
VAL183g2 0.53 0.05 
ILE186d1 0.52 0.07 
LEU187d1 0.53 0.33 
LEU187d2 0.51 0.05 
LEU190d1 0.35 0.04 
LEU190d2 0.36 0.04 
LEU195d1 0.53 0.04 
LEU195d2 0.53 0.04 
ILE196d1 0.52 0.04 
ILE203d1 0.45 0.08 
VAL204g2 0.57 0.06 
VAL204g1 0.55 0.07 
VAL205g1 0.36 0.12 
VAL205g2 0.53 0.07 
ALA36 0.56 0.05 
ID	   O2axis Err	  
ALA48 0.7 0.11 
MET59 0.25 0.05 
ALA84 0.97 0.19 
ALA88 0.6 0.04 
ALA91 0.67 0.14 
ALA95 0.72 0.15 
MET114 0.18 0.05 
ALA118 0.68 0.05 
MET120 0.19 0.03 
ALA121 0.85 0.18 
ALA135 0.68 0.05 
ALA144 0.49 0.1 
ALA151 0.43 0.03 
ALA156 0.52 0.04 
MET157 0.11 0.02 
MET163 0.38 0.03 
MET189 0.29 0.02 
ALA198 0.49 0.03 
	  
Table C-41: Methyl Order Parameters of CAP(T127L/S128I):cAMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.16 0.03 
LEU11d1 0.29 0.03 
LEU15d2 0.48 0.04 
LEU15d1 0.52 0.02 
ILE20d1 0.12 0.02 
LEU29d2 0.22 0.03 
LEU29d1 0.18 0.02 
ILE30 0.3 0.03 
LEU39d2 0.44 0.02 
LEU39d1 0.44 0.02 
ILE42d1 0.53 0.03 
VAL43g1 0.47 0.05 
VAL43g2 0.42 0.03 
VAL47g1 0.63 0.02 
VAL47g2 0.64 0.04 
VAL49g2 0.4 0.02 
ID	   O2axis Err	  
VAL49g1 0.4 0.02 
LEU50d1 0.21 0.04 
LEU50d2 0.21 0.03 
ILE51d1 0.45 0.03 
ILE60d1 0.14 0.01 
LEU61d1 0.33 0.03 
LEU61d2 0.32 0.03 
LEU64d2 0.4 0.02 
LEU64d1 0.34 0.02 
ILE70d1 0.44 0.04 
LEU73d2 0.26 0.03 
LEU73d1 0.31 0.02 
LEU75d2 0.26 0.03 
LEU75d1 0.24 0.03 
VAL86g1 0.73 0.06 
VAL86g2 0.6 0.03 
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ID	   O2axis Err	  
VAL94g1 0.53 0.03 
VAL94g2 0.55 0.02 
ILE97d1 0.57 0.02 
LEU105d1 0.43 0.02 
LEU105d2 0.47 0.02 
ILE106d1 0.48 0.03 
VAL108g2 0.32 0.02 
VAL108g1 0.47 0.02 
ILE112d1 0.48 0.05 
LEU113d2 0.54 0.05 
LEU113d1 0.6 0.04 
LEU116d1 0.19 0.03 
LEU116d2 0.13 0.03 
LEU124d2 0.29 0.02 
LEU124d1 0.28 0.02 
VAL126g2 0.89 0.03 
VAL126g1 0.76 0.02 
LEU127D1 0.74 0.05 
LEU127D2 0.7 0.05 
ILE128 0.6 0.03 
VAL131g2 0.6 0.03 
VAL131g1 0.66 0.03 
LEU134d1 0.74 0.03 
LEU134d2 0.53 0.06 
LEU137d2 0.15 0.06 
LEU137d1 0.14 0.03 
VAL139g1 0.44 0.05 
VAL139g2 0.32 0.09 
ILE143d1 0.35 0.04 
LEU147d1 0.48 0.03 
LEU147d2 0.44 0.04 
LEU148d2 0.58 0.03 
LEU148d1 0.47 0.03 
LEU150d1 0.57 0.03 
LEU150d2 0.6 0.03 
ILE165d1 0.48 0.05 
ILE167d1 0.58 0.04 
ILE172d1 0.37 0.03 
ILE175d1 0.35 0.04 
ID	   O2axis Err	  
VAL176g2 0.76 0.04 
VAL176g1 0.7 0.03 
VAL183g1 0.6 0.06 
VAL183g2 0.58 0.03 
ILE186d1 0.52 0.04 
LEU187d1 0.57 0.06 
LEU187d2 0.54 0.07 
LEU190d1 0.42 0.03 
LEU190d2 0.4 0.03 
LEU195d1 0.57 0.03 
LEU195d2 0.6 0.03 
ILE196d1 0.7 0.02 
ILE203d1 0.48 0.08 
VAL204g2 0.7 0.03 
VAL204g1 0.68 0.23 
VAL205g1 0.4 0.2 
VAL205g2 0.61 0.22 
ALA36 0.46 0.14 
ALA48 0.73 0.12 
MET59 0.27 0.13 
ALA84 0.81 0.14 
ALA88 0.68 0.52 
ALA91 0.78 0.1 
ALA95 0.56 0.13 
MET114 0.24 0.09 
ALA118 0.69 0.18 
MET120 0.31 0.06 
ALA121 0.51 0.1 
ALA135 0.54 0.12 
ALA144 0.67 0.07 
ALA151 0.94 0.21 
ALA156 0.34 0.04 
MET157 0.27 0.06 
MET163 0.19 0.1 
MET189 0.32 0.16 




Table C-42: Methyl Order Parameters of CAP(G141S) 
ID	   O2axis Err	  
LEU11d2 0.17 0.04 
LEU11d1 0.24 0.04 
LEU15d2 0.32 0.06 
LEU15d1 0.34 0.06 
ILE20d1 0.15 0.03 
LEU29d2 0.2 0.05 
LEU29d1 0.18 0.05 
ILE30d1 0.24 0.08 
LEU39d2 0.3 0.08 
LEU39d1 0.3 0.08 
ILE42d1 0.35 0.08 
VAL43g1 0.32 0.09 
VAL43g2 0.3 0.09 
VAL47g1 0.39 0.09 
VAL47g2 0.4 0.08 
VAL49g2 0.29 0.09 
VAL49g1 0.29 0.09 
LEU50d1 0.2 0.04 
LEU50d2 0.19 0.04 
ILE51d1 0.31 0.07 
ILE60d1 0.16 0.04 
LEU61d1 0.25 0.05 
LEU61d2 0.25 0.05 
LEU64d2 0.29 0.08 
LEU64d1 0.25 0.09 
ILE70d1 0.31 0.08 
LEU73d2 0.22 0.09 
LEU73d1 0.24 0.08 
LEU75d2 0.22 0.07 
LEU75d1 0.21 0.06 
VAL86g1 0.44 0.08 
VAL86g2 0.38 0.08 
VAL94g1 0.35 0.08 
VAL94g2 0.35 0.08 
ILE97d1 0.36 0.07 
LEU105d1 0.3 0.08 
ID	   O2axis Err	  
LEU105d2 0.32 0.08 
ILE106d1 0.32 0.04 
VAL108g2 0.25 0.07 
VAL108g1 0.32 0.06 
ILE112d1 0.32 0.08 
LEU113d2 0.35 0.07 
LEU113d1 0.38 0.05 
LEU116d1 0.19 0.03 
LEU116d2 0.16 0.03 
LEU124d2 0.24 0.03 
LEU124d1 0.23 0.03 
VAL126g2 0.52 0.07 
VAL126g1 0.45 0.06 
VAL131g2 0.45 0.07 
VAL131g1 0.43 0.06 
LEU134d1 0.38 0.07 
LEU134d2 0.38 0.07 
LEU137d2 0.41 0.08 
LEU137d1 0.45 0.06 
VAL139g1 0.42 0.06 
VAL139g2 0.46 0.06 
ILE143d1 0.34 0.06 
LEU147d1 0.38 0.07 
LEU147d2 0.46 0.08 
LEU148d2 0.45 0.04 
LEU148d1 0.32 0.04 
LEU150d1 0.3 0.06 
LEU150d2 0.37 0.06 
ILE165d1 0.32 0.06 
ILE167d1 0.37 0.06 
ILE172d1 0.38 0.05 
ILE175d1 0.32 0.07 
VAL176g2 0.37 0.07 
VAL176g1 0.27 0.07 
VAL183g1 0.34 0.08 
VAL183g2 0.45 0.08 
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ID	   O2axis Err	  
ILE186d1 0.43 0.08 
LEU187d1 0.38 0.07 
LEU187d2 0.37 0.08 
LEU190d1 0.34 0.06 
LEU190d2 0.36 0.06 
LEU195d1 0.35 0.08 
LEU195d2 0.29 0.08 
ILE196d1 0.28 0.08 
ILE203d1 0.36 0.07 
VAL204g2 0.38 0.07 
VAL204g1 0.43 0.06 
VAL205g1 0.32 0.07 
VAL205g2 0.43 0.06 
ALA36 0.41 0.1 
ALA48 0.28 0.16 
MET59 0.38 0.09 
ID	   O2axis Err	  
ALA84 0.46 0.16 
ALA88 0.61 0.1 
ALA91 0.3 0.16 
ALA95 0.58 0.16 
MET114 0.62 0.11 
ALA118 0.6 0.11 
MET120 0.53 0.09 
ALA121 0.28 0.15 
ALA135 0.6 0.13 
ALA144 0.34 0.17 
ALA151 0.5 0.08 
ALA156 0.52 0.16 
MET157 0.6 0.07 
MET163 0.63 0.09 
MET189 0.36 0.09 
ALA198 0.3 0.15 
	  
Table C-43: Methyl Order Parameters of CAP(G141S):DNA 
ID	   O2axis Err	  
LEU11d2 0.25 0.06 
LEU11d1 0.27 0.05 
LEU15d2 0.36 0.08 
LEU15d1 0.29 0.06 
ILE20d1 0.17 0.04 
LEU29d2 0.28 0.06 
LEU29d1 0.25 0.05 
ILE30d1 0.28 0.07 
LEU39d2 0.28 0.07 
LEU39d1 0.28 0.07 
ILE42d1 0.33 0.07 
VAL43g1 0.39 0.08 
VAL43g2 0.31 0.07 
VAL47g1 0.27 0.08 
VAL47g2 0.3 0.06 
VAL49g2 0.23 0.08 
VAL49g1 0.23 0.08 
LEU50d1 0.22 0.05 
LEU50d2 0.21 0.05 
ID	   O2axis Err	  
ILE51d1 0.25 0.06 
ILE60d1 0.17 0.05 
LEU61d1 0.28 0.05 
LEU61d2 0.26 0.05 
LEU64d2 0.26 0.08 
LEU64d1 0.26 0.08 
ILE70d1 0.32 0.07 
LEU73d2 0.26 0.07 
LEU73d1 0.26 0.06 
LEU75d2 0.21 0.07 
LEU75d1 0.22 0.06 
VAL86g1 0.39 0.08 
VAL86g2 0.29 0.07 
VAL94g1 0.32 0.07 
VAL94g2 0.25 0.06 
ILE97d1 0.3 0.07 
LEU105d1 0.29 0.06 
LEU105d2 0.29 0.06 
ILE106d1 0.34 0.06 
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ID	   O2axis Err	  
VAL108g2 0.27 0.07 
VAL108g1 0.27 0.06 
ILE112d1 0.31 0.07 
LEU113d2 0.39 0.08 
LEU113d1 0.35 0.07 
LEU116d1 0.26 0.05 
LEU116d2 0.26 0.04 
LEU124d2 0.28 0.06 
LEU124d1 0.25 0.05 
VAL126g2 0.39 0.08 
VAL126g1 0.28 0.07 
VAL131g2 0.39 0.07 
VAL131g1 0.39 0.07 
LEU134d1 0.35 0.07 
LEU134d2 0.33 0.06 
LEU137d2 0.38 0.08 
LEU137d1 0.45 0.07 
VAL139g1 0.37 0.08 
VAL139g2 0.34 0.07 
ILE143d1 0.27 0.06 
LEU147d1 0.38 0.08 
LEU147d2 0.39 0.08 
LEU148d2 0.37 0.07 
LEU148d1 0.34 0.06 
LEU150d1 0.35 0.08 
LEU150d2 0.34 0.07 
ILE165d1 0.3 0.05 
ILE167d1 0.3 0.04 
ILE172d1 0.31 0.06 
ILE175d1 0.33 0.06 
VAL176g2 0.37 0.06 
VAL176g1 0.34 0.06 
VAL183g1 0.39 0.05 
VAL183g2 0.47 0.05 
ID	   O2axis Err	  
ILE186d1 0.46 0.05 
LEU187d1 0.39 0.08 
LEU187d2 0.39 0.07 
LEU190d1 0.39 0.08 
LEU190d2 0.39 0.07 
LEU195d1 0.39 0.07 
LEU195d2 0.39 0.06 
ILE196d1 0.37 0.06 
ILE203d1 0.39 0.08 
VAL204g2 0.35 0.07 
VAL204g1 0.33 0.07 
VAL205g1 0.39 0.08 
VAL205g2 0.32 0.07 
ALA36 0.38 0.07 
ALA48 0.39 0.15 
MET59 0.24 0.12 
ALA84 0.39 0.15 
ALA88 0.55 0.09 
ALA91 0.39 0.15 
ALA95 0.49 0.15 
MET114 0.52 0.11 
ALA118 0.45 0.09 
MET120 0.47 0.11 
ALA121 0.32 0.15 
ALA135 0.54 0.14 
ALA144 0.35 0.15 
ALA151 0.38 0.09 
ALA156 0.48 0.1 
MET157 0.45 0.11 
MET163 0.47 0.1 
MET189 0.37 0.09 
ALA198 0.37 0.08 
	  
Table C-44: Methyl Order Parameters of CAP(G141S):cAMP2 
ID	   O2axis Err	  
LEU11d2 0.39 0.08 
ID	   O2axis Err	  
LEU11d1 0.36 0.08 
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ID	   O2axis Err	  
LEU15d2 0.53 0.07 
LEU15d1 0.39 0.06 
ILE20d1 0.32 0.04 
LEU29d2 0.39 0.04 
LEU29d1 0.34 0.06 
ILE30d1 0.55 0.07 
LEU39d2 0.48 0.06 
LEU39d1 0.47 0.06 
ILE42d1 0.47 0.06 
VAL43g1 0.65 0.07 
VAL43g2 0.67 0.06 
VAL47g1 0.66 0.07 
VAL47g2 0.58 0.06 
VAL49g2 0.71 0.06 
VAL49g1 0.71 0.06 
LEU50d1 0.32 0.05 
LEU50d2 0.24 0.05 
ILE51d1 0.5 0.06 
ILE60d1 0.43 0.06 
LEU61d1 0.27 0.06 
LEU61d2 0.26 0.06 
LEU64d2 0.6 0.07 
LEU64d1 0.7 0.06 
ILE70d1 0.55 0.09 
LEU73d2 0.62 0.07 
LEU73d1 0.57 0.06 
LEU75d2 0.45 0.06 
LEU75d1 0.38 0.06 
VAL86g1 0.57 0.07 
VAL86g2 0.56 0.06 
VAL94g1 0.56 0.09 
VAL94g2 0.57 0.06 
ILE97d1 0.47 0.12 
LEU105d1 0.56 0.07 
LEU105d2 0.56 0.07 
ILE106d1 0.37 0.09 
VAL108g2 0.46 0.1 
VAL108g1 0.37 0.1 
ILE112d1 0.36 0.09 
ID	   O2axis Err	  
LEU113d2 0.49 0.08 
LEU113d1 0.45 0.07 
LEU116d1 0.3 0.09 
LEU116d2 0.24 0.07 
LEU124d2 0.24 0.06 
LEU124d1 0.28 0.06 
VAL126g2 0.45 0.09 
VAL126g1 0.41 0.09 
VAL131g2 0.44 0.09 
VAL131g1 0.37 0.09 
LEU134d1 0.49 0.06 
LEU134d2 0.42 0.09 
LEU137d2 0.52 0.09 
LEU137d1 0.36 0.06 
VAL139g1 0.42 0.1 
VAL139g2 0.41 0.09 
ILE143d1 0.36 0.09 
LEU147d1 0.51 0.17 
LEU147d2 0.56 0.13 
LEU148d2 0.34 0.08 
LEU148d1 0.52 0.08 
LEU150d1 0.39 0.07 
LEU150d2 0.34 0.12 
ILE165d1 0.37 0.11 
ILE167d1 0.47 0.08 
ILE172d1 0.47 0.14 
ILE175d1 0.3 0.13 
VAL176g2 0.24 0.1 
VAL176g1 0.41 0.1 
VAL183g1 0.39 0.1 
VAL183g2 0.46 0.1 
ILE186d1 0.44 0.14 
LEU187d1 0.47 0.14 
LEU187d2 0.4 0.14 
LEU190d1 0.35 0.13 
LEU190d2 0.37 0.15 
LEU195d1 0.59 0.13 
LEU195d2 0.55 0.17 
ILE196d1 0.6 0.13 
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ID	   O2axis Err	  
ILE203d1 0.51 0.11 
VAL204g2 0.51 0.11 
VAL204g1 0.41 0.1 
VAL205g1 0.5 0.1 
VAL205g2 0.37 0.08 
ALA36 0.8 0.18 
ALA48 0.76 0.17 
MET59 0.29 0.07 
ALA84 0.75 0.17 
ALA88 0.64 0.14 
ALA91 0.73 0.18 
ALA95 0.75 0.19 
ID	   O2axis Err	  
MET114 0.45 0.03 
ALA118 0.69 0.19 
MET120 0.31 0.09 
ALA121 0.46 0.09 
ALA135 0.64 0.22 
ALA144 0.67 0.23 
ALA151 0.73 0.23 
ALA156 0.6 0.21 
MET157 0.22 0.09 
MET163 0.3 0.1 
MET189 0.28 0.15 
ALA198 0.7 0.13 
	  
Table C-45: Methyl Order Parameters of CAP(G141S):cAMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.41 0.04 
LEU11d1 0.37 0.04 
LEU15d2 0.59 0.07 
LEU15d1 0.48 0.08 
ILE20d1 0.25 0.02 
LEU29d2 0.48 0.03 
LEU29d1 0.32 0.03 
ILE30d1 0.54 0.08 
LEU39d2 0.52 0.08 
LEU39d1 0.5 0.06 
ILE42d1 0.51 0.08 
VAL43g1 0.7 0.06 
VAL43g2 0.71 0.05 
VAL47g1 0.77 0.06 
VAL47g2 0.66 0.05 
VAL49g2 0.71 0.09 
VAL49g1 0.77 0.07 
LEU50d1 0.39 0.04 
LEU50d2 0.36 0.05 
ILE51d1 0.48 0.06 
ILE60d1 0.48 0.05 
LEU61d1 0.32 0.05 
LEU61d2 0.31 0.07 
ID	   O2axis Err	  
LEU64d2 0.59 0.08 
LEU64d1 0.65 0.08 
ILE70d1 0.5 0.07 
LEU73d2 0.53 0.08 
LEU73d1 0.58 0.08 
LEU75d2 0.57 0.07 
LEU75d1 0.42 0.06 
VAL86g1 0.54 0.08 
VAL86g2 0.52 0.08 
VAL94g1 0.57 0.06 
VAL94g2 0.48 0.07 
ILE97d1 0.5 0.05 
LEU105d1 0.47 0.08 
LEU105d2 0.43 0.07 
ILE106d1 0.43 0.04 
VAL108g2 0.49 0.03 
VAL108g1 0.49 0.04 
ILE112d1 0.55 0.03 
LEU113d2 0.59 0.09 
LEU113d1 0.57 0.08 
LEU116d1 0.31 0.05 
LEU116d2 0.29 0.05 
LEU124d2 0.4 0.09 
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ID	   O2axis Err	  
LEU124d1 0.3 0.09 
VAL126g2 0.59 0.04 
VAL126g1 0.5 0.06 
VAL131g2 0.51 0.06 
VAL131g1 0.46 0.05 
LEU134d1 0.48 0.07 
LEU134d2 0.52 0.07 
LEU137d2 0.54 0.07 
LEU137d1 0.45 0.04 
VAL139g1 0.37 0.09 
VAL139g2 0.36 0.08 
ILE143d1 0.31 0.1 
LEU147d1 0.48 0.09 
LEU147d2 0.5 0.08 
LEU148d2 0.3 0.09 
LEU148d1 0.41 0.07 
LEU150d1 0.37 0.06 
LEU150d2 0.33 0.06 
ILE165d1 0.45 0.04 
ILE167d1 0.59 0.08 
ILE172d1 0.57 0.08 
ILE175d1 0.38 0.11 
VAL176g2 0.27 0.1 
VAL176g1 0.43 0.07 
VAL183g1 0.47 0.09 
VAL183g2 0.48 0.09 
ILE186d1 0.46 0.1 
LEU187d1 0.48 0.11 
LEU187d2 0.48 0.11 
LEU190d1 0.39 0.1 
ID	   O2axis Err	  
LEU190d2 0.45 0.09 
LEU195d1 0.55 0.09 
LEU195d2 0.59 0.08 
ILE196d1 0.58 0.08 
ILE203d1 0.51 0.04 
VAL204g2 0.42 0.06 
VAL204g1 0.41 0.05 
VAL205g1 0.59 0.05 
VAL205g2 0.51 0.06 
ALA36 0.88 0.1 
ALA48 0.89 0.14 
MET59 0.3 0.07 
ALA84 0.89 0.17 
ALA88 0.91 0.12 
ALA91 0.88 0.15 
ALA95 0.86 0.11 
MET114 0.44 0.07 
ALA118 0.88 0.1 
MET120 0.48 0.1 
ALA121 0.69 0.11 
ALA135 0.69 0.11 
ALA144 0.64 0.14 
ALA151 0.71 0.15 
ALA156 0.64 0.17 
MET157 0.19 0.05 
MET163 0.18 0.06 
MET189 0.34 0.09 
ALA198 0.89 0.15 
	  
Table C-46: Methyl Order Parameters of CAP(G141S):cGMP2 
ID	   O2axis Err	  
LEU11d2 0.33 0.08 
LEU11d1 0.28 0.07 
LEU15d2 0.46 0.11 
LEU15d1 0.45 0.12 
ILE20d1 0.5 0.08 
ID	   O2axis Err	  
LEU29d2 0.37 0.15 
LEU29d1 0.47 0.11 
ILE30d1 0.5 0.17 
LEU39d2 0.49 0.07 
LEU39d1 0.53 0.12 
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ID	   O2axis Err	  
ILE42d1 0.52 0.12 
VAL43g1 0.47 0.11 
VAL43g2 0.43 0.08 
VAL47g1 0.53 0.11 
VAL47g2 0.52 0.14 
VAL49g2 0.48 0.11 
VAL49g1 0.44 0.13 
LEU50d1 0.26 0.1 
LEU50d2 0.22 0.04 
ILE51d1 0.33 0.08 
ILE60d1 0.28 0.06 
LEU61d1 0.3 0.06 
LEU61d2 0.45 0.13 
LEU64d2 0.48 0.16 
LEU64d1 0.45 0.17 
ILE70d1 0.52 0.12 
LEU73d2 0.48 0.14 
LEU73d1 0.46 0.15 
LEU75d2 0.33 0.09 
LEU75d1 0.36 0.1 
VAL86g1 0.48 0.17 
VAL86g2 0.56 0.12 
VAL94g1 0.41 0.11 
VAL94g2 0.29 0.13 
ILE97d1 0.52 0.1 
LEU105d1 0.58 0.1 
LEU105d2 0.39 0.07 
ILE106d1 0.43 0.11 
VAL108g2 0.37 0.06 
VAL108g1 0.47 0.06 
ILE112d1 0.59 0.13 
LEU113d2 0.52 0.08 
LEU113d1 0.48 0.17 
LEU116d1 0.56 0.05 
LEU116d2 0.45 0.17 
LEU124d2 0.44 0.15 
LEU124d1 0.46 0.12 
VAL126g2 0.52 0.09 
VAL126g1 0.6 0.12 
ID	   O2axis Err	  
VAL131g2 0.56 0.12 
VAL131g1 0.52 0.09 
LEU134d1 0.59 0.12 
LEU134d2 0.48 0.14 
LEU137d2 0.54 0.11 
LEU137d1 0.56 0.15 
VAL139g1 0.52 0.11 
VAL139g2 0.54 0.08 
ILE143d1 0.4 0.15 
LEU147d1 0.58 0.18 
LEU147d2 0.63 0.05 
LEU148d2 0.5 0.07 
LEU148d1 0.4 0.06 
LEU150d1 0.56 0.06 
LEU150d2 0.51 0.08 
ILE165d1 0.35 0.14 
ILE167d1 0.23 0.13 
ILE172d1 0.56 0.13 
ILE175d1 0.39 0.08 
VAL176g2 0.57 0.13 
VAL176g1 0.46 0.17 
VAL183g1 0.37 0.08 
VAL183g2 0.4 0.14 
ILE186d1 0.48 0.08 
LEU187d1 0.47 0.18 
LEU187d2 0.47 0.13 
LEU190d1 0.52 0.07 
LEU190d2 0.51 0.17 
LEU195d1 0.55 0.06 
LEU195d2 0.53 0.05 
ILE196d1 0.45 0.08 
ILE203d1 0.53 0.1 
VAL204g2 0.53 0.04 
VAL204g1 0.61 0.04 
VAL205g1 0.59 0.1 
VAL205g2 0.45 0.06 
ALA36 0.54 0.11 
ALA48 0.5 0.12 
MET59 0.37 0.08 
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ID	   O2axis Err	  
ALA84 0.38 0.07 
ALA88 0.6 0.1 
ALA91 0.49 0.11 
ALA95 0.45 0.13 
MET114 0.27 0.08 
ALA118 0.39 0.09 
MET120 0.3 0.08 
ALA121 0.42 0.1 
ID	   O2axis Err	  
ALA135 0.42 0.15 
ALA144 0.56 0.13 
ALA151 0.53 0.13 
ALA156 0.43 0.11 
MET157 0.22 0.05 
MET163 0.29 0.1 
MET189 0.39 0.09 
ALA198 0.48 0.12 
	  
Table C-47: Methyl Order Parameters of CAP(G141S):cGMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.28 0.05 
LEU11d1 0.24 0.06 
LEU15d2 0.39 0.06 
LEU15d1 0.41 0.14 
ILE20d1 0.44 0.06 
LEU29d2 0.38 0.1 
LEU29d1 0.46 0.12 
ILE30d1 0.45 0.13 
LEU39d2 0.49 0.05 
LEU39d1 0.54 0.04 
ILE42d1 0.51 0.04 
VAL43g1 0.48 0.11 
VAL43g2 0.42 0.13 
VAL47g1 0.54 0.1 
VAL47g2 0.51 0.07 
VAL49g2 0.49 0.06 
VAL49g1 0.44 0.13 
LEU50d1 0.29 0.08 
LEU50d2 0.23 0.13 
ILE51d1 0.37 0.05 
ILE60d1 0.34 0.05 
LEU61d1 0.35 0.03 
LEU61d2 0.47 0.12 
LEU64d2 0.49 0.1 
LEU64d1 0.47 0.03 
ILE70d1 0.48 0.03 
LEU73d2 0.33 0.03 
ID	   O2axis Err	  
LEU73d1 0.36 0.07 
LEU75d2 0.37 0.05 
LEU75d1 0.32 0.06 
VAL86g1 0.48 0.13 
VAL86g2 0.37 0.08 
VAL94g1 0.27 0.14 
VAL94g2 0.26 0.12 
ILE97d1 0.51 0.08 
LEU105d1 0.47 0.07 
LEU105d2 0.4 0.04 
ILE106d1 0.41 0.1 
VAL108g2 0.36 0.03 
VAL108g1 0.27 0.1 
ILE112d1 0.46 0.03 
LEU113d2 0.52 0.15 
LEU113d1 0.47 0.04 
LEU116d1 0.56 0.05 
LEU116d2 0.48 0.07 
LEU124d2 0.45 0.03 
LEU124d1 0.48 0.15 
VAL126g2 0.37 0.04 
VAL126g1 0.45 0.05 
VAL131g2 0.44 0.03 
VAL131g1 0.49 0.14 
LEU134d1 0.49 0.13 
LEU134d2 0.45 0.03 
LEU137d2 0.45 0.06 
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ID	   O2axis Err	  
LEU137d1 0.5 0.14 
VAL139g1 0.35 0.07 
VAL139g2 0.49 0.13 
ILE143d1 0.3 0.1 
LEU147d1 0.45 0.1 
LEU147d2 0.54 0.07 
LEU148d2 0.35 0.12 
LEU148d1 0.31 0.08 
LEU150d1 0.45 0.11 
LEU150d2 0.47 0.1 
ILE165d1 0.34 0.12 
ILE167d1 0.21 0.06 
ILE172d1 0.51 0.15 
ILE175d1 0.42 0.12 
VAL176g2 0.58 0.12 
VAL176g1 0.49 0.1 
VAL183g1 0.39 0.05 
VAL183g2 0.41 0.07 
ILE186d1 0.48 0.07 
LEU187d1 0.5 0.08 
LEU187d2 0.49 0.13 
LEU190d1 0.53 0.11 
LEU190d2 0.53 0.11 
LEU195d1 0.52 0.14 
LEU195d2 0.53 0.08 
ILE196d1 0.48 0.09 
ID	   O2axis Err	  
ILE203d1 0.52 0.09 
VAL204g2 0.48 0.13 
VAL204g1 0.54 0.05 
VAL205g1 0.55 0.03 
VAL205g2 0.43 0.1 
ALA36 0.54 0.1 
ALA48 0.51 0.11 
MET59 0.4 0.01 
ALA84 0.36 0.09 
ALA88 0.55 0.11 
ALA91 0.46 0.11 
ALA95 0.3 0.01 
MET114 0.29 0.07 
ALA118 0.45 0.1 
MET120 0.35 0.08 
ALA121 0.36 0.09 
ALA135 0.37 0.09 
ALA144 0.51 0.11 
ALA151 0.42 0.08 
ALA156 0.39 0.05 
MET157 0.21 0.06 
MET163 0.31 0.08 
MET189 0.4 0.1 
ALA198 0.46 0.04 
	  
Table C-48: Methyl Order Parameters of CAP(A144T) 
ID	   O2axis Err	  
LEU11d2 0.59 0.07 
LEU11d1 0.63 0.05 
LEU15d2 0.7 0.08 
LEU15d1 0.59 0.06 
ILE20d1 0.67 0.03 
LEU29d2 0.51 0.09 
LEU29d1 0.37 0.05 
ILE30d1 0.28 0.06 
LEU39d2 0.37 0.08 
ID	   O2axis Err	  
LEU39d1 0.62 0.07 
ILE42d1 0.35 0.09 
VAL43g1 0.56 0.08 
VAL43g2 0.33 0.06 
VAL47g1 0.44 0.13 
VAL47g2 0.51 0.1 
VAL49g2 0.46 0.07 
VAL49g1 0.74 0.06 
LEU50d1 0.5 0.04 
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ID	   O2axis Err	  
LEU50d2 0.38 0.04 
ILE51d1 0.62 0.05 
ILE60d1 0.53 0.04 
LEU61d1 0.59 0.04 
LEU61d2 0.46 0.07 
LEU64d2 0.48 0.07 
LEU64d1 0.59 0.07 
ILE70d1 0.45 0.07 
LEU73d2 0.49 0.13 
LEU73d1 0.55 0.06 
LEU75d2 0.6 0.06 
LEU75d1 0.74 0.06 
VAL86g1 0.49 0.13 
VAL86g2 0.77 0.07 
VAL94g1 0.6 0.06 
VAL94g2 0.66 0.06 
ILE97d1 0.63 0.06 
LEU105d1 0.66 0.07 
LEU105d2 0.66 0.06 
ILE106d1 0.49 0.05 
VAL108g2 0.56 0.05 
VAL108g1 0.57 0.06 
ILE112d1 0.49 0.04 
LEU113d2 0.4 0.08 
LEU113d1 0.42 0.07 
LEU116d1 0.42 0.05 
LEU116d2 0.33 0.05 
LEU124d2 0.77 0.06 
LEU124d1 0.6 0.04 
VAL126g2 0.52 0.07 
VAL126g1 0.65 0.05 
VAL131g2 0.66 0.06 
VAL131g1 0.64 0.05 
LEU134d1 0.36 0.07 
LEU134d2 0.67 0.06 
LEU137d2 0.68 0.07 
LEU137d1 0.65 0.13 
VAL139g1 0.45 0.08 
VAL139g2 0.64 0.08 
ID	   O2axis Err	  
ILE143d1 0.67 0.05 
LEU147d1 0.74 0.08 
LEU147d2 0.65 0.11 
LEU148d2 0.69 0.07 
LEU148d1 0.63 0.05 
LEU150d1 0.49 0.07 
LEU150d2 0.59 0.07 
ILE165d1 0.63 0.05 
ILE167d1 0.58 0.04 
ILE172d1 0.5 0.05 
ILE175d1 0.32 0.05 
VAL176g2 0.55 0.06 
VAL176g1 0.56 0.05 
VAL183g1 0.37 0.06 
VAL183g2 0.4 0.06 
ILE186d1 0.3 0.07 
LEU187d1 0.37 0.08 
LEU187d2 0.42 0.07 
LEU190d1 0.37 0.09 
LEU190d2 0.47 0.44 
LEU195d1 0.39 0.06 
LEU195d2 0.4 0.06 
ILE196d1 0.17 0.05 
ILE203d1 0.57 0.06 
VAL204g2 0.48 0.06 
VAL204g1 0.57 0.06 
VAL205g1 0.65 0.11 
VAL205g2 0.67 0.09 
ALA36 0.38 0.1 
ALA48   
MET59 0.2 0.1 
ALA84 0.51 0.05 
ALA88 0.5 0.08 
ALA91 0.56 0.07 
ALA95   
MET114 0.13 0.1 
ALA118 0.64 0.09 
MET120 0.14 0.06 
ALA121 0.64 0.35 
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ID	   O2axis Err	  
ALA135 0.66 0.11 
A144T   
ALA151 0.28 0.07 
ALA156 0.35 0.08 
MET157 0.13 0.03 
MET163 0.22 0.05 
ID	   O2axis Err	  
MET189 0.27 0.04 
ALA198 0.56 0.06 
MET163 0.19 0.1 
MET189 0.32 0.16 
ALA198 0.65 0.11 
	  
Table C-49: Methyl Order Parameters of CAP(A144T):DNA 
ID	   O2axis Err	  
LEU11d2 0.6 0.03 
LEU11d1 0.64 0.03 
LEU15d2 0.69 0.05 
LEU15d1 0.54 0.02 
ILE20d1 0.71 0.03 
LEU29d2 0.5 0.04 
LEU29d1 0.39 0.03 
ILE30d1 0.35 0.03 
LEU39d2 0.4 0.02 
LEU39d1 0.71 0.02 
ILE42d1 0.38 0.04 
VAL43g1 0.48 0.06 
VAL43g2 0.38 0.03 
VAL47g1 0.5 0.02 
VAL47g2 0.56 0.04 
VAL49g2 0.47 0.03 
VAL49g1 0.76 0.02 
LEU50d1 0.39 0.05 
LEU50d2 0.35 0.03 
ILE51d1 0.66 0.04 
ILE60d1 0.58 0.02 
LEU61d1 0.47 0.03 
LEU61d2 0.38 0.03 
LEU64d2 0.52 0.02 
LEU64d1 0.51 0.03 
ILE70d1 0.45 0.04 
LEU73d2 0.41 0.04 
LEU73d1 0.58 0.02 
LEU75d2 0.56 0.03 
ID	   O2axis Err	  
LEU75d1 0.68 0.03 
VAL86g1 0.45 0.08 
VAL86g2 0.72 0.04 
VAL94g1 0.64 0.03 
VAL94g2 0.62 0.03 
ILE97d1 0.66 0.02 
LEU105d1 0.66 0.02 
LEU105d2 0.61 0.02 
ILE106d1 0.59 0.03 
VAL108g2 0.57 0.02 
VAL108g1 0.57 0.03 
ILE112d1 0.5 0.06 
LEU113d2 0.4 0.06 
LEU113d1 0.4 0.05 
LEU116d1 0.41 0.04 
LEU116d2 0.42 0.03 
LEU124d2 0.76 0.03 
LEU124d1 0.6 0.02 
VAL126g2 0.45 0.03 
VAL126g1 0.72 0.03 
VAL131g2 0.6 0.06 
VAL131g1 0.54 0.06 
LEU134d1 0.38 0.03 
LEU134d2 0.67 0.03 
LEU137d2 0.73 0.04 
LEU137d1 0.63 0.03 
VAL139g1 0.5 0.07 
VAL139g2 0.53 0.07 
ILE143d1 0.57 0.03 
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ID	   O2axis Err	  
LEU147d1 0.6 0.06 
LEU147d2 0.61 0.11 
LEU148d2 0.59 0.05 
LEU148d1 0.65 0.04 
LEU150d1 0.56 0.05 
LEU150d2 0.66 0.04 
ILE165d1 0.66 0.04 
ILE167d1 0.6 0.04 
ILE172d1 0.6 0.04 
ILE175d1 0.4 0.06 
VAL176g2 0.51 0.04 
VAL176g1 0.54 0.04 
VAL183g1 0.47 0.05 
VAL183g2 0.5 0.04 
ILE186d1 0.44 0.04 
LEU187d1 0.47 0.07 
LEU187d2 0.47 0.04 
LEU190d1 0.41 0.05 
LEU190d2 0.5 0.08 
LEU195d1 0.41 0.09 
LEU195d2 0.5 0.04 
ILE196d1 0.29 0.04 
ILE203d1 0.6 0.04 
VAL204g2 0.59 0.03 
VAL204g1 0.59 0.03 
ID	   O2axis Err	  
VAL205g1 0.69 0.1 
VAL205g2 0.67 0.03 
ALA36 0.38 0.28 
ALA48   
MET59 0.11 0.06 
ALA84 0.4 0.16 
ALA88 0.6 0.31 
ALA91 0.6 0.19 
ALA95   
MET114 0.14 0.08 
ALA118 0.55 0.26 
MET120 0.12 0.04 
ALA121 0.49 0.18 
ALA135 0.59 0.24 
A144T   
ALA151 0.32 0.17 
ALA156 0.41 0.08 
MET157 0.16 0.13 
MET163 0.22 0.12 
MET189 0.3 0.12 
ALA198 0.64 0.14 
MET163 0.19 0.1 
MET189 0.32 0.16 
ALA198 0.65 0.11 
	  
Table C-50: Methyl Order Parameters of CAP(A144T):cAMP2 
ID	   O2axis Err	  
LEU11d2 0.54 0.05 
LEU11d1 0.54 0.04 
LEU15d2 0.74 0.06 
LEU15d1 0.73 0.04 
ILE20d1 0.52 0.02 
LEU29d2 0.73 0.06 
LEU29d1 0.67 0.04 
ILE30d1 0.78 0.04 
LEU39d2 0.5 0.06 
LEU39d1 0.5 0.05 
ID	   O2axis Err	  
ILE42d1 0.53 0.07 
VAL43g1 0.51 0.06 
VAL43g2 0.53 0.04 
VAL47g1 0.74 0.09 
VAL47g2 0.73 0.08 
VAL49g2 0.65 0.05 
VAL49g1 0.56 0.05 
LEU50d1 0.72 0.03 
LEU50d2 0.69 0.03 
ILE51d1 0.4 0.04 
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ID	   O2axis Err	  
ILE60d1 0.38 0.03 
LEU61d1 0.66 0.03 
LEU61d2 0.77 0.05 
LEU64d2 0.74 0.05 
LEU64d1 0.56 0.05 
ILE70d1 0.47 0.05 
LEU73d2 0.71 0.1 
LEU73d1 0.77 0.04 
LEU75d2 0.43 0.05 
LEU75d1 0.4 0.04 
VAL86g1 0.78 0.09 
VAL86g2 0.71 0.05 
VAL94g1 0.45 0.05 
VAL94g2 0.41 0.04 
ILE97d1 0.57 0.05 
LEU105d1 0.79 0.05 
LEU105d2 0.72 0.04 
ILE106d1 0.5 0.04 
VAL108g2 0.39 0.04 
VAL108g1 0.49 0.05 
ILE112d1 0.4 0.03 
LEU113d2 0.52 0.06 
LEU113d1 0.57 0.06 
LEU116d1 0.52 0.04 
LEU116d2 0.6 0.04 
LEU124d2 0.62 0.04 
LEU124d1 0.6 0.03 
VAL126g2 0.47 0.05 
VAL126g1 0.46 0.04 
VAL131g2 0.51 0.04 
VAL131g1 0.49 0.04 
LEU134d1 0.63 0.05 
LEU134d2 0.47 0.04 
LEU137d2 0.63 0.05 
LEU137d1 0.48 0.09 
VAL139g1 0.56 0.06 
VAL139g2 0.62 0.06 
ILE143d1 0.64 0.04 
LEU147d1 0.69 0.06 
ID	   O2axis Err	  
LEU147d2 0.66 0.08 
LEU148d2 0.76 0.05 
LEU148d1 0.67 0.04 
LEU150d1 0.57 0.05 
LEU150d2 0.52 0.05 
ILE165d1 0.52 0.03 
ILE167d1 0.29 0.03 
ILE172d1 0.43 0.03 
ILE175d1 0.39 0.04 
VAL176g2 0.34 0.04 
VAL176g1 0.35 0.04 
VAL183g1 0.58 0.04 
VAL183g2 0.59 0.04 
ILE186d1 0.53 0.05 
LEU187d1 0.58 0.06 
LEU187d2 0.56 0.05 
LEU190d1 0.38 0.07 
LEU190d2 0.52 0.33 
LEU195d1 0.58 0.05 
LEU195d2 0.56 0.04 
ILE196d1 0.56 0.04 
ILE203d1 0.5 0.04 
VAL204g2 0.48 0.04 
VAL204g1 0.51 0.04 
VAL205g1 0.49 0.08 
VAL205g2 0.45 0.06 
ALA36 0.73 0.11 
ALA48   
MET59 0.5 0.07 
ALA84 0.79 0.1 
ALA88 0.74 0.11 
ALA91 0.84 0.12 
ALA95   
MET114 0.35 0.07 
ALA118 0.97 0.11 
MET120 0.5 0.05 
ALA121 0.87 0.26 
ALA135 0.88 0.18 
A144T   
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ID	   O2axis Err	  
ALA151 0.88 0.15 
ALA156 0.68 0.16 
MET157 0.28 0.12 
ID	   O2axis Err	  
MET163 0.41 0.13 
MET189 0.38 0.03 
ALA198 0.78 0.09 
	  
	  
Table C-51: Methyl Order Parameters of CAP(A144T):cAMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.57 0.03 
LEU11d1 0.61 0.03 
LEU15d2 0.8 0.04 
LEU15d1 0.79 0.02 
ILE20d1 0.45 0.02 
LEU29d2 0.58 0.03 
LEU29d1 0.56 0.02 
ILE30d1 0.75 0.03 
LEU39d2 0.62 0.02 
LEU39d1 0.6 0.02 
ILE42d1 0.57 0.03 
VAL43g1 0.65 0.05 
VAL43g2 0.66 0.03 
VAL47g1 0.66 0.02 
VAL47g2 0.62 0.04 
VAL49g2 0.75 0.02 
VAL49g1 0.71 0.02 
LEU50d1 0.67 0.04 
LEU50d2 0.66 0.03 
ILE51d1 0.5 0.03 
ILE60d1 0.46 0.01 
LEU61d1 0.71 0.03 
LEU61d2 0.71 0.03 
LEU64d2 0.76 0.02 
LEU64d1 0.7 0.02 
ILE70d1 0.65 0.04 
LEU73d2 0.55 0.03 
LEU73d1 0.61 0.02 
LEU75d2 0.47 0.03 
LEU75d1 0.41 0.03 
ID	   O2axis Err	  
VAL86g1 0.62 0.06 
VAL86g2 0.56 0.03 
VAL94g1 0.61 0.03 
VAL94g2 0.59 0.02 
ILE97d1 0.59 0.02 
LEU105d1 0.64 0.02 
LEU105d2 0.59 0.02 
ILE106d1 0.26 0.03 
VAL108g2 0.47 0.02 
VAL108g1 0.56 0.02 
ILE112d1 0.38 0.05 
LEU113d2 0.49 0.05 
LEU113d1 0.54 0.04 
LEU116d1 0.57 0.03 
LEU116d2 0.61 0.03 
LEU124d2 0.59 0.02 
LEU124d1 0.59 0.02 
VAL126g2 0.47 0.03 
VAL126g1 0.44 0.02 
VAL131g2 0.46 0.05 
VAL131g1 0.37 0.05 
LEU134d1 0.49 0.03 
LEU134d2 0.45 0.03 
LEU137d2 0.52 0.03 
LEU137d1 0.37 0.03 
VAL139g1 0.45 0.06 
VAL139g2 0.44 0.06 
ILE143d1 0.51 0.03 
LEU147d1 0.53 0.05 
LEU147d2 0.57 0.09 
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ID	   O2axis Err	  
LEU148d2 0.67 0.04 
LEU148d1 0.67 0.03 
LEU150d1 0.43 0.04 
LEU150d2 0.36 0.03 
ILE165d1 0.36 0.03 
ILE167d1 0.35 0.03 
ILE172d1 0.48 0.03 
ILE175d1 0.3 0.05 
VAL176g2 0.47 0.04 
VAL176g1 0.46 0.03 
VAL183g1 0.61 0.04 
VAL183g2 0.57 0.04 
ILE186d1 0.52 0.03 
LEU187d1 0.51 0.06 
LEU187d2 0.6 0.03 
LEU190d1 0.43 0.04 
LEU190d2 0.37 0.06 
LEU195d1 0.63 0.07 
LEU195d2 0.54 0.03 
ILE196d1 0.63 0.03 
ILE203d1 0.5 0.03 
VAL204g2 0.51 0.03 
VAL204g1 0.45 0.02 
ID	   O2axis Err	  
VAL205g1 0.49 0.08 
VAL205g2 0.38 0.03 
ALA36 0.63 0.16 
ALA48   
MET59 0.54 0.15 
ALA84 0.89 0.17 
ALA88 0.67 0.23 
ALA91 0.74 0.11 
ALA95   
MET114 0.25 0.11 
ALA118 0.87 0.21 
MET120 0.57 0.26 
ALA121 0.96 0.7 
ALA135 0.97 0.14 
A144T   
ALA151 0.93 0.25 
ALA156 0.63 0.1 
MET157 0.24 0.07 
MET163 0.41 0.12 
MET189 0.39 0.19 
ALA198 0.79 0.11 
	  
Table C-52: Methyl Order Parameters of CAP(A144T):cGMP2 
ID	   O2axis Err	  
LEU11d2 0.52 0.05 
LEU11d1 0.45 0.04 
LEU15d2 0.64 0.06 
LEU15d1 0.73 0.04 
ILE20d1 0.4 0.02 
LEU29d2 0.6 0.06 
LEU29d1 0.72 0.04 
ILE30d1 0.81 0.04 
LEU39d2 0.78 0.06 
LEU39d1 0.67 0.05 
ILE42d1 0.59 0.07 
VAL43g1 0.87 0.06 
ID	   O2axis Err	  
VAL43g2 0.84 0.04 
VAL47g1 0.78 0.09 
VAL47g2 0.71 0.08 
VAL49g2 0.65 0.05 
VAL49g1 0.65 0.05 
LEU50d1 0.58 0.03 
LEU50d2 0.63 0.03 
ILE51d1 0.93 0.04 
ILE60d1 0.96 0.03 
LEU61d1 0.63 0.03 
LEU61d2 0.58 0.05 
LEU64d2 0.58 0.05 
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ID	   O2axis Err	  
LEU64d1 0.57 0.05 
ILE70d1 0.64 0.05 
LEU73d2 0.63 0.1 
LEU73d1 0.56 0.04 
LEU75d2 0.55 0.05 
LEU75d1 0.57 0.04 
VAL86g1 0.54 0.09 
VAL86g2 0.52 0.05 
VAL94g1 0.62 0.05 
VAL94g2 0.59 0.04 
ILE97d1 0.51 0.05 
LEU105d1 0.5 0.05 
LEU105d2 0.49 0.04 
ILE106d1 0.49 0.04 
VAL108g2 0.49 0.04 
VAL108g1 0.48 0.05 
ILE112d1 0.62 0.03 
LEU113d2 0.36 0.06 
LEU113d1 0.41 0.06 
LEU116d1 0.4 0.04 
LEU116d2 0.33 0.04 
LEU124d2 0.53 0.04 
LEU124d1 0.52 0.03 
VAL126g2 0.56 0.05 
VAL126g1 0.56 0.04 
VAL131g2 0.47 0.04 
VAL131g1 0.5 0.04 
LEU134d1 0.55 0.05 
LEU134d2 0.47 0.04 
LEU137d2 0.45 0.05 
LEU137d1 0.38 0.09 
VAL139g1 0.43 0.06 
VAL139g2 0.42 0.06 
ILE143d1 0.55 0.04 
LEU147d1 0.64 0.06 
LEU147d2 0.61 0.08 
LEU148d2 0.56 0.05 
LEU148d1 0.6 0.04 
LEU150d1 0.56 0.05 
ID	   O2axis Err	  
LEU150d2 0.61 0.05 
ILE165d1 0.56 0.03 
ILE167d1 0.55 0.03 
ILE172d1 0.52 0.03 
ILE175d1 0.6 0.04 
VAL176g2 0.55 0.04 
VAL176g1 0.48 0.04 
VAL183g1 0.5 0.04 
VAL183g2 0.55 0.04 
ILE186d1 0.48 0.05 
LEU187d1 0.53 0.06 
LEU187d2 0.56 0.05 
LEU190d1 0.55 0.07 
LEU190d2 0.43 0.33 
LEU195d1 0.52 0.05 
LEU195d2 0.51 0.04 
ILE196d1 0.71 0.04 
ILE203d1 0.76 0.04 
VAL204g2 0.62 0.04 
VAL204g1 0.6 0.04 
VAL205g1 0.56 0.08 
VAL205g2 0.54 0.06 
ALA36 0.82 0.07 
ALA48   
MET59 0.24 0.07 
ALA84 0.82 0.04 
ALA88 0.78 0.06 
ALA91 0.75 0.05 
ALA95   
MET114 0.13 0.07 
ALA118 0.82 0.07 
MET120 0.45 0.05 
ALA121 0.69 0.26 
ALA135 0.82 0.08 
A144T   
ALA151 0.81 0.05 
ALA156 0.53 0.06 
MET157 0.24 0.02 
MET163 0.41 0.04 
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ID	   O2axis Err	  
MET189 0.17 0.03 
ID	   O2axis Err	  
ALA198 0.61 0.04 
	  
Table C-53: Methyl Order Parameters of CAP(A144T):cGMP2:DNA 
ID	   O2axis Err	  
LEU11d2 0.54 0.03 
LEU11d1 0.54 0.03 
LEU15d2 0.55 0.04 
LEU15d1 0.56 0.02 
ILE20d1 0.6 0.02 
LEU29d2 0.7 0.03 
LEU29d1 0.54 0.02 
ILE30d1 0.34 0.03 
LEU39d2 0.38 0.02 
LEU39d1 0.4 0.02 
ILE42d1 0.4 0.03 
VAL43g1 0.42 0.05 
VAL43g2 0.44 0.03 
VAL47g1 0.45 0.02 
VAL47g2 0.43 0.04 
VAL49g2 0.68 0.02 
VAL49g1 0.68 0.02 
LEU50d1 0.63 0.04 
LEU50d2 0.7 0.03 
ILE51d1 0.74 0.03 
ILE60d1 0.69 0.01 
LEU61d1 0.25 0.03 
LEU61d2 0.43 0.03 
LEU64d2 0.42 0.02 
LEU64d1 0.29 0.02 
ILE70d1 0.38 0.04 
LEU73d2 0.44 0.03 
LEU73d1 0.43 0.02 
LEU75d2 0.39 0.03 
LEU75d1 0.35 0.03 
VAL86g1 0.44 0.06 
VAL86g2 0.39 0.03 
VAL94g1 0.57 0.03 
VAL94g2 0.55 0.02 
ID	   O2axis Err	  
ILE97d1 0.47 0.02 
LEU105d1 0.32 0.02 
LEU105d2 0.34 0.02 
ILE106d1 0.44 0.03 
VAL108g2 0.5 0.02 
VAL108g1 0.44 0.02 
ILE112d1 0.54 0.05 
LEU113d2 0.42 0.05 
LEU113d1 0.5 0.04 
LEU116d1 0.46 0.03 
LEU116d2 0.42 0.03 
LEU124d2 0.54 0.02 
LEU124d1 0.54 0.02 
VAL126g2 0.26 0.03 
VAL126g1 0.48 0.02 
VAL131g2 0.55 0.05 
VAL131g1 0.55 0.05 
LEU134d1 0.48 0.03 
LEU134d2 0.46 0.03 
LEU137d2 0.46 0.03 
LEU137d1 0.46 0.03 
VAL139g1 0.47 0.06 
VAL139g2 0.49 0.06 
ILE143d1 0.54 0.03 
LEU147d1 0.61 0.05 
LEU147d2 0.57 0.09 
LEU148d2 0.59 0.04 
LEU148d1 0.51 0.03 
LEU150d1 0.55 0.04 
LEU150d2 0.54 0.03 
ILE165d1 0.64 0.03 
ILE167d1 0.61 0.03 
ILE172d1 0.56 0.03 
ILE175d1 0.54 0.05 
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ID	   O2axis Err	  
VAL176g2 0.6 0.04 
VAL176g1 0.5 0.03 
VAL183g1 0.5 0.04 
VAL183g2 0.64 0.04 
ILE186d1 0.51 0.03 
LEU187d1 0.57 0.06 
LEU187d2 0.6 0.03 
LEU190d1 0.56 0.04 
LEU190d2 0.44 0.06 
LEU195d1 0.51 0.07 
LEU195d2 0.49 0.03 
ILE196d1 0.68 0.03 
ILE203d1 0.7 0.03 
VAL204g2 0.57 0.03 
VAL204g1 0.56 0.02 
VAL205g1 0.55 0.08 
VAL205g2 0.53 0.03 
ALA36 0.63 0.12 
ID	   O2axis Err	  
ALA48   
MET59 0.25 0.02 
ALA84 0.85 0.12 
ALA88 0.59 0.13 
ALA91 0.56 0.11 
ALA95   
MET114 0.14 0.01 
ALA118 0.83 0.17 
MET120 0.46 0.18 
ALA121 0.4 0.12 
ALA135 0.83 0.1 
A144T   
ALA151 0.82 0.22 
ALA156 0.34 0.04 
MET157 0.14 0.01 
MET163 0.42 0.1 
MET189 0.18 0.03 
ALA198 0.62 0.1 
	  
Table C-54: Methyl Order Parameters of Apo Galectin 
ID	   O2axis Err	  
l114d1 0.51 0.02 
l114d2 0.48 0.01 
i115d1 0.22 0 
i115g2 0.44 0.01 
v116g1 0.46 0.01 
l120d1 0.63 0.03 
v126g1 0.78 0.03 
v126g2 0.77 0.05 
v127g1 0.25 0.01 
m130e 0.48 0.01 
l131d1 0.51 0.01 
i132d1 0.38 0.01 
i132g2 0.67 0.02 
i134d1 0.82 0.02 
l135d2 0.38 0.01 
t137g2 0.55 0.01 
v138g1 1 0.1 
ID	   O2axis Err	  
v138g2 0.9 0.03 
a142b 0.92 0.05 
i145d1 0.77 0.02 
i145g2 0.78 0.02 
a146b 0.83 0.01 
l147d1 0.52 0.08 
l147d2 0.28 0.01 
v170g1 0.41 0.02 
v170g2 0.49 0.01 
i171g2 0.85 0.02 
v172g1 0.82 0.05 
v172g2 0.87 0.03 
t175g2 0.96 0.04 
v189g2 0.79 0.05 
i200d1 0.78 0.02 
i200g2 0.8 0.02 
v202g1 0.52 0.01 
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ID	   O2axis Err	  
v202g2 0.69 0.06 
l203d2 0.62 0.02 
v204g1 0.88 0.03 
v204g2 0.91 0.03 
v211g1 0.85 0.02 
a212b 0.97 0.03 
v213g1 0.94 0.05 
a216b 0.91 0.02 
l218d1 0.74 0.06 
v225g1 0.76 0.02 
v225g2 0.76 0.02 
l228d1 0.61 0.03 
l228d2 0.62 0.03 
ID	   O2axis Err	  
i231d1 0.71 0.02 
i231g2 0.89 0.03 
l234d1 0.71 0.04 
l234d2 0.68 0.06 
i236g2 0.82 0.02 
i240d1 0.57 0.01 
l242d1 0.42 0.04 
t243g2 0.68 0.04 
a245b 0.68 0.03 
t248g2 0.62 0.02 
m249e 0.45 0.01 
i250d1 0.38 0.01 
i250g2 0.55 0.01 
	  
Table C-55: Methyl Order Parameters of Galectin bound to L2 
ID	   O2axis Err	  
m113e 0.01 0 
l114d1 0.47 0.01 
l114d2 0.42 0.01 
i115d1 0.21 0 
i115g2 0.4 0.01 
v116g1 0.44 0.01 
l120d1 0.57 0.02 
v126g1 0.69 0.02 
v126g2 0.67 0.03 
v127g2 0.26 0.01 
m130e 0.5 0.02 
l131d1 0.49 0.01 
i132d1 0.39 0.01 
i132g2 0.65 0.02 
i134d1 0.83 0.07 
l135d2 0.32 0 
t137g2 0.49 0.01 
v138g2 0.82 0.02 
a142b 0.83 0.03 
i145d1 0.73 0.02 
i145g2 0.7 0.02 
a146b 0.81 0.02 
ID	   O2axis Err	  
l147d1 0.29 0.01 
l147d2 0.55 0.08 
v155g2 0.82 0.04 
a156b 0.82 0.05 
v170g1 0.41 0.02 
i171g2 0.77 0.02 
v172g1 0.82 0.03 
v172g2 0.72 0.03 
v189g2 0.73 0.04 
i200d1 0.67 0.01 
i200g2 0.77 0.01 
v202g2 0.55 0.01 
l203d2 0.56 0.02 
v204g1 0.82 0.02 
v204g2 0.82 0.02 
v211g1 0.78 0.02 
a212b 0.88 0.02 
v213g1 0.84 0.03 
a216b 0.88 0.02 
l218d1 0.7 0.04 
l219d2 0.75 0.06 
v225g2 0.71 0.01 
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ID	   O2axis Err	  
l228d1 0.53 0.02 
l228d2 0.62 0.02 
i231d1 0.63 0.01 
i231g2 0.8 0.02 
l234d1 0.68 0.03 
i236d1 0.53 0.01 
i236g2 0.8 0.02 
i240d1 0.55 0.01 
i240g2 0.63 0.01 
ID	   O2axis Err	  
l242d1 0.69 0.07 
l242d2 0.61 0.03 
t243g2 0.46 0.01 
a245b 0.73 0.03 
t248g2 0.55 0.01 
m249e 0.43 0 
i250d1 0.48 0.02 
i250g2 0.5 0.01 
	  
Table C-56: Methyl Order Parameters of Galectin bound to L3 
ID	   O2axis Err	  
m113e 0.01 0 
l114d1 0.51 0.01 
l114d2 0.47 0.01 
i115d1 0.21 0 
i115g2 0.44 0.01 
v116g1 0.53 0.02 
l120d1 0.56 0.02 
v126g1 0.63 0.02 
v126g2 0.75 0.03 
v127g2 0.25 0.01 
m130e 0.47 0 
l131d1 0.54 0.01 
i132d1 0.43 0.03 
i132g2 0.73 0.02 
i134d1 0.78 0.02 
l135d2 0.35 0.01 
t137g2 0.55 0.01 
v138g2 0.87 0.03 
a142b 0.84 0.04 
i145d1 0.75 0.02 
i145g2 0.74 0.02 
a146b 0.91 0.02 
l147d1 0.26 0.01 
l147d2 0.27 0.01 
v155g2 0.79 0.04 
a156b 0.98 0.06 
ID	   O2axis Err	  
v170g1 0.57 0.08 
v170g2 0.54 0.01 
i171g2 0.82 0.02 
v172g2 0.65 0.04 
v189g2 0.64 0.01 
i200d1 0.73 0.01 
i200g2 0.77 0.02 
v202g1 0.75 0.05 
v202g2 0.58 0.01 
l203d2 0.57 0.02 
v204g1 0.89 0.02 
v204g2 0.83 0.02 
v211g1 0.83 0.02 
a212b 0.9 0.02 
v213g1 0.84 0.03 
a216b 0.88 0.02 
l218d1 0.83 0.06 
l219d2 0.81 0.08 
l228d1 0.65 0.02 
l228d2 0.62 0.03 
i231d1 0.65 0.01 
i231g2 0.84 0.02 
l234d1 0.72 0.03 
l234d2 0.69 0.05 
i236d1 0.64 0.05 
i236g2 0.83 0.02 
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ID	   O2axis Err	  
i240d1 0.54 0.01 
l242d1 0.88 0.08 
a245b 0.98 0.03 
t248g2 0.59 0.01 
ID	   O2axis Err	  
m249e 0.45 0 
i250d1 0.38 0 
i250g2 0.56 0.01 
	  
Table C-57: Methyl Order Parameters of Galectin bound to Lactose 
ID	   O2axis Err	  
l114d1 0.51 0.02 
l114d2 0.48 0.01 
i115d1 0.22 0 
i115g2 0.44 0.01 
v116g1 0.46 0.01 
l120d1 0.63 0.03 
v126g1 0.78 0.03 
v126g2 0.77 0.05 
v127g1 0.25 0.01 
m130e 0.48 0.01 
l131d1 0.51 0.01 
i132d1 0.38 0.01 
i132g2 0.67 0.02 
i134d1 0.82 0.02 
l135d2 0.38 0.01 
t137g2 0.55 0.01 
v138g1 1 0.1 
v138g2 0.9 0.03 
a142b 0.92 0.05 
i145d1 0.77 0.02 
i145g2 0.78 0.02 
a146b 0.83 0.01 
l147d1 0.52 0.08 
l147d2 0.28 0.01 
v170g1 0.41 0.02 
v170g2 0.49 0.01 
i171g2 0.85 0.02 
v172g1 0.82 0.05 
v172g2 0.87 0.03 
t175g2 0.96 0.04 
v189g2 0.79 0.05 
ID	   O2axis Err	  
i200d1 0.78 0.02 
i200g2 0.8 0.02 
v202g1 0.52 0.01 
v202g2 0.69 0.06 
l203d2 0.62 0.02 
v204g1 0.88 0.03 
v204g2 0.91 0.03 
v211g1 0.85 0.02 
a212b 0.97 0.03 
v213g1 0.94 0.05 
a216b 0.91 0.02 
l218d1 0.74 0.06 
v225g1 0.76 0.02 
v225g2 0.76 0.02 
l228d1 0.61 0.03 
l228d2 0.62 0.03 
i231d1 0.71 0.02 
i231g2 0.89 0.03 
l234d1 0.71 0.04 
l234d2 0.68 0.06 
i236g2 0.82 0.02 
i240d1 0.57 0.01 
l242d1 0.42 0.04 
t243g2 0.68 0.04 
a245b 0.68 0.03 
t248g2 0.62 0.02 
m249e 0.45 0.01 
i250d1 0.38 0.01 




Table C-58: Methyl Order Parameters of Apo HEWL 
ID	   O2axis Err	  
VAL2CG2 0.598 0.021 
LEU8CD1 0.767 0.019 
LEU8CD2 0.803 0.031 
ALA9CB 1 0.029 
ALA10CB 0.901 0.018 
ALA11CB 0.861 0.009 
MET12CE 0.812 0.013 
LEU17CD1 0.63 0.016 
LEU17CD2 0.632 0.017 
LEU25CD1 1 0.028 
LEU25CD2 0.609 0.022 
VAL29CG1 0.871 0.013 
VAL29CG2 0.791 0.032 
ALA31CB 0.984 0.018 
THR43CG2 0.361 0.003 
THR47CG2 0.327 0.021 
THR51CG2 0.778 0.005 
ILE55CG2 0.739 0.028 
ILE55CD1 0.323 0.025 
LEU56CD1 0.734 0.01 
LEU56CD2 0.681 0.017 
ILE58CG2 1 0.024 
ILE58CD1 0.16 0.016 
THR69CG2 0.984 0.034 
LEU75CD2 0.588 0.03 
ILE78CG2 0.81 0.014 
ILE78CD1 0.416 0.014 
ID	   O2axis Err	  
ALA82CB 0.88 0.034 
LEU83CD1 0.783 0.012 
LEU83CD2 0.884 0.029 
LEU84CD1 0.879 0.012 
LEU84CD2 1 0.022 
ILE88CG2 0.697 0.026 
ILE88CD1 0.722 0.01 
THR89CG2 1 0.037 
ALA90CB 0.919 0.013 
VAL92CG1 0.764 0.004 
VAL92CG2 0.707 0.024 
ALA95CB 0.68 0.026 
ILE98CG2 0.74 0.016 
ILE98CD1 0.815 0.012 
VAL99CG1 0.487 0.028 
VAL99CG2 0.517 0.028 
MET105CE 0.63 0.011 
ALA107CB 0.832 0.024 
VAL109CG1 0.354 0.01 
VAL120CG1 0.66 0.015 
ALA122CB 0.879 0.011 
ILE124CG2 0.753 0.016 
ILE124CD1 0.351 0.003 
LEU129CD1 0.525 0.031 
LEU129CD2 0.507 0.028 
	  
Table C-59: Methyl Order Parameters of HEWL:Chitotriose 
ID	   O2axis Err	  
VAL2CG2 0.57 0.011 
LEU8CD1 0.773 0.021 
LEU8CD2 0.658 0.021 
ALA9CB 0.962 0.022 
ALA10CB 0.931 0.01 
ID	   O2axis Err	  
ALA11CB 1 0.03 
MET12CE 0.932 0.009 
LEU17CD1 0.555 0.015 
LEU17CD2 0.58 0.025 
LEU25CD1 0.87 0.018 
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ID	   O2axis Err	  
LEU25CD2 0.657 0.032 
VAL29CG1 0.84 0.019 
VAL29CG2 1 0.049 
ALA31CB 0.941 0.038 
THR43CG2 0.394 0.016 
THR47CG2 0.3 0.007 
THR51CG2 0.927 0.034 
ILE55CG2 1 0.049 
ILE55CD1 0.393 0.007 
LEU56CD1 0.816 0.022 
LEU56CD2 0.815 0.02 
ILE58CG2 1 0.028 
ILE58CD1 0.262 0.045 
THR69CG2 0.702 0.031 
LEU75CD2 0.744 0.016 
ILE78CG2 0.831 0.028 
ILE78CD1 0.599 0.02 
ALA82CB 0.868 0.016 
LEU83CD1 1 0.035 
LEU83CD2 1 0.047 
LEU84CD1 0.778 0.021 
ID	   O2axis Err	  
LEU84CD2 1 0.038 
ILE88CG2 0.793 0.021 
ILE88CD1 0.655 0.024 
THR89CG2 1 0.039 
ALA90CB 1 0.027 
VAL92CG1 1 0.032 
VAL92CG2 0.705 0.025 
ALA95CB 0.904 0.023 
ILE98CG2 0.61 0.022 
ILE98CD1 0.394 0.038 
VAL99CG1 0.21 0.038 
VAL99CG2 0.248 0.028 
MET105CE 1 0.041 
ALA107CB 1 0.031 
VAL109CG1 0.201 0.037 
VAL120CG1 0.736 0.023 
ALA122CB 0.831 0.023 
ILE124CG2 0.731 0.022 
ILE124CD1 0.452 0.019 
LEU129CD1 0.615 0.03 
LEU129CD2 0.329 0.034 
	  
Table C-60: Methyl Order Parameters of the SAP90 PDZ3  
ID	   O2axis Err	  
i307d1 0.337 0.006 
i307g2 0.605 0.019 
i314d1 0.303 0.005 
i314g2 0.768 0.016 
v315g1 0.812 0.018 
v315g2 0.771 0.014 
i316d1 0.37 0.007 
i316g2 0.46 0.01 
t321g2 0.576 0.006 
l323d1 0.67 0.05 
l323d2 0.697 0.027 
i327d1 0.725 0.012 
i327g2 0.881 0.017 
v328g1 0.785 0.03 
ID	   O2axis Err	  
v328g2 0.728 0.03 
i336d1 0.686 0.015 
i336g2 0.807 0.023 
i338d1 0.501 0.009 
i338g2 0.905 0.019 
i341d1 0.251 0.005 
i341g2 0.857 0.017 
l342d1 0.263 0.005 
l342d2 0.419 0.021 
a343b 0.87 0.011 
a347b 0.931 0.022 
l349d2 0.368 0.005 
l353d1 0.634 0.034 
l353d2 0.624 0.016 
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ID	   O2axis Err	  
i359d1 0.505 0.01 
i359g2 0.843 0.015 
l360d2 0.616 0.012 
v362g1 0.575 0.011 
v362g2 0.592 0.013 
v365g1 0.858 0.018 
l367d1 0.55 0.032 
l367d2 0.615 0.035 
a370b 0.932 0.02 
a375b 0.898 0.039 
i377d1 0.423 0.005 
i377g2 0.622 0.006 
ID	   O2axis Err	  
l379d1 0.737 0.029 
l379d2 0.74 0.023 
a382b 0.979 0.021 
t385g2 0.783 0.017 
i388d1 0.505 0.009 
i388g2 0.786 0.015 
i389d1 0.255 0.005 
i389g2 0.911 0.016 
a390b 0.919 0.019 
a402b 0.118 0.002 
	  
Table C-61: Methyl Order Parameters of the SAP90 PDZ3 bound to the CRIPT peptide 
ID	   O2axis Err	  
i307d1 0.334 0.007 
i307g2 0.581 0.021 
i314d1 0.305 0.03 
i314g2 0.762 0.016 
v315g1 0.739 0.014 
v315g2 0.723 0.012 
i316d1 0.372 0.006 
i316g2 0.415 0.008 
t321g2 0.55 0.009 
l323d1 0.796 0.079 
l323d2 0.724 0.027 
i327d1 0.738 0.014 
i327g2 0.887 0.023 
v328g1 0.57 0.141 
v328g2 0.823 0.059 
i336d1 0.676 0.014 
i336g2 0.827 0.021 
i338d1 0.571 0.01 
i338g2 0.858 0.021 
i341d1 0.221 0.009 
i341g2 0.84 0.02 
l342d1 0.42 0.01 
l342d2 0.505 0.018 
ID	   O2axis Err	  
a347b 0.937 0.026 
l349d2 0.362 0.006 
l353d1 0.624 0.05 
l353d2 0.632 0.018 
i359d1 0.49 0.011 
i359g2 0.83 0.02 
l360d2 0.603 0.014 
v362g1 0.57 0.01 
v362g2 0.61 0.012 
v365g1 0.857 0.015 
l367d1 0.486 0.037 
l367d2 0.64 0.029 
a370b 0.869 0.016 
a375b 0.927 0.035 
i377d1 0.412 0.005 
i377g2 0.613 0.009 
l379d1 0.866 0.03 
l379d2 0.844 0.025 
a382b 0.923 0.019 
t385g2 0.747 0.014 
i388d1 0.498 0.008 
i388g2 0.777 0.014 
i389d1 0.234 0.005 
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ID	   O2axis Err	  
i389g2 0.887 0.016 
a390b 0.891 0.016 
ID	   O2axis Err	  
a402b 0.168 0.002 
a402b 0.118 0.002 
	  
	  
Table C-62: Methyl Order Parameters of the SAP90 PDZ3Δ7 
ID	   O2axis Err	  
i307d1 0.25 0.009 
i307g2 0.48 0.034 
i314d1 0.256 0.013 
i314g2 0.668 0.041 
v315g1 0.696 0.04 
v315g2 0.622 0.028 
i316d1 0.316 0.016 
i316g2 0.442 0.027 
i327d1 0.563 0.026 
i327g2 0.767 0.043 
v328g2 0.529 0.035 
i336d1 0.567 0.03 
i336g2 0.632 0.041 
i338d1 0.406 0.024 
i341g2 0.67 0.041 
l342d1 0.306 0.068 
l342d2 0.261 0.014 
a347b 0.833 0.054 
l349d1 0.301 0.036 
l349d2 0.317 0.015 
l353d1 0.484 0.049 
l353d2 0.468 0.032 
ID	   O2axis Err	  
i359d1 0.343 0.021 
i359g2 0.714 0.039 
l360d1 0.498 0.032 
l360d2 0.525 0.029 
v362g1 0.542 0.032 
v362g2 0.498 0.025 
v365g1 0.709 0.037 
l367d1 0.445 0.042 
l367d2 0.46 0.059 
a370b 0.763 0.046 
a375b 0.819 0.079 
i377d1 0.358 0.013 
i377g2 0.418 0.017 
l379d1 0.668 0.068 
l379d2 0.574 0.038 
t385g2 0.726 0.044 
i388d1 0.386 0.019 
i389d1 0.227 0.013 
i389g2 0.849 0.045 
a390b 0.751 0.047 
	  
Table C-63: Methyl Order Parameters of the SAP90 PDZ3Δ7 bound to the CRIPT peptide 
ID	   O2axis Err	  
i307d1 0.307 0.01 
i307g2 0.528 0.02 
i314d1 0.295 0.007 
i314g2 0.758 0.024 
v315g1 0.697 0.017 
ID	   O2axis Err	  
v315g2 0.742 0.022 
i316d1 0.37 0.01 
i316g2 0.409 0.014 
t321g2 0.577 0.01 
l323d1 0.826 0.058 
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ID	   O2axis Err	  
l323d2 0.753 0.034 
i327d1 0.731 0.02 
i327g2 0.887 0.033 
v328g1 0.589 0.011 
v328g2 0.809 0.046 
i336d1 0.786 0.03 
i336g2 0.695 0.023 
i338d1 0.539 0.015 
i338g2 0.846 0.031 
i341d1 0.248 0.006 
i341g2 0.788 0.025 
l342d1 0.487 0.026 
a343b 0.863 0.016 
a347b 0.886 0.039 
l349d1 0.395 0.016 
l349d2 0.362 0.009 
l353d1 0.567 0.042 
l353d2 0.559 0.021 
i359d1 0.378 0.011 
i359g2 0.805 0.023 
l360d1 0.581 0.019 
ID	   O2axis Err	  
l360d2 0.608 0.017 
v362g1 0.599 0.019 
v362g2 0.559 0.015 
v365g1 0.802 0.013 
v365g2 0.835 0.023 
l367d1 0.559 0.048 
l367d2 0.621 0.042 
a370b 0.848 0.027 
a375b 0.93 0.051 
a376b 0.894 0.023 
i377d1 0.382 0.007 
i377g2 0.564 0.011 
l379d1 0.789 0.034 
l379d2 0.789 0.034 
t385g2 0.732 0.023 
v386g2 0.725 0.016 
i388d1 0.474 0.012 
i388g2 0.732 0.023 
i389d1 0.226 0.006 
i389g2 0.852 0.025 
a390b 0.867 0.026 
	  
Table C-64: Methyl Order Parameters of the ecDHFR:Folate binary complex 
ID	   O2axis Err	  
m1e 0.1 0.01 
i2d1 0.42 0.01 
i2g2 0.69 0.02 
l4d1 0.43 0.01 
l4d2 0.44 0.03 
i5d1 0.68 0.07 
i5g2 0.82 0.07 
a6b 0.71 0.05 
a7b 0.83 0.07 
l8d1 0.31 0.01 
l8d2 0.24 0.01 
a9b 0.79 0.06 
v10g1 0.63 0.02 
v10g2 0.64 0.09 
ID	   O2axis Err	  
v13g2 0.7 0.04 
i14d1 0.69 0.03 
i14g2 0.71 0.03 
m16e 0.22 0.01 
a19b 0.66 0.01 
m20e 0.14 0.01 
l24d1 0.58 0.12 
l24d2 0.47 0.06 
a26b 0.86 0.04 
l28d1 0.36 0.01 
l28d2 0.33 0.01 
t35g2 0.75 0.05 
l36d1 0.27 0.01 
l36d2 0.27 0.01 
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ID	   O2axis Err	  
v40g1 0.75 0.02 
v40g2 0.71 0.03 
i41d1 0.62 0.02 
i41g2 0.8 0.02 
m42e 0.82 0.01 
t46g2 0.61 0.01 
i50d1 0.76 0.03 
i50g2 0.61 0.01 
l54d2 0.81 0.06 
i60d1 0.3 0.01 
i60g2 0.82 0.03 
i61d1 0.25 0.01 
i61g2 0.76 0.04 
l62d1 0.38 0.01 
l62d2 0.38 0.01 
v72g1 0.75 0.04 
v72g2 0.74 0.03 
t73g2 0.82 0.03 
v75g2 0.87 0.03 
v78g1 0.8 0.01 
v78g2 0.79 0.02 
a81b 0.89 0.03 
i82d1 0.5 0.01 
i82g2 0.83 0.01 
a84b 0.8 0.02 
v88g1 0.75 0.02 
v88g2 0.77 0.02 
i91d1 0.76 0.02 
ID	   O2axis Err	  
i91g2 0.85 0.02 
m92e 0.75 0.01 
v93g1 0.9 0.03 
v93g2 0.92 0.03 
i94d1 0.68 0.05 
v99g1 0.77 0.03 
v99g2 0.8 0.02 
l104d2 0.52 0.02 
a107b 0.78 0.03 
l110d1 0.66 0.07 
l110d2 0.65 0.04 
l112d1 0.36 0.02 
l112d2 0.82 0.06 
i115d1 0.59 0.04 
i115g2 0.82 0.06 
a117b 0.76 0.03 
v119g1 0.27 0.01 
v119g2 0.25 0.01 
t123g2 0.5 0.01 
v136g2 0.67 0.02 
a143b 0.92 0.02 
a145b 0.82 0.02 
i155d1 0.73 0.03 
i155g2 0.84 0.03 
l156d1 0.37 0.01 
l156d2 0.37 0.01 
	  
Table C-65: Methyl Order Parameters of the ecDHFR:Folate:NADP+ ternary complex 
ID	   O2axis Err	  
m1e 0.09 0.01 
i2d1 0.48 0.01 
i2g2 0.74 0.03 
l4d1 0.52 0.01 
l4d2 0.48 0.05 
i5d1 0.8 0.06 
i5g2 0.86 0.11 
ID	   O2axis Err	  
a6b 0.81 0.09 
l8d1 0.31 0.02 
l8d2 0.28 0.01 
a9b 0.77 0.05 
v10g1 0.66 0.03 
v10g2 0.77 0.06 
v13g1 0.79 0.02 
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ID	   O2axis Err	  
v13g2 0.69 0.07 
i14g2 0.81 0.1 
m16e 0.31 0.01 
m20e 0.34 0.01 
l24d1 0.52 0.1 
l24d2 0.49 0.16 
a26b 1 0.01 
l28d2 0.32 0.02 
a29b 0.91 0.02 
t35g2 0.78 0.07 
l36d1 0.29 0.01 
l36d2 0.29 0.01 
v40g2 0.84 0.05 
i41d1 0.7 0.03 
i41g2 0.79 0.03 
m42e 0.84 0.02 
t46g2 0.58 0.05 
i50d1 0.8 0.04 
i50g2 0.65 0.02 
l54d1 0.71 0.12 
l54d2 0.82 0.04 
i60d1 0.29 0.01 
i60g2 0.81 0.03 
i61d1 0.2 0.01 
i61g2 0.75 0.08 
l62d1 0.46 0.02 
l62d2 0.43 0.04 
t68g2 0.7 0.01 
v72g1 0.78 0.12 
v72g2 0.78 0.06 
t73g2 0.79 0.03 
v75g1 0.77 0.02 
v75g2 0.9 0.04 
v78g1 0.85 0.02 
v78g2 0.87 0.02 
ID	   O2axis Err	  
a81b 0.91 0.03 
i82d1 0.52 0.01 
i82g2 0.78 0.03 
a83b 0.9 0.02 
a84b 0.84 0.03 
v88g2 0.76 0.03 
i91d1 0.8 0.02 
i91g2 0.85 0.04 
m92e 0.76 0.01 
v93g1 0.87 0.03 
v93g2 0.89 0.03 
i94d1 0.67 0.05 
i94g2 0.7 0.08 
v99g2 0.85 0.05 
l104d1 0.47 0.02 
l104d2 0.52 0.03 
a107b 0.85 0.05 
l110d1 0.69 0.12 
l112d1 0.36 0.04 
l112d2 0.84 0.06 
t113g2 0.86 0.04 
i115d1 0.63 0.05 
i115g2 0.89 0.07 
v119g2 0.45 0.02 
t123g2 0.69 0.18 
v136g1 0.68 0.02 
v136g2 0.68 0.02 
a143b 0.87 0.04 
a145b 0.78 0.03 
i155d1 0.77 0.03 
i155g2 0.85 0.04 
l156d1 0.33 0.01 






Table C-66: Methyl Order Parameters of the SAP SH2 domain 
ID	   O2axis Err	  
a3b 0.463 0.018 
v6g2 0.696 0.022 
i11d1 0.808 0.024 
i11g2 0.822 0.025 
l20d2 0.628 0.021 
l21d2 0.572 0.017 
t23g2 0.606 0.018 
l25d1 0.477 0.009 
l25d2 0.444 0.014 
l30d1 0.837 0.054 
l30d2 0.87 0.106 
v37g1 0.743 0.031 
v40g2 0.808 0.025 
l43d2 0.695 0.027 
v45g1 0.495 0.024 
l46d1 0.652 0.026 
l46d2 0.838 0.041 
i51d1 0.235 0.022 
i51g2 0.73 0.042 
ID	   O2axis Err	  
a66b 0.822 0.029 
t68g2 0.755 0.052 
i80d1 0.22 0.008 
i80g2 0.345 0.017 
l83d1 0.67 0.044 
l83d2 0.72 0.018 
i84d1 0.285 0.016 
i84g2 0.819 0.017 
a86b 0.908 0.022 
i94d1 0.747 0.045 
i94g2 0.814 0.04 
v95g1 0.699 0.026 
v95g2 0.708 0.041 
i96g2 0.25 0.019 
i96g2 0.809 0.027 
l98d1 0.931 0.166 
l98d2 0.864 0.042 
v102g1 0.838 0.034 
	  
Table C-67: Methyl Order Parameters of the SAP SH2 domain bound to Y281 
ID	   O2axis Err	  
a3b 0.432 0.019 
v4g2 0.335 0.011 
v6g2 0.739 0.026 
i11g2 0.782 0.019 
l20d2 0.688 0.054 
l21d2 0.434 0.013 
t23g2 0.648 0.021 
l25d1 0.399 0.018 
l25d2 0.343 0.01 
l30d1 0.751 0.023 
l30d2 0.917 0.125 
l31d1 0.334 0.02 
v37g1 0.717 0.033 
v37g2 0.683 0.018 
ID	   O2axis Err	  
v40g2 0.8 0.021 
l43d2 0.604 0.021 
v45g1 0.55 0.015 
v45g2 0.635 0.026 
l46d1 0.787 0.03 
i51d1 0.373 0.014 
i51g2 0.832 0.058 
t53g2 0.855 0.061 
v56g1 0.597 0.026 
v56g2 0.6 0.017 
a66b 0.89 0.037 
t68g2 0.618 0.036 
a69b 0.908 0.031 
v72g1 0.656 0.058 
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ID	   O2axis Err	  
i80d1 0.178 0.012 
i80g2 0.302 0.01 
l83d1 0.721 0.097 
l83d2 0.781 0.027 
i84d1 0.329 0.015 
a86b 0.903 0.034 
i94d1 0.788 0.048 
i94g2 0.892 0.029 
ID	   O2axis Err	  
v95g1 0.648 0.014 
v95g2 0.64 0.026 
i96d1 0.4 0.012 
l98d1 0.796 0.256 
l98d2 0.887 0.051 
v102g1 0.818 0.014 
v102g2 0.83 0.038 
	  
Table C-68: Methyl Order Parameters of the SAP SH2 domain bound to pY281 
ID	   O2axis Err	  
a3b 0.463 0.018 
v6g2 0.696 0.022 
i11d1 0.808 0.024 
i11g2 0.822 0.025 
l20d2 0.628 0.021 
l21d2 0.572 0.017 
t23g2 0.606 0.018 
l25d1 0.477 0.009 
l25d2 0.444 0.014 
l30d1 0.837 0.054 
l30d2 0.87 0.106 
v37g1 0.743 0.031 
v40g2 0.808 0.025 
l43d2 0.695 0.027 
v45g1 0.495 0.024 
l46d1 0.652 0.026 
l46d2 0.838 0.041 
i51d1 0.235 0.022 
i51g2 0.73 0.042 
ID	   O2axis Err	  
a66b 0.822 0.029 
t68g2 0.755 0.052 
i80d1 0.22 0.008 
i80g2 0.345 0.017 
l83d1 0.67 0.044 
l83d2 0.72 0.018 
i84d1 0.285 0.016 
i84g2 0.819 0.017 
a86b 0.908 0.022 
i94d1 0.747 0.045 
i94g2 0.814 0.04 
v95g1 0.699 0.026 
v95g2 0.708 0.041 
i96g2 0.25 0.019 
i96g2 0.809 0.027 
l98d1 0.931 0.166 
l98d2 0.864 0.042 
v102g1 0.838 0.034 
	  
Table C-69: Methyl Order Parameters of the hPTP1e PDZ2 domain 
ID	   O2axis Err	  
i6d1 0.256 0.008 
i6g2 0.684 0.021 
v9g1 0.512 0.027 
v9g2 0.506 0.02 
ID	   O2axis Err	  
l11d2 0.284 0.05 
a12b 0.743 0.02 
l18d1 0.605 0.071 
l18d2 0.541 0.037 
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ID	   O2axis Err	  
i20d1 0.602 0.019 
i20g2 0.351 0.012 
v22g1 0.803 0.037 
v22g2 0.755 0.028 
t23g2 0.718 0.05 
v26g2 0.563 0.019 
t28g2 0.742 0.035 
v30g1 0.549 0.021 
v30g2 0.529 0.026 
i35d1 0.651 0.032 
i35g2 0.844 0.039 
v37g1 0.881 0.043 
a39b 0.872 0.023 
v40g1 0.609 0.021 
i41d1 0.177 0.013 
i41g2 0.78 0.026 
a45b 0.91 0.04 
a46b 0.92 0.053 
i52d1 0.709 0.026 
i52g2 0.764 0.032 
v58g1 0.805 0.043 
ID	   O2axis Err	  
v58g2 0.806 0.031 
l59d1 0.55 0.043 
l59d2 0.535 0.027 
v61g2 0.769 0.028 
v64g1 0.496 0.014 
v64g2 0.484 0.007 
l66d2 0.596 0.069 
a69b 0.797 0.035 
t70g2 0.801 0.036 
a74b 0.644 0.049 
t77g2 0.814 0.061 
l78d2 0.478 0.018 
t81g2 0.872 0.059 
v84g1 0.692 0.02 
v85g1 0.667 0.032 
v85g2 0.699 0.034 
l87d1 0.427 0.056 
l88d1 0.631 0.023 
l89d1 0.524 0.078 
l89d2 0.581 0.132 
	  
Table C-70: Methyl Order Parameters of the hPTP1e PDZ2 domain bound to RA-GEF2 
ID	   O2axis Err	  
i6d1 0.236 0.005 
i6g2 0.635 0.012 
v9g1 0.471 0.011 
v9g2 0.459 0.016 
l11d2 0.234 0.021 
l18d1 0.511 0.05 
l18d2 0.571 0.015 
i20d1 0.646 0.013 
i20g2 0.355 0.006 
v22g1 0.752 0.019 
v22g2 0.704 0.02 
t23g2 0.605 0.078 
v26g1 0.681 0.013 
v26g2 0.65 0.017 
ID	   O2axis Err	  
v30g2 0.606 0.022 
i35d1 0.605 0.015 
i35g2 0.783 0.021 
a39b 0.841 0.014 
v40g1 0.574 0.012 
i41d1 0.186 0.004 
i41g2 0.698 0.014 
a45b 0.841 0.023 
a46b 0.871 0.033 
i52d1 0.68 0.015 
i52g2 0.766 0.021 
v58g1 0.779 0.023 
v58g2 0.768 0.018 
l59d1 0.566 0.051 
137	  
	  
ID	   O2axis Err	  
v61g2 0.67 0.017 
v64g1 0.647 0.013 
v64g2 0.573 0.009 
l66d1 0.589 0.041 
l66d2 0.586 0.014 
a69b 0.856 0.022 
t70g2 0.867 0.021 
v75g2 0.803 0.031 
t77g2 0.678 0.017 
l78d1 0.779 0.037 
ID	   O2axis Err	  
l78d2 0.791 0.044 
t81g2 0.784 0.028 
v84g1 0.624 0.012 
v84g2 0.622 0.009 
v85g1 0.535 0.014 
v85g2 0.555 0.015 
l87d1 0.434 0.038 
l87d2 0.499 0.029 
l88d1 0.597 0.013 
	  
Table C-71: Methyl Order Parameters of Barnase 
ID	   O2axis Err	  
ALA1CB 0.351 0.012 
VAL3CG2 0.633 0.024 
VAL3CG1 0.509 0.008 
ILE4CD1 0.578 0.028 
ILE4CG2 0.974 0.028 
THR6CG2 0.994 0.012 
VAL10CG2 0.994 0.044 
VAL10CG1 0.851 0.014 
ALA11CB 0.994 0.039 
LEU14CD2 0.588 0.011 
LEU14CD1 0.747 0.02 
THR16CG2 0.954 0.032 
LEU20CD2 0.821 0.04 
LEU20CD1 0.836 0.011 
ILE25CD1 0.776 0.03 
ILE25CG2 0.242 0.003 
THR26CG2 0.979 0.046 
ALA30CB 0.994 0.019 
ALA32CB 0.994 0.032 
LEU33CD1 0.712 0.035 
LEU33CD2 0.732 0.028 
VAL36CG1 0.905 0.029 
LEU42CD2 0.717 0.033 
LEU42CD1 0.855 0.012 
ALA43CB 0.994 0.013 
ID	   O2axis Err	  
VAL45CG1 0.964 0.036 
VAL45CG2 0.855 0.033 
ALA46CB 0.994 0.044 
ILE51CD1 0.464 0.014 
ILE51CG2 0.841 0.028 
ILE55CD1 0.385 0.005 
ILE55CG2 0.841 0.033 
LEU63CD2 0.697 0.018 
LEU63CD1 0.732 0.023 
THR70CG2 0.464 0.021 
ALA74CB 0.994 0.03 
ILE76CG2 0.836 0.027 
ILE76CD1 0.648 0.02 
THR79CG2 0.846 0.041 
ILE88CD1 0.781 0.012 
ILE88CG2 0.534 0.024 
LEU89CD1 0.722 0.032 
LEU89CD2 0.628 0.03 
LEU95CD1 0.44 0.017 
LEU95CD2 0.494 0.017 
ILE96CD1 0.653 0.02 
ILE96CG2 0.994 0.045 
THR99CG2 0.994 0.019 
THR107CG2 0.974 0.042 




Table C-72: Methyl Order Parameters of Barnase bound to dCGAC 
ID	   O2axis Err	  
ALA1CB 0.291 0.003 
VAL3CG2 0.489 0.012 
VAL3CG1 0.455 0.022 
ILE4CD1 0.484 0.008 
ILE4CG2 0.821 0.028 
THR6CG2 0.994 0.047 
VAL10CG2 0.994 0.031 
VAL10CG1 0.9 0.021 
ALA11CB 0.93 0.011 
LEU14CD2 0.756 0.016 
LEU14CD1 0.761 0.036 
THR16CG2 0.94 0.034 
LEU20CD2 0.752 0.014 
LEU20CD1 0.821 0.009 
ILE25CD1 0.722 0.016 
ILE25CG2 0.148 0.003 
THR26CG2 0.895 0.019 
ALA30CB 0.994 0.039 
ALA32CB 0.994 0.026 
LEU33CD1 0.672 0.015 
LEU33CD2 0.633 0.017 
VAL36CG1 0.86 0.042 
LEU42CD2 0.623 0.023 
LEU42CD1 0.836 0.023 
ALA43CB 0.994 0.047 
VAL45CG1 0.86 0.02 
ID	   O2axis Err	  
VAL45CG2 0.89 0.017 
ALA46CB 0.994 0.024 
ILE51CD1 0.435 0.009 
ILE51CG2 0.964 0.043 
ILE55CD1 0.296 0.01 
ILE55CG2 0.717 0.023 
LEU63CD2 0.712 0.014 
LEU63CD1 0.796 0.019 
THR70CG2 0.45 0.008 
ALA74CB 0.994 0.03 
ILE76CG2 0.841 0.023 
ILE76CD1 0.653 0.013 
THR79CG2 0.697 0.008 
ILE88CD1 0.667 0.016 
ILE88CG2 0.558 0.013 
LEU89CD1 0.727 0.011 
LEU89CD2 0.643 0.029 
LEU95CD1 0.326 0.004 
LEU95CD2 0.455 0.014 
ILE96CD1 0.44 0.014 
ILE96CG2 0.92 0.011 
THR99CG2 0.514 0.02 
THR105CG2 0.628 0.01 
THR107CG2 0.93 0.03 
ILE109CG2 0.687 0.022 
	  
Table C-73: Methyl Order Parameters of HBP(D24R) 
ID	   O2axis Err	  
ALA6CB 0.898 0.032 
ALA13CB 0.796 0.025 
ALA17CB 0.769 0.01 
LEU21CD1 0.668 0.015 
ALA23CB 0.93 0.042 
VAL25CG2 0.652 0.028 
ID	   O2axis Err	  
VAL25CG1 0.657 0.031 
VAL28CG2 0.652 0.059 
MET31CE 0.577 0.041 
VAL32CG2 0.421 0.03 
VAL32CG1 0.652 0.043 
VAL41CG1 0.812 0.009 
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ID	   O2axis Err	  
THR47CG2 0.855 0.05 
VAL49CG2 0.812 0.069 
MET52CE 0.111 0.045 
ALA53CB 0.871 0.058 
VAL56CG2 0.437 0.052 
VAL56CG1 0.314 0.036 
ILE63CD1 0.555 0.045 
ILE63CG2 0.855 0.049 
LEU68CD1 0.164 0.026 
LEU68CD2 0.084 0.033 
MET70CE 0.084 0.02 
ALA73CB 0.716 0.045 
THR75CG2 0.523 0.009 
ALA80CB 0.903 0.077 
THR81CG2 0.582 0.002 
THR85CG2 0.85 0.035 
ALA86CB 0.941 0.048 
VAL87CG2 0.86 0.019 
VAL87CG1 0.909 0.024 
MET89CE 0.116 0.039 
ALA97CB 0.919 0.018 
VAL107CG2 0.598 0.03 
THR109CG2 0.716 0.02 
VAL111CG2 0.47 0.031 
ID	   O2axis Err	  
ILE112CD1 0.212 0.074 
ILE112CG2 0.764 0.02 
ALA113CB 0.903 0.076 
VAL121CG1 0.903 0.015 
ILE122CG2 0.727 0.044 
VAL124CG1 0.582 0.007 
THR127CG2 0.346 0.074 
LEU136CD2 0.491 0.013 
LEU136CD1 0.475 0.04 
THR138CG2 0.561 0.044 
ILE144CD1 0.652 0.043 
ILE144CG2 0.828 0.009 
ALA146CB 0.887 0.013 
LEU149CD2 0.507 0.038 
ALA156CB 0.909 0.008 
VAL157CG2 0.33 0.06 
VAL157CG1 0.694 0.027 
THR161CG2 0.464 0.017 
VAL164CG2 0.877 0.024 
VAL164CG1 0.828 0.013 
ALA168CB 0.759 0.026 
LEU170CD2 0.266 0.078 
LEU170CD1 0.255 0.068 
	  
	  
Table C-74: Methyl Order Parameters of HBP(D24R) bound to histamine 
ID	   O2axis Err	  
ALA6CB 0.839 0.03 
ALA13CB 0.855 0.019 
ALA17CB 0.769 0.012 
LEU21CD1 0.63 0.021 
ALA23CB 0.866 0.037 
VAL25CG2 0.652 0.018 
VAL25CG1 0.646 0.039 
VAL28CG2 0.662 0.03 
MET31CE 0.577 0.033 
ID	   O2axis Err	  
VAL32CG2 0.47 0.023 
VAL32CG1 0.641 0.017 
VAL41CG1 0.807 0.026 
THR47CG2 0.871 0.03 
VAL49CG2 0.743 0.025 
MET52CE 0.111 0.046 
ALA53CB 0.871 0.04 
VAL56CG2 0.421 0.047 
VAL56CG1 0.277 0.051 
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ID	   O2axis Err	  
ILE63CD1 0.582 0.031 
ILE63CG2 0.871 0.038 
LEU68CD1 0.191 0.046 
LEU68CD2 0.079 0.04 
MET70CE 0.084 0 
ALA73CB 0.641 0.023 
THR75CG2 0.496 0.027 
ALA80CB 0.85 0.026 
THR81CG2 0.539 0.01 
THR85CG2 0.802 0.03 
ALA86CB 0.935 0.029 
VAL87CG2 0.802 0.008 
VAL87CG1 0.855 0.03 
MET89CE 0.116 0.046 
ALA97CB 0.946 0.035 
VAL107CG2 0.593 0.028 
THR109CG2 0.689 0.019 
VAL111CG2 0.459 0.031 
ILE112CD1 0.229 0.08 
ILE112CG2 0.78 0.008 
ALA113CB 0.839 0.039 
ID	   O2axis Err	  
VAL121CG1 0.85 0.011 
ILE122CG2 0.743 0.024 
VAL124CG1 0.598 0.035 
THR127CG2 0.346 0.078 
LEU136CD2 0.496 0.033 
LEU136CD1 0.502 0.018 
THR138CG2 0.55 0.034 
ILE144CD1 0.63 0.01 
ILE144CG2 0.818 0.033 
ALA146CB 0.871 0.028 
LEU149CD2 0.502 0.023 
ALA156CB 0.903 0.03 
VAL157CG2 0.314 0.027 
VAL157CG1 0.657 0.016 
THR161CG2 0.437 0.001 
VAL164CG2 0.834 0.022 
VAL164CG1 0.812 0.031 
ALA168CB 0.732 0.02 
LEU170CD2 0.277 0.049 
LEU170CD1 0.261 0.015 
	  
	   	  
141	  
	  
APPENDIX D: Chapter 4 
	  
Materials and Methods 
	  
Sample Preparation 
 BIRB796 and SB203580 were obtained from LC Laboratories (Woburn, MA) and 
SelleckChem (Houston, TX) respectively. p38α2-349  was expressed and purified as essentially as 
described previously [129]. The sole exception is that before anion exchange by MonoQ, the 
protein was treated with Lambda Protein Phosphatase (New England Biolabs) at a ratio of  
400U:mg of protein to remove endogenous phosphorylation which was found to occur during 
expression. The final NMR sample for relaxation measurements contained 0.5 mM protein in 
10mM HEPES, 150mM NaCl, 5mM DTT, pH 7.4. To ensure solubilization of the inhibitors, all 
samples contained 1% v/v DMSO-d6 in the final sample. SB203580 and BIRB796 were 
solubilized in DMSO-d6 and added at a ratio of 1.2:1 ligand:protein to ensure complete titration, 
which was confirmed by NMR. 
NMR Spectroscopy 
 Assignment and NMR relaxation data were collected at 600MHz and 750 MHz. Several 
experiments employed the use of non-uniformly sampled (NUS) data. This involves sampling the 
indirect dimensions of multidimensional NMR spectra data using a variety of sampling 
"schedules" followed by data reconstruction during data processing. The details of various 
approach to NUS NMR are extensively outlined elsewhere [131, 177]. To illustrate briefly how 
NUS works, let us consider a 2D 15N HSQC experiment. A typical experiment of this nature would 
contain 2048 x 320 (1H x 15N) total points. In a Cartesian-sampled experiment, the data would be 
collected as 320 separate FIDs each of 2048 points in the directly detected dimension. In a non-
uniformly sampled experiment, one would collect a smaller percentage of these FIDs that are 
separated by some non-uniform distribution. For example, one could collect 25%, or 80, of these 
FIDs with a non-uniform spacing. The data in the indirect dimension can then be reconstructed to 
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320 total points using a variety of algorithms. Of paramount concern, of course, is the fidelity of 
the reconstruction. Historically, this method was fraught with artifacts in the final reconstructed 
spectrum. Wagner and colleagues recently overcame these boundaries with the use of a 
Poisson-Gap sampling schedule and reconstruction using the Iterative Soft Thresholding (IST) 
algorithm [131]. This approach allows for NMR data to be reconstructed with high fidelity. 
Unpublished data from our lab have demonstrated that the sampling sparsityrequired for high-
quality reconstruction of 2D and 3D spectra are 10% and 25% respectively. . All NUS data 
collected in this study followed this requirement   For 15N and 13C relaxation data, which are 
Pseudo-3D experiments, a sampling sparsity of 25% was used. All standard (Cartesian) pulse 
sequences used in this study were converted to NUS by Matthew Stetz, graduate student in the 
Wand laboratory. 
Relaxation Data Analysis 
 All 15N and 13C relaxation data were collected as NUS experiments. After reconstruction 
as described above, exponential decays were fit using in-house software to determine T1 and T1p 
rates. T1p rates were corrected for the off-resonance tilted field using the relation: 
2 2
2 1 1/ cos / tanR R Rρ ρθ θ= −  
Where tanθ=ω1/Ω where ω1 is the spin-lock RF field and Ω is the offset from either the 15N or 13C 
carrier, depending on the nucleus being probed. Macromolecular tumbling was determined from 
T1 and T2 rates at 2 magnetic fields fitting to the Lipari-Szabo formalism using in-house software 
[21].  15N residues were excluded from the molecular tumbling fitting routine if their fits for τm, τe, 
and O2NH produced statistical outliers to the normalized χ2 values of the fit. Residues displaying 
statistically significant Rex were also omitted for the determination of molecular tumbling. 
approximately 115 residues were used to calculate overall tumbling for the apo and drug-bound 
complexes. Methyl order parameters were determined from T1 and T2 rates at two magnetic fields. 
Model free parameters (O2 and τe ) were determined using a grid search approach[155] utilizing 
software and parameters as described elsewhere.[156] Errors were determined using the Monte 
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Carlo method. O2axis values were obtained by division by 0.111, which assumes a tetrahedral 
geometry of the methyl groups.   
Isothermal Titration Calorimetry 
 Isothermal titration calorimetry (ITC) measurements were carried out on a VP-ITC 
instrument (Microcal) at the same temperature and buffer conditions as the corresponding NMR 
relaxation data. The sole exception to the buffer conditions were that 0.2mM DTT was used 
instead of 5mM DTT to minimize the impact of DTT on the ITC trace. This effect is due to the 
release of heat upon oxidation of DTT which can cause baseline distortions across the 
experiment.  
p38α was purified as outlined above and dialyzed in NMR buffer. Samples were centrifuged at 
4000 RPM for 10 minutes to remove any precipitate. The sample was degassed at 293K for 5 
minutes. DMSO-d6 was added to the p38α sample immediately before the experiment.185uM 
p38α was titrated into 5-15uM inhibitor in 5ul injections.  Example traces can be found in Figure 
4-2 of the main text. Data analysis was performed using the Origin software. The data were 
corrected for the heat of dilution as necessary. 
Data Tables 
 
Table D-1: Backbone assignments of p38α in the apo and inhibitor-bound states 
 
 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
GLY 1 110.55 8.389 110.614 8.398 110.574 8.393 
SER 2 115.947 8.187 116.048 8.204   
GLN 3 122.216 8.45 122.275 8.451 122.289 8.459 
GLU 4 122.475 8.347 122.486 8.346 122.438 8.334 
ARG 5 125.277 8.412 125.357 8.422 125.279 8.414 
THR 7 117.457 8.508 117.52 8.503 117.459 8.495 
PHE 8 127.248 8.816 127.412 8.836 127.277 8.822 
TYR 9 120.059 9.143 120.063 9.13 120.087 9.131 
ARG 10 120.093 8.475 120.058 8.445 119.759 8.422 
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
GLN 11 122.264 8.961 122.719 9.002 122.839 9.003 
GLU 12 125.452 8.866 125.554 8.865 125.779 8.872 
LEU 13 128.539 9.003 128.392 8.999 128.367 9.041 
ASN 14 115.956 7.38     
LYS 15 109.9 8.903 110.156 8.893 110.19 8.89 
THR 16 115.658 7.854 116.281 7.833 116.297 7.853 
ILE 17 125.497 8.636 126.121 8.627 125.992 8.602 
TRP 18 131.007 9.297 130.872 9.245 130.888 9.205 
GLU 19 128.235 8.315 128.133 8.316 128.087 8.266 
VAL 20 112.392 7.649 111.866 7.644 111.72 7.656 
GLU 22 118.937 8.132 118.873 8.13 118.721 8.112 
ARG 23 117.451 7.485 117.125 7.543 117.163 7.512 
TYR 24 118.055 7.793 118.334 7.785 118.266 7.8 
GLN 25 122.52 9.191 122.711 9.196 122.6 9.238 
ASN 26 117.38 8.839 117.326 8.805 117.403 8.829 
LEU 27 120.218 8.565 120.173 8.52 120.215 8.499 
SER 28 115.971 8.759 115.759 8.747 115.965 8.817 
VAL 30 120.825 8.662 120.263 8.651 121.016 8.561 
GLY 31 108.319 7.77 108.743 7.83   
SER 32 115.278 8.398     
GLY 33 110.393 8.174 108.716 7.845 109.782 8.321 
ALA 34       
TYR 35 113.363 8.092 113.14 8.163   
GLY 36 108.411 7.31     
SER 37 115.899 8.135   116.519 8.321 
VAL 38 122.449 8.715 123.306 8.618   
CYS 39 125.429 9.276 125.667 9.287 124.348 9.207 
ALA 40 125.63 8.804 125.734 8.8   
ALA 41 120.598 9.035   119.555 9.018 
PHE 42 122.278 9.222 123.423 9.3 123.188 9.336 
ASP 43 125.977 8.324 125.675 8.231 125.814 8.227 
THR 44 117.282 8.943 117.686 9.257 117.47 9.175 
LYS 45 121.715 7.897 121.675 7.811 121.849 7.848 
THR 46 104.947 6.586 104.678 6.521 104.912 6.575 
GLY 47 112.255 8.373 112.474 8.361 112.295 8.312 
LEU 48 119.64 7.105 119.248 7.125 119.407 7.13 
ARG 49 119.653 8.243 118.606 8.31 118.536 8.342 
VAL 50 116.423 8.81   116.742 8.609 
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
ALA 51 122.597 8.825     
VAL 52 122.921 9.222 122.252 9.199 117.892 7.998 
LYS 53 129.246 9.569     
LYS 54 128.287 8.624   128.409 8.504 
LEU 55 128.582 8.001 128.172 7.829 129.01 8.055 
SER 56 117.881 8.038 117.277 8.034 117.632 7.857 
ARG 57 123.091 8.74 123.152 8.693 123.164 8.764 
PHE 59 112.293 7.908 112.122 7.919 112.297 7.849 
GLN 60 115.439 7.085 115.702 7.063 115.667 7.14 
SER 61 110.647 7.447 110.508 7.442 110.443 7.437 
ILE 62 122.993 9.19     
ILE 63 118.844 7.593 118.934 7.591 119.189 7.601 
HIS 64       
ALA 65 123.477 8.612   123.611 8.569 
LYS 66 118.165 7.833 117.974 7.851 118.008 7.875 
ARG 67 119.22 7.471 119.483 7.526   
THR 68 119.927 8.412     
TYR 69 121.338 7.571   121.435 7.644 
ARG 70       
GLU 71       
LEU 72       
ARG 73       
LEU 74       
LEU 75       
LYS 76       
HIS 77       
MET 78       
LYS 79 128.668 8.512 128.335 8.552 128.318 8.492 
HIS 80 123.931 8.733 124.63 8.705 123.785 8.59 
GLU 81 125.494 8.064 124.722 8.043 124.828 7.998 
ASN 82       
VAL 83 119.91 7.697 119.894 7.61 120.532 7.618 
ILE 84 129.474 8.373   128.709 8.191 
GLY 85 109.526 7.626   108.822 7.679 
LEU 86 121.03 8.215   120.583 8.746 
LEU 87 126.536 8.973   125.259 9.042 
VAL 89 120.227 7.834 120.607 7.701   
PHE 90     119.532 8.209 
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
THR 91 113.454 8.956 113.402 8.932 113.675 8.945 
ALA 93 122.263 7.718 122.214 7.651 122.313 7.73 
ARG 94 121.039 9.277 121.293 9.302 121.038 9.28 
SER 95 111.301 7.38 111.223 7.383 111.201 7.369 
LEU 96 122.401 8.483 122.396 8.49 122.188 8.45 
GLU 97 117.302 8.307 117.329 8.312 117.058 8.269 
GLU 98 115.345 7.026 115.289 7.021 115.32 7.024 
PHE 99 122.113 7.295 122.13 7.295 122.1 7.255 
ASN 100 125.522 8.547 125.523 8.651 126.114 8.779 
ASP 101 115.874 7.624 115.7 7.55   
VAL 102 121.129 8.482 121.123 8.514 120.719 8.217 
TYR 103       
LEU 104       
VAL 105     120.942 7.65 
THR 106 117.977 9.012     
HIS 107 119.39 8.936     
LEU 108 125.256 8.191   124.729 7.927 
MET 109 126.102 8.725   127.141 8.252 
GLY 110 108.737 8.145   106.425 7.886 
ALA 111 123.81 7.879   123.316 8.072 
ASP 112 118.501 7.997 118.67 7.967 117.039 7.951 
LEU 113 117.325 7.788 116.986 7.85 117.977 7.594 
ASN 114 115.536 7.661 116.593 7.703 114.787 7.605 
ASN 115 118.176 7.978 117.858 8.043 118.127 7.937 
ILE 116 118.784 7.502   119.116 7.477 
VAL 117 116.521 7.522 116.33 7.48 116.284 7.509 
LYS 118 117.318 7.381 117.566 7.408 117.288 7.389 
CYS 119 114.474 7.643 114.476 7.644 114.348 7.646 
GLN 120 119.531 8.017 119.426 8.04 119.455 8 
LYS 121 121.843 8.244 121.903 8.259 121.769 8.228 
LEU 122 126.679 8.541 126.585 8.526 126.587 8.528 
THR 123       
ASP 124 120.653 8.982 120.768 8.981 120.59 8.977 
ASP 125 115.381 7.945 115.321 7.949 115.49 7.921 
HIS 126 119.303 7.518 119.397 7.529 119.149 7.504 
VAL 127 119.977 8.137 119.952 8.122 119.894 8.134 
GLN 128 118.193 8.402 118.197 8.409 118.188 8.391 
PHE 129 116.182 7.438 116.095 7.416 116.276 7.457 
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
LEU 130 120.656 8.798 120.389 8.735 120.837 8.855 
ILE 131       
TYR 132     119.654 8.963 
GLN 133 116.504 8.584     
ILE 134       
LEU 135       
ARG 136       
GLY 137 107.104 8.129 107.212 8.086 107.186 8.205 
LEU 138 121.555 8.687 121.4 8.65 121.67 8.677 
LYS 139 119.271 8.688 119.13 8.681 119.264 8.674 
TYR 140 118.11 6.818 117.981 6.846 118.097 6.821 
ILE 141 120.179 8.454   120.475 8.51 
HIS 142 119.585 9.508 120.64 9.539 119.431 9.538 
SER 143 116.368 7.858 115.812 7.859 116.046 7.833 
ALA 144 126.304 7.421 126.28 7.418 126.47 7.457 
ASP 145 115.198 8.207 115.317 8.204 115.194 8.219 
ILE 146 119.057 7.246 119.359 7.323 119.479 7.233 
ILE 147 122.947 7.852   123.674 7.858 
HIS 148 120.813 7.367 120.853 7.368 120.971 7.348 
ARG 149       
ASP 150       
LEU 151       
LYS 152       
SER 154 106.09 7.557     
ASN 155 118.95 7.802 119.286 7.829 120.56 7.679 
LEU 156 119.092 7.048 119.11 6.865 117.908 7.166 
ALA 157 125.766 8.598   127.602 8.818 
VAL 158 117.957 8.169 118.031 7.729 119.547 8.731 
ASN 159 122.259 7.895 121.358 7.852 123 8.134 
GLU 160 117.466 8.852 118.071 8.918 117.663 8.883 
ASP 161 118.659 7.519 118.532 7.567 118.834 7.56 
CYS 162 111.265 8.298 111.752 8.273 110.715 8.325 
GLU 163 117.644 7.669 117.766 7.562 118.432 7.654 
LEU 164 125.257 7.981 124.189 7.854 124.195 7.852 
LYS 165 122.692 8.984   122.217 9.111 
ILE 166 121.863 8.215   121.278 8.089 
LEU 167 125.152 8.484   124.088 8.406 
ASP 168       
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
PHE 169       
GLY 170     109.818 8.078 
LEU 171       
ALA 172 119.232 8.09 119.209 8.102 119.59 8.071 
ARG 173 116.995 8.424 117.027 8.426 120.797 8.04 
HIS 174       
THR 175 115.494 7.321     
ASP 177 119.989 8.092 119.984 8.099   
GLU 178 120.433 8.124 120.481 8.127   
MET 179 119.823 8.149 119.855 8.139   
THR 180 113.886 7.94 113.724 7.934   
GLY 181 111.201 8.211 111.488 8.224   
TYR 182 120.786 7.87 120.835 7.896 121.001 7.888 
VAL 183 123.125 7.811   123.169 7.736 
ALA 184       
THR 185       
ARG 186       
TRP 187       
TYR 188       
ARG 189 122.419 7.35 122.443 7.344 122.35 7.358 
ALA 190 126.08 8.853 125.567 8.972 126.131 8.866 
GLU 192       
ILE 193       
MET 194       
LEU 195 126.488 9.212 126.274 9.215 126.498 9.219 
ASN 196 115.24 7.893 115.178 7.881 115.31 7.902 
TRP 197 125.08 8.582 124.895 8.536 124.959 8.6 
MET 198 120.129 8.691 119.923 8.682 120.061 8.703 
HIS 199 115.068 7.207     
TYR 200 126.788 10.114 126.883 10.089 127.289 10.315 
ASN 201 124.787 8.78     
GLN 202 118.48 7.218   118.729 7.243 
THR 203 115.388 8.358 115.477 8.367 115.376 8.355 
VAL 204       
ASP 205       
ILE 206 119.19 7.285 119.364 7.331 119.332 7.286 
TRP 207 120.778 7.519 120.904 7.503 120.948 7.53 
SER 208 112.511 7.593 112.542 7.556 112.354 7.568 
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
VAL 209 119.838 8.009 119.874 8.005 120.023 7.987 
GLY 210 110.176 8.512 110.345 8.532 110.141 8.492 
CYS 211 119.201 7.89 119.309 7.885 119.126 7.861 
ILE 212 124.145 8.44 124.25 8.454 123.827 8.406 
MET 213 120.463 9.306 120.626 9.331 120.283 9.275 
ALA 214 118.375 8.158 118.461 8.137 118.348 8.173 
GLU 215 119.669 7.12 120.058 7.126 119.373 7.081 
LEU 216 116.304 7.283 116.367 7.285 116.291 7.281 
LEU 217 118.32 8.508 118.353 8.506 118.27 8.509 
THR 218 105.961 7.964 105.98 7.956 105.954 7.96 
GLY 219 112.584 8.416 112.876 8.491 112.431 8.375 
ARG 220 119.037 8.02 119.19 8.035 119.038 8.02 
THR 221 119.842 7.954 119.957 7.956 119.816 7.953 
LEU 222 117.789 7.86 117.855 7.864 118.163 7.876 
PHE 223       
GLY 225 113.546 8.357 113.597 8.36 113.623 8.357 
THR 226 116.615 10.123 116.648 10.126 116.665 10.127 
ASP 227 130.629 8.648 130.72 8.667 130.565 8.6 
HIS 228 114.214 8.574 114.22 8.562 114.261 8.581 
ILE 229       
ASP 230       
GLN 231       
LEU 232       
LYS 233       
LEU 234       
ILE 235       
LEU 236       
ARG 237 117.316 8.243     
LEU 238 117.728 7.627 117.736 7.62 117.806 7.608 
VAL 239   107.743 8.229 107.672 8.214 
GLY 240 113.142 8.152   113.12 8.156 
THR 241       
GLY 243 108.622 8.309 108.62 8.315 108.684 8.303 
ALA 244 121.283 8.377 121.388 8.383 121.46 8.376 
GLU 245 116.35 8.608 116.262 8.611 116.349 8.563 
LEU 246 120.434 7.485 120.512 7.487 120.407 7.477 
LEU 247 118.013 7.874 117.952 7.875   
LYS 248       
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
LYS 249   120.51 7.498   
ILE 250       
SER 251       
SER 252       
GLU 253       
SER 254 114.114 8.364     
ALA 255 125.676 7.714 125.665 7.722 125.685 7.705 
ARG 256   125.497 9.23   
ASN 257       
TYR 258       
ILE 259       
GLN 260 118.107 8.1 118.128 8.119 118.039 8.096 
SER 261 113.882 7.44 113.883 7.443 113.92 7.431 
LEU 262       
THR 263       
GLN 264 126.745 8.541     
MET 265 124.211 8.694 124.315 8.703 124.215 8.694 
LYS 267 120.372 8.285 120.409 8.291 120.37 8.282 
MET 268 125.976 8.414 126.054 8.422 126.001 8.412 
ASN 269 120.256 8.569 120.319 8.586 120.275 8.582 
PHE 270 129.885 9.409 129.916 9.407 129.898 9.407 
ALA 271 122.277 8.552 122.354 8.554 122.255 8.546 
ASN 272 112.993 7.46 113.06 7.463 112.965 7.453 
VAL 273 119.975 7.212 120.02 7.209 119.97 7.212 
PHE 274 120.691 7.625 120.751 7.619 120.94 7.624 
ILE 275 120.838 6.887 120.88 6.891 120.834 6.881 
GLY 276 116.263 9.018 116.318 9.023 116.242 9.012 
ALA 277 121.912 7.399 121.945 7.404 121.918 7.399 
ASN 278 122.458 9.113 122.548 9.131 122.384 9.081 
LEU 280 117.062 8.435 117.092 8.443 117.049 8.429 
ALA 281 120.965 7.103 121.078 7.108 120.948 7.1 
VAL 282 116.308 7.088 116.316 7.078 116.33 7.083 
ASP 283 117.832 7.486 117.869 7.495 117.854 7.474 
LEU 284 117.513 7.112 117.604 7.119 117.515 7.114 
LEU 285 120.246 8.284     
GLU 286 117.418 7.968 117.269 8.009   
LYS 287 116.211 7.335 116.311 7.34 116.178 7.332 
MET 288 118.262 7.569     
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
LEU 289 118.914 7.841 118.849 7.881   
VAL 290       
LEU 291       
ASP 292       
SER 293       
ASP 294 120.913 8.458 121.06 8.484 120.984 8.479 
LYS 295 117.429 7.636 117.551 7.622 117.4 7.651 
ARG 296 122.422 7.056 122.824 7.075 122.423 7.048 
ILE 297 125.032 7.09 124.98 7.006 124.881 7.059 
THR 298 109.389 7.397 109.115 7.405 109.161 7.382 
ALA 299 122.038 9.498 121.949 9.464 122.028 9.499 
ALA 300 116.107 8.619 116.183 8.603 116.098 8.617 
GLN 301 115.832 7.424 115.913 7.413 115.795 7.408 
ALA 302 123.728 8.673 123.778 8.668 123.708 8.657 
LEU 303 116.442 7.648 116.432 7.663 116.52 7.657 
ALA 304 114.765 6.555 114.829 6.569 114.672 6.543 
HIS 305 122.693 7.964 122.741 7.968 122.692 7.964 
ALA 306 132.636 8.343 132.623 8.331 132.694 8.345 
TYR 307       
PHE 308 110.39 7.669 110.48 7.671 110.404 7.678 
ALA 309 123.434 7.522 123.444 7.517 123.477 7.523 
GLN 310 114.006 8.671 114.046 8.663 113.966 8.674 
TYR 311 115.987 7.513 116.14 7.509 115.939 7.501 
HIS 312 115.898 7.811 116.098 7.807 115.832 7.82 
ASP 313 125.029 7.584 125.084 7.545 124.931 7.526 
ASP 315 117.274 7.944 117.485 7.975 117.222 7.94 
ASP 316 121.2 8.037 121.24 8.025 121.304 8.037 
GLU 317 121.456 7.766 121.739 7.831 121.602 7.801 
VAL 319 109.141 7.868 109.396 7.878 108.796 7.854 
ALA 320 123.478 8.441 123.665 8.415 123.49 8.506 
ASP 321 120.91 8.099 120.923 8.107 120.988 8.075 
TYR 323       
ASP 324 122.845 6.964 122.91 6.973 122.862 6.962 
GLN 325       
GLU 328 114.81 9.912 114.933 9.964 114.549 9.865 
SER 329 111.832 7.436 112.175 7.477 111.769 7.442 
ARG 330 121.792 7.607 121.805 7.597 121.864 7.615 
ASP 331 124.703 8.589 124.532 8.589 124.58 8.586 
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 Apo SB203580-Bound BIRB796-Bound 
Residue 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 15N (ppm) 1H (ppm) 
LEU 332 123.015 7.835 123.152 7.844 123.085 7.829 
LEU 333 119.762 8.782 119.914 8.803 119.849 8.792 
ILE 334 121.681 8.979 121.748 8.995 121.766 8.989 
ASP 335 115.76 8.401 116.058 8.383 115.745 8.386 
GLU 336 120.419 7.103 120.544 7.125 120.447 7.117 
TRP 337 119.669 7.698 119.619 7.707 119.479 7.71 
LYS 338 121.384 8.764 121.313 8.772 121.407 8.756 
SER 339 114.455 7.62 114.463 7.624 114.506 7.62 
LEU 340 120.293 7.927 120.457 7.933 120.159 7.984 
TYR 342 124.711 8.818 125.008 8.85 124.905 8.809 
ASP 343 117.23 8.086 117.383 8.08 117.402 8.101 
GLU 344 118.192 7.491 118.233 7.508 118.007 7.503 
VAL 345 121.141 8.082 121.36 8.083 121.326 8.04 
ILE 346 114.434 8.105 114.769 8.135 115.087 8.098 
SER 347 113.182 7.397 113.153 7.43 112.795 7.418 
PHE 348 124.884 7.283 124.914 7.314 124.961 7.308 
VAL 349 130.056 6.901 130.008 6.943 130.262 6.938 
 
 
Table D-2: ILV methyl assignments of p38α in the apo and inhibitor-bound states 
 
 Apo SB203580-Bound BIRB796-Bound 
ID 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 
LEU13CD1 23.109 0.142 22.858 0.165 22.732 0.243 
LEU13CD2 21.266 0.584 21.342 0.573 21.544 0.553 
ILE17CD 7.866 0.624 7.904 0.622 7.999 0.617 
VAL20CG1 16.672 0.555 16.472 0.54 16.473 0.515 
VAL20CG2 18.811 0.8 18.861 0.794 18.859 0.749 
LEU27CD1 21.749 0.453 21.337 0.384 21.285 0.403 
LEU27CD2 21.747 0.594 21.656 0.557 21.702 0.559 
VAL30CG1 18.544 0.814 17.819 0.817 18.655 0.916 
VAL30CG2 17.878 0.736 18.725 0.981   
VAL38CG1 18.865 0.746 19.26 0.501 18.299 0.797 
VAL38CG2 18.54 0.687   18.585 0.676 
LEU48CD1 22.003 0.698 22.202 0.768 22.262 0.73 
LEU48CD2 19.698 0.789 19.635 0.88 20.489 0.921 
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 Apo SB203580-Bound BIRB796-Bound 
ID 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 
VAL50CG1 19.455 0.641 18.885 0.585 19.286 0.63 
VAL50CG2 15.642 0.512 15.527 0.491 15.652 0.5 
VAL52CG1 19.586 0.958 19.428 0.964 19.718 0.953 
VAL52CG2 17.503 0.415 17.028 0.4 17.001 0.443 
LEU55CD1 22.883 0.674 22.636 0.647 22.446 0.573 
LEU55CD2 19.99 0.638 19.938 0.605   
ILE62CD 10.951 1.135 10.839 1.151 10.857 1.149 
ILE63CD 9.544 0.728 9.529 0.731 9.461 0.751 
LEU72CD1 24.735 0.783 24.623 0.821 21.824 0.769 
LEU72CD2 22.26 0.767 21.987 0.833 25.706 0.807 
LEU74CD1 22.307 0.501 22.216 0.512 22.834 0.52 
LEU74CD2 21.823 0.316   23.155 0.641 
LEU75CD1 23.788 0.737 24.27 1.006 24.553 0.858 
LEU75CD2 20.372 0.721 20.719 0.954 22.034 0.664 
VAL83CG1 19.563 1.002 19.533 0.997 19.064 1.135 
VAL83CG2 18.818 0.609 18.922 0.605 18.992 0.669 
ILE84CD 11.498 0.992 12.837 0.719 10.783 -0.602 
LEU86CD1 21.535 0.774 21.461 0.696 21.939 0.691 
LEU86CD2 23.204 0.483 23.12 0.612 22.44 0.799 
LEU87CD1 22.291 0.358 21.978 0.17 22.196 0.316 
LEU87CD2 19.868 0.572 19.865 0.614 20.618 0.549 
VAL89CG1 16.909 0.581 17.399 0.644 17.999 0.622 
VAL89CG2 20.191 0.822 20.396 0.752 20.662 0.619 
LEU96CD1 20.177 0.521 20.083 0.534 20.134 0.517 
LEU96CD2 22.449 0.684 22.341 0.695 22.412 0.683 
VAL102CG1 18.159 0.647 18.258 0.667 18.372 0.641 
VAL102CG2 19.658 0.823 19.198 0.84 19.706 0.823 
LEU104CD1 22.939 0.619   22.895 0.617 
LEU104CD2 21.553 0.621   21.4 0.655 
VAL105CG1 18.044 0.734 17.694 0.772 18.107 0.595 
VAL105CG2 18.194 0.58 18.484 0.654   
LEU108CD1 20.328 0.778 24.039 0.9 23.504 0.732 
LEU108CD2       
LEU113CD1 21.7 0.706 24.275 0.529 22.168 0.463 
LEU113CD2 22.919 0.591 24.812 0.486 22.955 0.416 
ILE116CD 8.787 0.569 9.064 0.569 8.696 0.575 
VAL117CG1 18.494 0.872 18.363 0.883 18.475 0.865 
VAL117CG2 19.251 0.892 19.317 0.897 19.095 0.882 
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 Apo SB203580-Bound BIRB796-Bound 
ID 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 
LEU122CD1 23.854 0.705 23.707 0.707 23.84 0.707 
LEU122CD2 19.94 0.479 20.051 0.496 19.887 0.473 
VAL127CG1 19.612 1 19.543 0.998 20.742 0.928 
VAL127CG2 20.805 0.922 20.684 0.917 19.573 1.003 
LEU130CD1 23.823 0.668 23.4 0.705 23.943 0.682 
LEU130CD2 21.459 0.612 22.074 0.64 21.557 0.625 
ILE131CD 5.619 0.447 5.575 0.435 5.63 0.454 
ILE134CD 11.611 0.514 11.497 0.486 11.429 0.522 
LEU135CD1 25.862 0.538 25.739 0.539 25.899 0.547 
LEU135CD2 19.346 0.627 19.305 0.61 19.897 0.644 
LEU138CD1 24.037 0.497 24.03 0.489 23.928 0.515 
LEU138CD2 18.905 0.517 18.801 0.527 18.983 0.563 
ILE141CD 11.51 0.574   11.736 0.784 
ILE146CD 10.091 0.394 10.067 0.489 10.061 0.502 
ILE147CD 10.169 0.726 10.544 0.729 10.29 0.71 
LEU151CD1 22.203 0.428     
LEU151CD2 22.744 0.319 22.641 0.734   
LEU156CD1 25.084 0.543   25.005 0.563 
LEU156CD2 23.212 0.676 20.996 0.312 22.842 0.688 
VAL158CG1 17.911 0.529 17.619 0.436 18.134 0.537 
VAL158CG2 19.389 0.694 19.206 0.606 19.196 0.755 
LEU164CD1 24.203 0.581 23.242 0.593 23.972 0.594 
LEU164CD2 21.434 0.377 21.8 0.389 21.522 0.382 
ILE166CD 11.216 0.69 10.764 0.621 11.721 0.742 
LEU167CD1 21.538 0.715 18.8 0.756 24.578 0.311 
LEU167CD2 22.807 0.754 21.461 0.696 20.542 0.513 
LEU171CD1 22.295 0.537 22.492 0.385 23.611 0.837 
LEU171CD2       
VAL183CG1 18.241 0.705 18.142 0.742 18.264 0.686 
VAL183CG2 17.74 0.736   17.732 0.709 
ILE193CD 8.802 0.366 8.709 0.401 8.727 0.354 
LEU195CD1 20.075 0.739 19.939 0.748 20.03 0.749 
LEU195CD2 22.076 0.84   22.134 0.857 
ILE202CD       
VAL204CG1 19.746 1.185 19.762 1.196 19.823 1.175 
VAL204CG2 16.963 1.074 16.996 1.078 17.022 1.057 
ILE206CD 5.284 0.499 5.317 0.499 5.366 0.503 
VAL209CG1 22.11 0.865 22.139 0.87 22.128 0.889 
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 Apo SB203580-Bound BIRB796-Bound 
ID 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 
VAL209CG2 20.25 0.723 19.947 0.716 20.158 0.748 
ILE212CD 10.2 0.175 9.998 0.138 10.206 0.205 
LEU216CD1 19.888 0.847 19.877 0.851 19.832 0.847 
LEU216CD2 23.542 0.411 23.434 0.411 23.519 0.412 
LEU217CD1 23.319 0.723 23.406 0.737 23.466 0.717 
LEU217CD2       
LEU222CD1 25.621 0.131 25.493 0.14 25.594 0.127 
LEU222CD2 18.937 0.331 18.837 0.337 18.929 0.331 
ILE229CD 7.743 0.443 7.698 0.449 7.71 0.436 
LEU232CD1   22.818 0.623   
LEU232CD2       
ILE235CD 11.087 0.487 10.964 0.5 11.034 0.49 
LEU236CD1 23.481 0.731     
LEU236CD2 20.021 0.701 19.986 0.698 19.937 0.715 
LEU238CD1 21.054 0.504 20.965 0.507 21.028 0.503 
LEU238CD2 23.648 0.638 23.581 0.641 23.602 0.639 
VAL239CG1 19.563 1.332 19.468 1.344 19.533 1.334 
VAL239CG2 16.772 1.181 16.629 1.189 16.764 1.189 
LEU246CD1     22.764 0.74 
LEU246CD2       
LEU247CD1 20.771 0.79 20.69 0.792 20.758 0.799 
LEU247CD2       
ILE250CD       
ILE259CD 10.102 0.682 10.01 0.705 10.181 0.672 
LEU262CD1 22.063 0.675 21.984 0.69 21.989 0.657 
LEU262CD2 20.895 0.623 20.792 0.64 20.805 0.619 
VAL273CG1 16.801 -0.26 16.694 -0.254 16.784 -0.257 
VAL273CG2 18.507 0.574 18.422 0.582 18.487 0.579 
ILE275CD 9.606 0.759 9.502 0.766 9.568 0.76 
LEU280CD1 22.739 0.858 22.649 0.864 22.718 0.861 
LEU280CD2 19.845 0.795 19.765 0.8 19.821 0.8 
VAL282CG1 19.93 0.895 19.846 0.901 19.903 0.898 
VAL282CG2 20.888 0.863 20.773 0.868 20.845 0.866 
LEU284CD1 20.045 0.572 19.844 0.581 20.017 0.584 
LEU284CD2 25.182 0.579 25.167 0.58 25.194 0.586 
LEU285CD1 21.613 -0.19 21.492 -0.195 21.579 -0.187 
LEU285CD2 21.899 0.432 21.789 0.441 21.879 0.434 
LEU289CD1 23.71 0.399 23.6 0.41 23.728 0.4 
156	  
	  
 Apo SB203580-Bound BIRB796-Bound 
ID 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 13C (ppm) 1H (ppm) 
LEU289CD2 19.108 -0.377 18.999 -0.374 19.056 -0.378 
VAL290CG1 18.001 0.812 18.035 0.816 17.98 0.816 
VAL290CG2 19.202 0.978 19.035 0.984 19.177 0.982 
LEU291CD1       
LEU291CD2 21.268 0.682 21.04 0.682 21.246 0.696 
ILE297CD 11.067 0.708 11.025 0.705 11.097 0.705 
LEU303CD1 24.062 0.583 23.88 0.574 24.134 0.598 
LEU303CD2 22.529 0.302 22.463 0.287 22.556 0.303 
VAL319CG1 19.716 0.966 19.599 0.97 19.752 0.978 
VAL319CG2 14.74 0.826 14.709 0.831 14.664 0.83 
LEU332CD1 21.163 -0.829 21.117 -0.804 21.162 -0.823 
LEU332CD2 19.193 0.342 19.123 0.349 19.192 0.342 
LEU333CD1 22.495 0.822 22.389 0.834 22.476 0.826 
LEU333CD2 19.291 0.83 19.439 0.822 19.281 0.834 
ILE334CD 11.047 0.823 10.938 0.823 11.04 0.822 
LEU340CD1 22.726 0.124 22.716 0.142 22.706 0.153 
LEU340CD2 20.046 0.563 19.935 0.616 20.322 0.525 
VAL345CG1 18.693 0.804 18.507 0.811   
VAL345CG2 20.198 1.009 20.129 1.027 20.442 1.001 
ILE346CD 9.709 0.448 9.503 0.456 9.361 0.439 
VAL349CG1 17.549 0.746 17.494 0.773 17.552 0.758 
VAL349CG2 18.611 0.756 18.52 0.782 18.558 0.767 
 
 
Table D-3: ILV Methyl Order Parameters of p38α in the apo and inhibitor-bound states 
Residues which are spectrally resolved but not assigned are appended to the end of this table. 
They were included in the calculation of <O2axis> for the entropy meter. 
 
ID Apo SB203580-Bound BIRB796-Bound 
 O2axis O2axis O2axis 
LEU13CD1 0.441±0.005 0.391±0.012 0.345±0.046 
LEU13CD2 0.323±0.016 0.287±0.013  
ILE17CD 0.162±0.051 0.171±0.056 0.158±0.052 
VAL20CG1 0.56±0.021 0.622±0.01 0.762±0.03 
VAL20CG2  0.734±0.018  
LEU27CD1 0.293±0.002 0.317±0.035 0.289±0.018 
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ID Apo SB203580-Bound BIRB796-Bound 
 O2axis O2axis O2axis 
LEU27CD2 0.339±0.031 0.241±0.001  
VAL30CG1 0.317±0.012  0.385±0.035 
VAL30CG2  0.576±0.011  
VAL38CG1  0.857±0.045 0.79±0.031 
VAL38CG2 0.572±0.025   
LEU48CD1 0.552±0.001 0.65±0.026  
LEU48CD2 0.473±0.009 0.574±0.012 0.638±0.035 
VAL50CG1    
VAL50CG2 0.784±0.04 0.832±0.016 0.818±0.025 
VAL52CG1    
VAL52CG2 0.768±0.043 0.776±0.02 0.77±0.01 
LEU55CD1 0.506±0.015 0.522±0.024 0.383±0.005 
LEU55CD2    
ILE62CD 0.281±0.011 0.333±0.035 0.251±0.01 
ILE63CD 0.162±0.051 0.231±0.037  
LEU72CD1 0.381±0.028  0.489±0.029 
LEU72CD2 0.451±0.016 0.51±0.013 0.437±0.005 
LEU74CD1 0.806±0.022 0.784±0.022 0.596±0.007 
LEU74CD2 0.702±0.01  0.325±0.038 
LEU75CD1  0.816±0.03 0.734±0.022 
LEU75CD2  0.877±0.048  
VAL83CG1   0.971±0.031 
VAL83CG2 0.792±0.016  0.83±0.017 
ILE84CD 0.556±0.005  0.738±0.038 
LEU86CD1 0.522±0.011 0.524±0.014  
LEU86CD2 0.61±0.026 0.411±0.027 0.558±0.025 
LEU87CD1 0.469±0.002 0.487±0.005 0.443±0.005 
LEU87CD2 0.546±0.027  0.463±0.005 
VAL89CG1 0.548±0.016 0.526±0.02 0.357±0.01 
VAL89CG2 0.5±0.033 0.369±0.03 0.349±0.032 
LEU96CD1 0.616±0.025 0.586±0.023 0.622±0.023 
LEU96CD2 0.604±0.021 0.586±0.021 0.58±0.017 
VAL102CG1 0.395±0.012 0.425±0.002 0.415±0.013 
VAL102CG2 0.417±0.016 0.485±0.007 0.562±0.013 
LEU104CD1 0.514±0.006  0.491±0.007 
LEU104CD2   0.648±0.004 
VAL105CG1    
VAL105CG2 0.849±0.035 0.425±0.016  
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ID Apo SB203580-Bound BIRB796-Bound 
 O2axis O2axis O2axis 
LEU108CD1 0.421±0.022 0.81±0.025 0.696±0.037 
LEU108CD2    
LEU113CD1  0.901±0.035 0.427±0.017 
LEU113CD2 0.598±0.01 0.889±0.033 0.425±0.019 
ILE116CD 0.231±0.031 0.219±0.012 0.303±0.017 
VAL117CG1 0.313±0.018 0.269±0.012 0.333±0.036 
VAL117CG2 0.371±0.044 0.413±0.028 0.427±0.037 
LEU122CD1 0.469±0.011 0.385±0.034 0.487±0.043 
LEU122CD2  0.465±0.046  
VAL127CG1 0.83±0.043  0.895±0.055 
VAL127CG2  0.774±0.025 0.865±0.026 
LEU130CD1 0.786±0.021 0.636±0.017 0.461±0.03 
LEU130CD2  0.291±0.028 0.648±0.004 
ILE131CD 0.616±0.031 0.642±0.032 0.626±0.028 
ILE134CD    
LEU135CD1 0.959±0.036 0.889±0.026 0.961±0.053 
LEU135CD2    
LEU138CD1 0.965±0.061 0.997±0.029 0.917±0.024 
LEU138CD2 0.58±0.029 0.552±0.017 0.612±0.011 
ILE141CD   0.686±0.023 
ILE146CD   0.269±0.034 
ILE147CD   0.662±0.033 
LEU151CD1 0.766±0.032  0.887±0.021 
LEU151CD2  0.604±0.028  
LEU156CD1 0.832±0.009  0.818±0.024 
LEU156CD2 0.764±0.025 0.724±0.021 0.73±0.02 
VAL158CG1 0.339±0.065  0.411±0.058 
VAL158CG2 0.399±0.014 0.315±0.051 0.419±0.026 
LEU164CD1  0.65±0.032  
LEU164CD2 0.67±0.029  0.343±0.064 
ILE166CD    
LEU167CD1 0.467±0.014 0.518±0.015 0.516±0.038 
LEU167CD2  0.997±0.05  
LEU171CD1 0.812±0.025   
LEU171CD2   0.766±0.016 
VAL183CG1 0.361±0.033 0.409±0.036 0.419±0.055 
VAL183CG2   0.413±0.046 
ILE193CD    
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ID Apo SB203580-Bound BIRB796-Bound 
 O2axis O2axis O2axis 
LEU195CD1 0.814±0.022   
LEU195CD2  0.714±0.008  
ILE202CD    
VAL204CG1 0.997±0.064 0.997±0.049 0.997±0.068 
VAL204CG2    
ILE206CD 0.425±0.002  0.489±0.014 
VAL209CG1  0±0.006  
VAL209CG2    
ILE212CD 0.794±0.013 0.798±0.016 0.786±0.038 
LEU216CD1 0.524±0.02 0.558±0.026 0.584±0.012 
LEU216CD2   0.688±0.01 
LEU217CD1  0.732±0.012 0.688±0.031 
LEU217CD2    
LEU222CD1 0.837±0.051 0.826±0.016 0.863±0.051 
LEU222CD2 0.65±0.018 0.764±0.029 0.702±0.028 
ILE229CD 0.415±0.047 0.441±0.019 0.429±0.034 
LEU232CD1  0.614±0.014  
LEU232CD2    
ILE235CD    
LEU236CD1    
LEU236CD2 0.778±0.021  0.62±0.029 
LEU238CD1 0.64±0.029 0.678±0.027 0.658±0.019 
LEU238CD2 0.808±0.031 0.889±0.027 0.837±0.022 
VAL239CG1 0.865±0.009 0.863±0.023 0.857±0.014 
VAL239CG2 0.76±0.019 0.708±0.028 0.784±0.021 
LEU246CD1   0.596±0.017 
LEU246CD2   0.497±0.024 
LEU247CD1 0.512±0.035 0.371±0.025  
LEU247CD2    
ILE250CD    
ILE259CD 0.437±0.003 0.423±0.001  
LEU262CD1  0.584±0.03  
LEU262CD2 0.361±0.026 0.389±0.008  
VAL273CG1 0.674±0.028 0.65±0.014 0.702±0.012 
VAL273CG2 0.758±0.014 0.75±0.017 0.732±0.011 
ILE275CD 0.164±0.059 0.124±0.083  
LEU280CD1 0.612±0.021 0.6±0.01 0.628±0.018 
LEU280CD2 0.473±0.035 0.445±0.032 0.508±0.039 
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ID Apo SB203580-Bound BIRB796-Bound 
 O2axis O2axis O2axis 
VAL282CG1 0.788±0.041 0.61±0.019 0.788±0.028 
VAL282CG2 0.746±0.013 0.718±0.023 0.8±0.025 
LEU284CD1    
LEU284CD2 0.835±0.03 0.837±0.033 0.843±0.028 
LEU285CD1 0.558±0.024 0.55±0.019 0.572±0.019 
LEU285CD2  0.554±0.018 0.548±0.029 
LEU289CD1 0.74±0.009 0.704±0.027 0.694±0.021 
LEU289CD2 0.722±0.028  0.738±0.012 
VAL290CG1 0.736±0.013  0.698±0.013 
VAL290CG2 0.323±0.02 0.297±0.035 0.317±0.046 
LEU291CD1    
LEU291CD2 0.808±0.03 0.794±0.019 0.676±0.021 
ILE297CD  0.72±0.02 0.832±0.028 
LEU303CD1  0.804±0.028  
LEU303CD2 0.744±0.023 0.758±0.017 0.744±0.023 
VAL319CG1    
VAL319CG2 0.977±0.033 0.997±0.025 0.917±0.019 
LEU332CD1 0.774±0.016 0.744±0.032 0.79±0.015 
LEU332CD2 0.624±0.014 0.594±0.027 0.61±0.018 
LEU333CD1 0.614±0.018 0.58±0.025 0.604±0.027 
LEU333CD2 0.481±0.019 0.489±0.027 0.495±0.024 
ILE334CD 0.333±0.055 0.265±0.056 0.331±0.05 
LEU340CD1 0.652±0.019 0.6±0.041 0.686±0.013 
LEU340CD2   0.495±0.055 
VAL345CG1    
VAL345CG2 0.845±0.02 0.893±0.039 0.853±0.022 
ILE346CD 0.391±0.038 0.419±0.013 0.379±0.041 
VAL349CG1 0.07±0.062 0.058±0.047 0.05±0.059 
VAL349CG2 0.092±0.046 0.064±0 0.06±0.049 
UNASS 0.508±0.028 0.542±0.014 0.461±0.011 
UNASS 0.997±0.044  0.656±0.004 
UNASS   0.5±0.042 
UNASS   0.853±0.046 
UNASS   0.351±0.033 
UNASS   0.51±0.006 
UNASS   0.632±0.035 
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